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The potential of the filamentous fungus Aspergillus fumigatus to act
as an opportunistic pathogen may be related to its ability to resist
the host defence network. Whilst phagocytic cells are clearly
important in host defences against invading microorganisms their
precise role in the killing of A. fumigatus remains undefined.
The purpose of this study was to examine the basic interactions
between phagocytic cells, from humans and rodents, with spores of
A. fumigatus. In particular the mechanisms whereby phagocytic cells
bind and kill spores of A. fumigatus, when compared with the
relatively non-pathogenic fungus Penicillium ochrochloron were
investigated.
In order to investigate why people with asthma may develop some
hypersensitivity reactions to A. fumigatus, in particular, rather
than to the many other fungi in the atmosphere, the possibility that
there may be a defect in the handling of the fungus by such patients
has been tested. A comparison of the fungal handling by phagocytes
from asthmatic patients, both sensitised and unsensitised to
A. fumigatus with phagocytes from non-asthmatic subjects has been
made.
The principal findings from this study are that spores of
A. fumigatus bind to the surface of the phagocytic cell yet are
relatively resistant to phagocytosis. The spores also fail to
trigger the phagocytic cells into releasing the potentially
(ii)
microbicidal reactive oxygen intermediates. These results may be
related to a further finding which is that spores of A. fumigatus
release a low molecular weight substance (diffusate) which interferes
with various aspects of phagocytic cell activation. Spore
diffusates were shown to inhibit the phagocytosis of radiolabelled
antibody-coated sheep red blood cells and to suppress the spontaneous
release of reactive oxygen intermediates by Corynebacterium parvum
stimulated mouse peritoneal exudate cells. In addition spores
diffusates inhibited the ability of phagocytic cells to spread on
glass and reduce the number of phagocytic cells migrating towards a
known chemoattractant.
Studies on spore killing showed that spores of A. fumigatus opsonised
in autologous serum were more resistant to killing by phagocytic
cells from humans and rodents than similarly opsonised spores of P.
ochrochloron. However, the ability of the phagocytic cells to kill
spores of A. fumigatus was substantially increased when the spores
were opsonised in sera which had been heat-treated for 30 minutes at
56°C. No increased killing was found with P. ochrochloron.
People with asthma sensitised to A. fumigatus showed significant
differences in their handling of A. fumigatus in vitro when compared
with the control group. Monocytes from these sensitised patients
killed significantly fewer spores of A. fumigatus (opsonised in auto¬
logous sera) whilst their polymorphonuclear leucocytes killed
significantly more. No such differences were found for P.
ochrochloron.
(iii)
The work reported in this Thesis has given us a clearer understanding
of why Aspergillus fumigatus is an important cause of disease in man,
and how the defence mechanisms that it has evolved in its natural
environment the soil, enable it to act as a saprophyte or parasite in
the lungs of humans and animals. The results also suggest a
mechanism whereby heat-labile serum components may be an advantage to
the survival of the fungus, thus perhaps explaining why it may be a
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1.1 The Genus Aspergillus
Aspergillus fumigatus belongs to the genus Aspergillus, the name given
to this group of fungi by Micheli in 1729 . Micheli noticed a resem¬
blance between the shape of the Aspergillus conidiophore and that of
the aspergillum - a device used to sprinkle holy water over the
congregation at church services (Fig 1.1). The genus Aspergillus,
which belongs to the class of 'Fungi imperfecti' as it reproduces
asexually by means of spores (conidia), comprises essentially sapro¬
phytic organisms which may be isolated from soil, water and decaying
2 3
vegetation throughout the world ' . Spores of Aspergillus have been
recovered from places as diverse as the upper atmosphere, snow in the
2 3
Antarctic and the sand and winds over the Sahara desert ' . Their
ubiquity and capacity to grow on many different substrates under such
a wide range of environmental conditions are obviously extremely
important factors in their potential pathogenicity.
The earliest account of Aspergillus causing disease was written at the
beginning of the 19th century by Mayer and Emmert who described a case
of aspergillosis in the lungs of a jay (Corvus glandularius)^. The
first reports of aspergillosis in humans are usually attributed to
c £
Bennett in 1844^ and Sluyter in 1847 . Bennett noted that the sputa
of a man contained:
'The most beautiful and regular vegetable structures'
-2-
Figure 1.1 A copy of the original illustrations made by Micheli in
1729 of the genus Aspergillus1
Bennett also found similar vegetable matter in the tuberculous
cavities of the lungs of the man at post mortem. In 1856, Virchow
published a report on bronchial and pulmonary fungal disease in four
patients with such an accurate description of the fungus as to allow
7
it to be recognisable, a few years later, as A. fumigatus .
The name Aspergillus fumigatus (Fresen) was given to this fungus in
1863 by Fresenius who described the fungus in samples of human lung
(given to him by Virchow) and in the air sac of the great bustard
O
(Otis tarda) . The association between A. fumigatus and pulmonary
disease was again noted in 1897 in people employed as pigeon
q
fatteners . These people filled their mouths with a mixture of water
and grain, put them over the beaks of the pigeons and transferred the
A
mixture by breathing out. Also in 1897, Renon published a compre¬
hensive review of the field of aspergillosis in man and animals in
which he concluded that the source of Aspergillus in the disease of
1D
pigeon fatteners was mouldy grain .
In 1926 Thorn and Church brought all the materials on the genus
Aspergillus together in a taxonomic monograph 'Manual of the Asper-
11 1 P
gilli' . This was updated by Thorn and Raper in 1945 and again in
13
1965 by Raper and Fennell in 'The Genus Aspergillus' . Out of the
115 recognised species and varieties of aspergilli described by Raper
13
and Fennell the ones which are the most pathogenic to man and
animals are the ones most frequently found in the air and derived
primarily from decaying vegetation, hay, straw or grain, viz.
A. fumigatus, A. flavus, A. nidulans, A. niger, A. terreus A. glaucus
and A. clavatus . However, out of all these species of aspergilli,
—4—
A. fumigatus is the one most commonly associated with disease in both
13
man and animals and is, therefore, the subject of this Thesis.
1.2 Growth and Dispersal of A. fumigatus
Spores of A. fumigatus are spherical and are generally 2.5-3 pm in
diameter. Spores are the reproductive form of the fungi which are
resistant to adverse physical conditions and preserve the species
through periods when the climate is unsuitable for successful germ¬
ination. However, under favourable conditions the spore will absorb
fluid (usually water) and a germ tube (hypha) will emerge. The hypha
elongates to form phialophores with the subsequent production of the
flask-shaped conidiophore from which the unicellular spores (or
conidia) are generated in chains so completing the life cycle (Fig
1.2) ' . The spores are chiefly liberated by bending and breaking
of spore-covered stems and leaves and during the handling or eating of
hay or straw. Their aerodynamic properties aid their dispersal
1A 17
throughout the environment ' . Although the natural habitat of
A. fumigatus is the soil, using decaying organic matter as a source of
food, their ability to grow over a temperature range from below 20°C
up to 50°C enables them to adapt to many different situations'1^.
High levels of A. fumigatus are found in decomposing vegetable matter
such as self-heating hay and compost where there is a plentiful supply
1 o d o 1 q
of food and heat ' ' . An estimation of the airborne spores in a
cow shed during the feeding of animals with hay and straw showed that
the concentration of spores of Aspergillus vastly increased during
20
feeding . Gregory and Lacey found that large numbers of Aspergillus
21
spores were released during the tumbling of hay . Emmons in 1960
-5-
Figure 1.2 Sporing heads of A. fumigatus suspended in lactophenol-
cotton blue
-6-
found that compost made of chopped leaves and branches, during the
course of microbiological self-heating, became a massive and virtually
pure culture of A. fumigatus; he described this work in an article
po
entitled 'the Jekyll-Hydes of mycology' .
There is a seasonal variation in the incidence of spores of
A. fumigatus in the atmosphere which tends to correlate with the
presence of decaying organic matter. Generally spore counts of
A. fumigatus are low, accounting for approximately 6% of the total
fungi present in the air spora, with increased levels occurring during
the winter months^' 19,23-26^
A study by Mullins et_ al_ on the release of A. fumigatus from compost
heaps recorded counts of up to 170,000 spores per gramme of compost in
the centre of a heap. Localised release of spores within one metre
3 3
gave an average air count of 33 spores/m rising to 200/m in early
spring whilst measurements taken 31 m away remained consistently low
3 3
(33/m ). Spore counts, in the immediate vicinity, rose to 527/m
1Q
after the compost was turned over once by a fork . Apart, there¬
fore, from exposure to spores in the general environment, people
working in agriculture and horticulture may be exposed to higher
concentrations in these localised environments.
1.3 Pathogenicity of A. fumigatus
Aspergillus illustrates particularly well the importance of the two
factors in pathogenicity, the inherent properties of the organism and
-7-
the defences of the individual host. Spores of A. fumigatus act as
primary pathogens in many animals, particularly those that feed on
hay, straw and grain. The type of reaction occurring depends to a
large extent on the susceptibility of the host and the prevalence of
spores in the atmosphere. High levels of air-borne spores can cause
27
acute respiratory distress in a number of animals . Heavy losses
have been reported in various species of birds including newly hatched
p P7_ pQ
chicks where the disease is known as 'brooder's pneumonia' ' ' .
Penguins in captivity seem to be particularly vulnerable to
Aspergillus infections^0. Respiratory disease by Aspergillus has
also been found in young lambs^1 and piglets1Zt and can cause mycotic
abortion in cattle . Experimental studies have shown that high
concentrations of A. fumigatus in mouldy straw may cause the death of
adult poultry within 24 hours . Austwick in 1962 conducted a survey
of the frequency of lesions containing A. fumigatus in the lungs of
healthy dairy cows at slaughter and 36/49 of the animals examined
showed evidence of A. fumigatus-related lesions .
Spores of A. fumigatus rarely act as primary pathogens in man.
Instead, they have the unusual ability to manifest themselves in a
33
variety of ways, especially in people with underlying disease . In
common with many other fungi, spores of A. fumigatus can be
17
allergenic ' provoking exacerbations of asthma especially during high
n/: nry OQ
seasonal concentrations of mould sporulation ' '' . Some of these
asthmatic patients go on to develop a hypersensitivity reaction,
3Q
allergic bronchopulmonary aspergillosis while non-asthmatic patients
exposed to very high levels of spores may develop typical allergic
alveolitis^0. Spores may also grow saprophytically within old
-8-
pulmonary cavities to form an aspergilloma^1. Finally, the spore may
act as a true opportunistic pathogen taking advantage of the presence
of local lung disease, such as infarct, tumour, pneumonia or of a
generalised impairment of the host defence network related to leuko¬
penia, leukocyte dysfunction or immunosuppressive therapy, to become
either localised invasive or disseminated disease^.
(i) Allergy: It is important to recognise that there is a
spectrum of allergic responses to the antigenic components of
A. fumigatus. These range from simple skin sensitisation in atopic
individuals to sensitisation with asthmatic symptoms, to asthma plus
occasional episodes of aspergillosis, to persistent aspergillosis with
/ o
progressive lung damage
Atopic subjects exposed to A. fumigatus can develop typical Type I
hypersensitivity reactions®-''^ which can be measured using the skin
prick test. This involves lightly scratching the skin through a
solution of allergen; a positive reaction results in a wheal and flare
AS
forming, usually within 15-20 min . This dermal hyper-reactivity is
caused by antigenic components of A. fumigatus^®'^ binding to IgE
molecules which attach via specific IgE receptors to mast cells and
basophils resulting in the release of mediators and vasoactive amines
and leading to increased vascular permeability, oedema and smooth
muscle contraction^®'^. Although the principal type of antibody in
Type I reactions is IgE, IgG (possibly IgG^ subclass) antibodies are
80 81
sometimes present^ ' .
-9-
Allergic bronchopulmonary aspergillosis usually occurs in asthmatic
individuals, although the first clinical sign of asthma may be an
/ *5
episode of aspergillosis . It may also occur occasionally in the
absence of clinical evidence of asthma, in otherwise healthy people,
52
though most of these will prove to be atopic on skin testing .
Patients with cystic fibrosis are also at risk of developing bronchial
colonisation by Aspergillus and may show evidence of bronchopulmonary
aspergillosis^' .
Allergic bronchopulmonary aspergillosis was first described in 1952 by
")Q
Hinson et al . It characteristically affects patients with chronic
asthma, who develop peripheral blood and pulmonary eosinophilia,
recurring pulmonary shadowing and expectoration of golden brown sputum
plugs containing hyphae of A. fumigatus. Delayed skin test reactions
to intradermal injection of antigen are a common feature. In these
patients, inhaled spores of A. fumigatus having deposited in the
bronchi, germinate and the growth of hyphae, together with an intense
immunological reaction to its presence, results in blockage of the
airways. However, in most cases no invasion of the bronchial wall
55 56
occurs ' . The patient exhibits Type I hypersensitivity with
elevated levels of specific IgE^' and produces precipitating IgG and
IgM antibodies which form immune complexes with A. fumigatus antigens
resulting in Type III hypersensitivity; which occurs when antigen-
antibody complexes in ratios of antigen excess are not immediately
phagocytosed and disposed off. These immune complexes may, there¬
fore, initiate the activation of complement via the classical pathway
at the site of their deposition which results in the recruitment of
polymorphonuclear leucocytes (PMN) which release tissue damaging
-10-
proteolytic enzymes. In addition the macrophage may become activated
to secrete substances which may cause further tissue damage®®-®1.
This reaction would account for the pulmonary infiltrates and damage
to bronchial walls and delayed skin reactions which are not found in
patients who only exhibit Type I reactions ' .
Inhalation of large numbers of air-borne conidia by both atopic and
non-atopic subjects can result in the development of hypersensitivity
z: p
pneumonitis (extrinsic allergic alveolitis) . The development of
this type of allergy following exposure to high levels of
A. fumigatus, although not very common, has been found in people
working with mouldy hay (farmer's lung) or compost heaps'. The
effect of the persistent antigenic challenge is to stimulate the
production of IgG precipitating antibodies in the serum which then
form immune complexes with the antigen; therefore, patients usually
exhibit Type III reactions. The ability of certain micro-organisms
to activate complement has also been implicated in extrinsic allergic
alveolitis®^'®®. Continued presence of immune complexes can result
in a T lymphocyte mediated response (Type IV hypersensitivity)^'®®.
Sentitised T lymphocytes can secrete lymphokines which have a direct
effect on cells involved in inflammatory responses resulting sometimes
in granuloma formation ' . Type IV hypersensitivity is also well
69
recognised in patients with bronchopulmonary aspergillosis .
(ii) Saprophytic existence; Spores of A. fumigatus may germinate
in cavitated lung tissue following damage by other disease processes,
for example, tuberculosis, sarcoidosis, bronchogenic cysts,
bronchiectasis> , radiation fibrosis and lung abscess^®'^. The
-11-
fungus grows within the cavity (usually preformed) to form a compact
7E
mass of mycelium called a mycetoma or aspergilloma' . Such lesions
occupy the cavity and tend not to grow further except when they form
(as happens occasionally) in the course of cavitating invasive
aspergillosis, infarction or pneumonia ' ^8 Out of the 51 cases of
mycetoma studied by Orie et al all were caused by A. fumigatus whilst
44 cases had pre-existing lung disease'1''.
Patients with aspergilloma, unless immunosuppressed have high levels
of IgG precipitating antibodies, often giving six or more arcs on
immunodiffusion tests'1®>58,77^ Aspergilloma nearly always occurs in
non-atopic individuals although some people go on to develop allergic
bronchopulmonary aspergillosis with Types I and III hypersens-
78
itivity . Sepulveda found weakly positive skin test reactions to
extracts of A. fumigatus in approximately 20% of the aspergilloma
patients tested. Some of these patients also had A. fumigatus-specific
7Q
IgE antibodies present . In another study, Bardana _ei^ al found
raised IgG and IgA levels in patients with aspergilloma. They did
80
not find elevated IgE levels .
(iii) Opportunistic Pathogen: Aspergillus fumigatus is one of the
commonest opportunistic pathogens found in the lungs of immuno-
AO Q-1 Op
suppressed patients ' Although the primary route of infection
is through inhalation, the fungus can be locally invasive or can
disseminate throughout the body resulting in intracranial, hepatic,
88—88
renal, bone, thyroid and cardiac involvement . Patients on high
dose corticosteroids and those with either defective granulocyte
-12-
function or neutropenia are particularly at risk from invasive asper-
Rf) R 7
gillosis ' . It therefore, tends to occur in people who have
malignant haematological conditions, carcinoma, or chronic granulo¬
matous disease and in those who have undergone organ trans-
oo q i
plantation . It may occasionally occur in a wide variety of
other clinical conditions, for example, following influenza or pulmon-
qp_qc:
ary infarction, and in the acquired immunodeficiency syndrome7 77.
People on high doses of corticosteroids, for the treatment of chronic
airflow obstruction have been known to develop invasive
Q6
aspergillosis7. Invasive aspergillosis has also developed following
Q7
resection of aspergilloma7 . Aspergillar endocarditis with multiple
systemic embolism has been described as a complication of open heart
surgery due to fungal contamination of the operating theatre venti¬
lating systems^®"
Invasive aspergillosis is often first diagnosed on the evidence of
radiological changes coupled with seeing hyphae on sputum microscopy
and culture of A. fumigatus from the sputum although the sputum may be
101
negative . At a later stage in the disease serum antibodies are
102
sometimes present . It is important that the disease is diagnosed
early so that treatment can be started, as the prognosis of patients
with invasive aspergillosis, especially in those with acute leukaemia
is usually very poor^'^®'®®'®^10®.
(iv) Mixed Syndromes: The different syndromes already described
(i-iii) may manifest themselves in the same patient. Locally invasive
aspergillosis successfully treated may be followed by mycetoma, asthma
and allergic aspergillosis converted (probably by corticosteroid
-13-
treatment) into invasive disease. Mycetoma may be complicated by
asthma, and allergic aspergillosis by mycetoma^'97.
The fungus A. fumigatus also produces a wide range of substances
<] A / -I f~\ /"
including some with mycotoxic and antibiotic properties .
Henrici in 1939 demonstrated that mycelial extracts of A. fumigatus
were neurotoxic, haemolytic and able to induce histological changes in
1 f)7
experimental animals . The production of endotoxins by
A. fumigatus has also been found by others''®®''"^. The antibiotic
substances produced by A. fumigatus include fumigatin, spinulosin,
fumigacin-helvolic acid, gliotoxin and the powerful amoebicide
11D 1 1 R
fumagillin . The toxic side-effects of these substances
prevent them being developed as chemotherapeutic agents in man except
111
for fumagillin which has been used in the treatment of amoebiasis
Although Poplawaska et_ al identified an aflatoxin-like substance in
the extracts of 56 out of 109 strains of A. fumigatus isolated from 74
patients with aspergillosis its presence did not correlate with an
1 1A
increased frequency of unusual clinical symptoms . The role that
these substances might play in the pathogenesis of disease in man is
unclear.
^^ Host Defences against A. fumigatus
1.4.1 Overview of the host defence network
The mechanisms whereby higher organisms defend themselves against
invading microorganisms can be separated into two categories: non-
117_120
specific (innate) and specific (adaptive) immune mechanisms '
The principal components of the non-specific and specific mechanisms
-14-
(Table 1.1) act in concert to provide a highly efficient host defence
system.
The lung, which is the main portal of entry of fungus into the body
has a very efficient filtering system. The size, density and surface
topography of the airborne spores determines their deposition among
air passages and the extent of their penetration. The mechanisms
used in the lung for deposition of particles larger than 1 pm are
primarily sedimentation and impaction. Deposition in the large air¬
ways is predominantly due to impaction then changes to sedimentation
in the small airways and alveoli as total airway cross-section
1 p -|
increases and airway velocities drop . During normal nose
breathing large spores (>10 pm) become impacted in the nasal hairs
which act as a mechanical barrier; however, many of these spores
penetrate further and become entrapped in the mucous layer of the
nasal labyrinth. They are then swept by the continually moving cilia
to the pharynx and removed via the gastrointestinal tract.
During mouth breathing a higher proportion of the large spores become
deposited on the ciliated epithelium of the tracheobronchial tree from
where they are swept up via the mucociliary escalator towards the
pharynx and swallowed. Small spores (1 pm - 5 wn) are able to pene¬
trate the lower regions of the respiratory tract where they are
deposited mainly by sedimentation. As the walls of the alveolar sacs
are not ciliated the spores have to be removed by phagocytic cells
IO1 ipp
(discussed in detail in section 1.4.3) ' . In addition to the
initial process of mechanical filtration in the lung the fluid which
lines the upper and lower airways contains many substances which
TABLE1.1PrincipalComponentsfthH stDefenceN twork NON-SPECIFIC
SPECIFIC
PHYSICALANDMECHANICALBARRIERS: skin,filter gystemofthupperr ratoryt act, membranesliningthebodyracts
LYMPHOCYTES: Bcells,Tl(lymphokines,dir ctactio )
BODYFLUIDS:
ANTIGENPRESENTI GC LLS:





prevent microbial invasion . The respiratory tract fluids
constitute a physical barrier to particulate contact with bronchial
and alveolar epithelia. The secretions that coat the ciliated epi-
thelia form the viscoelastic medium in which the cilia beat, propel¬
ling particles on the mucociliary escalator. This fluid also
contains many substances with antimicrobial properties including lyso-
zyme, immunoglobulins: IgG and secretory IgA (11S IgA), complement
1 O 1 10/
components, lactoferrin and protease inhibitors .
These non-specific mechanisms, for example the mechanical filtration
of the lung or physical barrier of the skin are used as the first
lines of defence to prevent microorganisms invading the tissues.
However, if the microorganism is able to breach this barrier it may be
adequately dealt with by the humoral and cellular components of the
body fluids, in particular, the phagocytic cells. These have the
capacity to engulf the microorganism and produce an armoury of sub¬
stances including enzymes and reactive oxygen intermediates which in
addition to complement components have potential microbicidal
properties1 ^' "125-133. effiCj_enCy with which the micro-organism
is eliminated by the phagocytic cells often determines whether a
1 O / 1 O A
specific immune response is required '. The central component
of the specific defence mechanism is the lymphocyte. The T and B
lymphocytes work in concert with the phagocytic cells to mount humoral
and cell-mediated immune responses which are specifically directed at
the offending microorganism"^-j\ breakdown or deficiency in
any one of these components of either the non-specific or specific
defence mechanisms renders the individual more susceptible to oppor¬
tunistic infections"^0-Classical examples of A. fumigatus
-17-
taking advantage of a defective host defence network are aspergillar
endocarditis (A. fumigatus entering the tissue at the site of incision
during surgery) and invasive aspergillosis in people with PMN dys¬
function either alone (e.g. as in chronic granulomatous disease) or
combined with lymphocyte dysfunction (e.g. as in acute leukaemia or in
subjects receiving cytotoxic drugs)®^'®®'^1
1.4.2 A. fumigatus in the lung
The normal portal of entry of A. fumigatus into the body is the
14S
lung . Spores of A. fumigatus can, because of their small size
(<5 urn) and their aerodynamic properties, bypass the upper respiratory
tract defences and may reach distal regions of the lung1'''' 1/t^' .
In this region the host defences rely upon phagocytic cells to remove
the spore efficiently"l^. jf? however, the phagocytic cells are
unable to clear the spore quickly, germination and fungal colonisation
i en
may occur J . A possible relationship between isolation of
A. fumigatus and lung disease was shown in 1959 by Pepys et_ al who
cultured spores of A. fumigatus more frequently from the sputum of
asthmatic patients than from the sputa of people with other lung
1S 1
diseases ^ . Mullins and Seaton who were able to show that spores of
A. fumigatus were recovered from post mortem lung specimens more
frequently than would have been anticipated from their prevalence in
the air spora, suggested that this fungus may have a specific ability
1S2
to resist the natural defences of the lung .
Experimental animal studies have also shown that spores of
A. fumigatus appear to be fairly resistant to the normal host defences
of the lung''-^-''^1-'. Treatment of animals with corticosteroids prior
-18-
to challenge with spores of A. fumigatus, substantially impairs their
host defences and renders them highly susceptible to disseminated
153 154
infection ' . Sandhu et al_ in 1970 exposed mice by inhalation,
to seven different species of Aspergillus (A. fumigatus, A. flavus,
A. tamarii, A. nidulans, A. nidulans var dentatus, A. niger,
A. terreus) and found that corticosteroid treatment lowered the host
resistance to all seven species. However, A. fumigatus was the most
pathogenic causing the highest mortality in the corticosteroid group
(13 out of 15) as well as in the untreated group (4 out of 15)
This effect of corticosteroid treatment was also shown by White in
1977, who found that inhaled conidia of A. fumigatus germinated at a
high rate in the lungs of cortisone-treated mice when compared with
134
naive mice . A study on the pathogenesis of experimental pulmonary
aspergillosis in normal and cortisone-treated rats by Turner et_ al_ in
1976 showed that rats were resistant to infection following
intratracheally administered spores of A. fumigatus even although they
developed a subacute interstitial pneumonia. Although the lesions
were more severe in animals whose inflammation was suppressed with
corticosteroids there was no evidence of hyphal growth in the
pulmonary tissue. They postulated that phagocytosis, followed by
digestion of spores, was of paramount importance in the control of
1
fungal infections JJ.
Rabbits exposed to spores of A. fumigatus and Penicillium sp. which
were inhaled or instilled directly into the stomach, did not produce
precipitating antibodies, even though fungi were isolated from the
157
tissue 16 days after exposure . Experimental studies of the
specific host defences against A. fumigatus by Smith, Williams et al,
-19-
and by Lehmann and White (1976) showed that mice, which had been pre-
treated with a sublethal dose of A. fumigatus spores were more resis¬
tant to a subsequent challenge with a higher dose1^®'^ Eskenasy
and Molan immunised rabbits with antigens of Aspergillus in order to
produce an animal model with a high titre of specific antibodies to
A. fumigatus. They challenged these sensitised and non-sensitised
rabbits intratracheally with spores of A. fumigatus and compared the
histopathological reaction. The lung tissue of rabbit sensitised
with aspergillar antigens showed extremely active granulocytic and
macrophage alveolar reactions whilst the titre of serum antibody
rapidly dropped; all animals survived. In contrast the unsensitised
animals developed a rapid exudative-necrotic alveolar reaction with a
1 A 1
high mortality .
The importance of the specific immune response in the elimination of
A. fumigatus nevertheless remains unclear. Turner _et _al, using rats
showed that antibodies to A. fumigatus did not exert a protective
role against the development of fungal infections and may even have
accelerated the disease . Williams et_ al showed that mice with
impaired T cell function could still resist infection with
A. fumigatus; however, they were not as efficient at dealing with a
1 'SQ
second challenge as were mice who were T cell competent
Taken together all these findings have led to the suggestion that
prevention of infection with A. fumigatus is primarily dependent
on the action of the phagocytic cells. Therefore examination of
the role that phagocytic cells may play in the eradication of
spores of A. fumigatus is the central theme of this Thesis.
-20-
1.4.3. Phagocytic cells
The importance of the phagocyte in the eradication of microorganisms
1 £ O
was first described by Metchnikoff over 100 years ago
Metchnikoff observed that cells which he named 1microphages' and
'macrophages' struggle against a wide variety of foreign bodies and
living organisms by attempting to ingest and degrade them intra-
cellularly. He understood these cellular actions to be the basis of
1
an organism's inflammatory response to wounding . We now know that
microphages (polymorphonuclear granulocytes) and macrophages
(mononuclear phagocytes) originate in the bone marrow from a common
stem cell, differentiate along separate pathways, before circulation
in the blood ^The granulocytes which comprise primary PMN, as
well as eosinophils, basophils and tissue mast cells are short-lived
cells with a half life of only a few days. When required PMN are
rapidly mobilised into the tissue to sites of inflammation"^' 167,
Monocytes remain in the circulation for a few days and then migrate to
1 C*\ V 1 Aft
the tissues to become long-lived tissue macrophages ' . Other
cells have been shown to exhibit limited phagocytic ability; these
include endothelial cells, epithelial cells and fibroblasts, referred
to as facultative or 'non-professional' phagocytes1^' , pmn and
mononuclear phagocytes are the 'professional' phagocytes because they
are rapidly mobilised to infectious foci and can phagocytose and kill
170
microorganisms
Phylogenetically phagocytosis is the most established defence
mechanism against foreign invaders. Among primitive forms of animal
life (for example, the amoebae), phagocytosis is the principal means
of ingesting food. This application of phagocytosis antedates its
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involvement into a defence mechanism among the more advanced multi-
171
cellular animals . The process of phagocytosis can for ease of
description, be arbritarily divided into four phases - (i)
recognition and chemotaxis, (ii) attachment, (iii) ingestion and (iv)
digestion.
(i) Recognition and chemotaxis
Phagocytic cells have the capacity to discriminate between foreign and
self materials as well as alterations to self. When phagocytic cells
first encounter foreign microorganisms, whether by chance or by
specific attraction to the cell surface of the micro-organism, they
are able to secrete or initiate the production of mediators which can
172
mobilise other phagocytic cells to the site of inflammation . The
ability of cells to migrate unidirectionally in response to chemical
signals enables them to accumulate at the site of inflammation.
Three types of cellular motility can be defined, (i) random migration
(ii) chemokinesis-stimulated random migration due to substances that
enhance phagocyte locomotion, (iii) chemotaxis - unidirectional loco¬
motion of cells along a concentration gradient of a chemoattractant:
173
this is the principal mechanism . Many substances attract or are
positively chemotactic for phagocytes (Table 1.2)one of the
most potent chemotactic factors generated during phagocyte activation
is the complement component Cha1^. Many microorganisms (including
A. fumigatus) have been shown to directly stimulate the production of
chemotactic factors from the complement system as well as the fibrino-
1 n£_ 170
lytic and kinin generating systems ' ' .
Recognition (as well as attachment) of microorganisms by phagocytosis
-22-










Mast cell release products - ECF-A
Miscellaneous
Products of tissue damage
Caseins (as - and B-casein)
Synthetic formyl-methionyl peptides
Bacterial signal peptides, bacterial lipids
Tumour cell supernatants
Pulmonary surfactant lipoprotein
Products of the fibrinolytic and kinin-generating systems
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is also promoted by coating them with serum factors called opsonins
170
which were first described by Wright and Douglas in 1904 . The two
principal serum opsonins are immunoglobulins (mainly IgG-| and IgG-j)
180 1R1
and complement (C3b, C3d) ' but other serum proteins are thought
to have opsonic activity. These include alpha and beta globulins and
1 R?
C- reactive protein (reviewed by Stossell, 1975) .
(ii) Attachment
The attachment process involves the apposition of phagocytic cell
membrane and the surface of the microorganism. Attachment can occur in
the absence of cellular metabolism and is dependent upon the interplay
of surface forces (surface tension, surface-free energy) cell surface
receptors, structural properties of the plasma membrane, as well as
1 PA 1 PR 1 PA
the molecular nature of the microorganism ' ' . Surface recep¬
tors present on phagocytic cells include those for complement (CR1,
CR2, CR3) immunoglobulins (FcRI, FcRII), lectin/sugars, lymphokines
and hormones1®^'1®®' 1®®. The most extensively studied of these
receptors are those for the principal opsonins, complement and immuno¬
globulin. Specific antibody binds to the microorganism via its (Fab')2
region; the antibody coated microorganism may then bind to the phago¬
cytic cell via the Fc receptors on the cell surface1®'''. Interaction
of specific IgM antibodies with the microorganism leads to activation
of the complement pathway; this results in the deposition of C3
1RR
components (mainly C3b) on the microorganism . The C3b coated
microorganism then binds to the phagocytic cells via complement
1RQ
receptors . Microorganisms which have been found to activate
complement directly via the alternate pathway may become coated with
C3b which could result in their attachment to the phagocytic cell in
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the absence of specific antibody^' ^'190-192<
Other receptors which bind the complement component iC3b are MAC-1,
LFA-1 and p150,95; these receptors have been shown to be closely
related to the CR3 receptor 193-195^
The ability of phagocytes to adhere to various surfaces in the absence
1 Q A 1 Q V
of antibody or complement is a well-known phenomenon ^ ' y. Lectin-
like receptors which can recognise carbohydrates on the surfaces of
microorganisms are thought to be part of a more primitive non-specific
1QR 1QQ
system of recognition ' . These receptors in the mouse appear to
be closely associated or identical to la antigens of the major histo-
compatability complex^*"1.
Perturbation of the plasma membrane may induce a phagocytic cell to
undergo a respiratory burst with the production of substantial
quantities of superoxide anion and hydrogen peroxide. These products
may interact to form a variety of short-lived oxygen species (for
example, hydroxyl radical, singlet oxygen) and longer-lived oxidants
(for example hypochlorous acid, monochloramine). These reactive
oxygen intermediates constitute key components of the oxygen-dependent
on 1_pnq
antimicrobial and cytocidal mechanisms of phagocytic cells
In addition to the reactive oxygen intermediates membrane perturbation
also induces the phagocytic cell to secrete a vast array of substances
including enzymes and chemotactic factors which are involved in the
eradication of the microorganism (see Table 1.3)^^"^^.
TABLE1.3Somefthesecretoryproduc sduc dbyPMNan /ormo n cl ap agoc t s implicatednanti-microbialdefens REACTIVEOXYGENINTERMEDIATES; Superoxideanion,hydrogenp ide,si l t oxygen,hydroxylradicaHORMONES: Neutrophilactivatingfa tor,int rleukin-1, interferon,cachecti ,olonystimulating factororgranulocytesa dm crophages, thyroidhormones COMPLEMENTCC PONENTS: Ci,2̂3cjfactorB, factorD,properdinC1bin ctivator,B-IHOTHERS: Plateletctivatingfa tor,lipoxygenasend cyclo-oxygenasepr ducts,chl rid ,la tic acid,lactoferrinGr nulaationicpro ei s transferrin OTHERENZYMES: Neutralproteases,last selysosym ,lysosomal acidhydrolases,catal s ,myeloperoxid se
-26-
(iii) Ingestion
Attachment of microorganisms via specific receptors can trigger the
cell to undergo the process of ingestion which is highly complex and
involves a coordinated interaction of the plasma membrane with
contractile elements in the cytoplasm. Phagocytes surround objects
with an area of peripheral cytoplasm which excludes organelles (called
hyaline-ectoplasm). The pseudopodia of the phagocytic cell extend
around the microorganism until the membrane fuses to form the phago-
P07 ?f)R
some '' . Since the cell actively crawls around large
objects, the machinery involved in locomotion and in phagocytosis of
large objects is nearly identical. The motor elements for phago¬
cytosis are mediated by an interaction of actin with other proteins
and the system is usually controlled by ionised calcium. Actin fila¬
ments interact with myosin in the presence of adenosine triphosphate
to cause contraction of the dispersed filaments into aggregates.
Each contractile unit is a set of actin filaments linked by myosin
filaments engaged in a 'tug of war' for the actin filaments. The net
result is propogation of the pseudopodia and ingestion of the
object20®.
During ingestion of microorganisms phagocytic cells release many anti¬
microbial substances including reactive oxygen intermediates and lyso-
somal enzymes204'205.206•209.
(IV) Digestion
During and after formation of the phagosome, adjoining lysosomes fuse
with the phagocytic vacuole and the contents of the lysosome discharge
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P 10
into the phagosome to form a phagolysosome . The lethal combin¬
ation of oxygen metabolites, radicals, ions and enzymes ensures the
O 11
rapid destruction of most microorganisms within this struture
1.4.A Mechanisms of resistance to phagocytic cells
A number of microorganisms have developed mechanisms of resistance to
pip
the phagocytic processes . Adult schistosomes are able to acquire
red cell determinants and MHC Class I antigens of the host on their
surface; these could mask the foreign antigens of the schistosomes,
thereby enabling them to evade recognition by the eosinophil of the
o i o o i />
adult worm ' . Many strains of pathogenic bacteria, eg
Staphylococcus aureus and Escherechia coli have surface structures
(capsules) that inhibit their binding and ingestion by phagocytic
pic
cells . Many pathogens are not readily ingested by phagocytic
cells because of antiphagocytic substances on their surfaces, for
example Candida albicans hyphae and slime-producing strains of
9 1 917
Pseudomonas aeruginosa ' '. For intracellular pathogens to
survive they must have developed means to circumvent the microbicidal
actions of the granules which empty into the phagosome during
phagolysomal fusion as well as those produced by the phagocyte during
ingestion. The ability of Toxoplasma gondii to survive within
certain mononuclear phagocytes is dependent in part upon it becoming
phagocytosed without eliciting the production of reactive oxygen
O I O
intermediates . The cell wall of Mycobacterium tuberculosis
contains a substance which inhibits degranulation of the lysosome.
However, M. tuberculosis and many other organisms can survive within
piq ppn
phagolysosomes ^' . A more comprehensive list of microorganisms
which have been shown to have mechanisms of resistance is given in
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Table 1.4 (adapted from the review by Densen and Mandell).
In comparison to the vast amount of literature on the importance of
phagocytic cells in the eradication of bacteria and viruses, little is
known about their role in the host defences against fungal infections.
However, it is generally thought that the mechanisms used are essen¬
tially similar to those involved in the resistance to bacterial
infections.
1.4.5 Phagocytic cells versus A. fumigatus
The importance of the phagocytic cell in the eradication of spores of
A. fumigatus was highlighted in 1897 by Renon who injected spores of
A. fumigatus into the peritoneal cavities of guinea-pigs and rabbits;
for comparison he used spores of A. niger which he considered to be
1D
non-pathogenic . After three hours he examined the peritoneal
exudates and found that the majority of spores of A. niger were then
within the leucocytes. However, the majority of spores of
A. fumigatus were still lying free within the exudate (Fig 1.3).
Renon also demonstrated that spores of A. fumigatus were still present
though not germinating in the lymphatic sac of frogs 35 hours after
injection (Fig 1.4). Renon suggested that the 'poor response' of the
leucocytes was the reason for pathogenicity of A. fumigatus. In the
90 years since the pioneering work of Renon our knowledge of the role
that phagocytic cells play in the eradication of A. fumigatus has not
really progressed. The few published studies on the interaction of
phagocytic cells with spores of A. fumigatus have produced conflicting
results. Kurup found that rabbit alveolar macrophages killed 80% of
spores of A. flavus, 60% of A. fumigatus and only 30% of
TABLE1.4Mechanismsofresistancesommicroorganismst ea t o sfphag cyticell INHIBITIONOFPHAGOCYTERECOGNITIONRCHEMOTAXIS Salmonellatyphi Neisseriameningitidis Neisseriagonorrhoe e Pseudomonasaeruginosa Serratiaspecies Mycobacteriumtuberculosis Staphylococcusaureus Capnocytophaga Escherichiaoli VibriocholeraINHIBITIONOFPHAGOCYTERESPIRAT RYBU ST
ORDEGRANULATION
Brucellaabortus Herpexsimplevirus Influenzavirus K.pneumoniae M.tuberculosis Newcastledisevirus Toxoplasmagondii Reovirus Vacciniavirus
INHIBITIONOFATTACHMENTTO/ORI GESTIBYPH GOCYTE Streptococcusneumoniae Streptococcusy gene Klebsiellapneumoni e Haemophilusinfluenzae Yersiniapestis Bacillus" anthracis Campylobacterfetus Cryptococcusne forman Pasteurellamultocid Bacteroidesfragili§~~ Mycoplasma Influenzavirus N.meningitidis ¥7gonorrhoea P.auruginosa S.aureus E.coli C.albicans
RESISTANCETOOXIDATIVRENZYMATICATT CK S.typhi B.abortus Salmonellainnesota E.coli Listeriamonocytogenes Mycobacteriumb v s M.tuberculosis Mycobacteriumleprae MICROBIALTACTICSES APEFR MPHAG SOME Reovirus M.bovis Rickettsiatsutsugumushi Vacciniavirus
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Figure 1.3 A copy of the original illustration made by Renon in
1897 of the interaction between spores and cells, found
in the peritoneal exudate which was obtained from guinea
pigs, 3 h after receiving an intraperitoneal injection
of spores of A. fumigatus . The majority of spores
(•) are lying free in the exudate.
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Figure 1.4 A copy of the original illustration made by Renon in
1897 of the spores of A. fumigatus (•) contained within
leucocytes taken fcom the lymphatic sac of a frog 35 h
after inoculation .
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A. niger following a two hour incubation in vitro. However, from
these results he concluded that rabbit alveolar macrophages effect-
221
ively killed all three fungi . The results of another study by
Schaffner e_t al comparing the ability of phagocytic cells, from
different anatomical sites, to kill these three fungi showed that
alveolar macrophages from mice and rabbits were more efficient than
peritoneal macrophages in the prevention of germination of all three
aspergilli. Schaffner et al found that the alveolar macrophages from
rabbits killed 82-90% of spores of A. fumigatus within 30 hours
whilst, in contrast, the ability of peritoneal macrophages to inhibit
222
germination of the ingested spores was substantially less . The
results of another study comparing natural immunity to A. fumigatus in
vivo with the action of phagocytes against the organism in vitro, led
Schaffner et al to suggest that monocytes may be concerned with
killing spores while PMN may be responsible for the eradication of
223
hyphae, apparently in the absence of a specific immune response .
Diamond _et al have also shown that PMN as well as monocytes can damage
hyphae^^'Lehrer and Jan found that serum was necessary for
optimal phagocytosis of spores of A. fumigatus by human leucocytes and
its opsonic activity was greatly diminished by heat inactivation
(56°C, 30 min). However, even after incubation for three hours with
P P
human monocytes and PMN the phagocytosed spores remained viable
In a later study by Kurup, in vitro experiments showed that pulmonary
alveolar macrophages from normal rabbits were relatively ineffective
at killing spores of A. fumigatus in four hours when compared with the
high percentage of spores killed of A. flavus (90%) and A. niger
(18.9% compared with 90% and 82% respectively). Prior opsonisation
of the spores in normal rabbit serum, rabbit anti-A. fumigatus sera,
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complement or lung lavage fluid had no real effect on the phagocytosis
221
or killing of the spores '. Waldorf et al showed that alveolar
macrophages of mice, challenged in vivo continued to kill spores of
ppQ
A. fumigatus when cultured in vitro . The results of two case
reports have shown that phagocytic cells from patients with recurrent
aspergillus infections are unable to kill spores of A. fumigatus
ppq ppn
efficiently ' . This led Fietta et_ al to suggest that oxygen-
independent mechanisms could play a basic role in Aspergillus
killing230.
The potential importance of reactive oxygen intermediates and of
hydrogen peroxide in particular for the eradication of spores and
hyphae has been demonstrated with cell-free systems of myelo-
231 222
peroxidase-hydrogen peroxide-iodide ' and ferrous iron-hydrogen
233
peroxide-iodide both of which are capable of killing A. fumigatus.
Although Lehrar and Jan found that the myeloperoxidase-hydrogen
peroxide-iodide system was efficient at killing spores of A. fumigatus
in vitro they also showed that spores of A. fumigatus were much more
resistant to the myeloperoxidase-hydrogen peroxide-chloride system.
As chloride is much more readily available to phagocytic cells than
iodide they suggested that the relative ineffectiveness of chloride in
the system could underlie the apparent inability of human neutrophils
P P A
to kill ingested spores of A. fumigatus .
It is, therefore, apparent from this review of the literature that
there is still considerable doubt and even confusion about the
mechanisms that may be used by phagocytic cells in the eradication of
this fungus.
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1.5 Aims of the Thesis
The principal aim of this work was to examine the ability of phago¬
cytic cells to handle spores of A. fumigatus with the intention of
increasing our understanding of the mechanisms involved in the patho¬
genesis of aspergillar diseases. The interactions between phago¬
cytic cells, from humans and rodents, with spores of A. fumigatus
were examined with particular emphasis on the different stages of the
phagocytosis and killing process.
To test the hypothesis that asthmatic patients, specifically sens¬
itised to A. fumigatus, may have a defect in their handling of this
fungus, a comparison of the handling of fungi by phagocytes from
asthmatic patients, both sensitised and unsensitised to A. fumigatus
with that by phagocytes from non-asthmatic subjects has been made.
In order to facilitate interpretation of both iri vivo and _in vitro
studies, spores of the non-pathogenic P. ochrochloron were used as a
control.
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2. MATERIALS AND METHODS
A number of different methods were used to examine the interaction of
phagocytic cells and fungal spores. As the majority of these methods
were routinely used in the laboratory at the I.O.M. no further stand¬
ardisation was required. However, some of the methods used did
require standardisation, in particular, the fungal spore killing
assay. The principal results of the standardisation experiments
can be found in this chapter under the specific method description.
2.1 Selection of Subjects
Prior to commencement of the study approval was obtained from the
local Ethics of Research Committee. Informed consent to donate blood
for the research was obtained from all participants.
The subjects chosen for this study fell into three main groups:
(i) asthmatic subjects non-sensitised to A fumigatus,
(ii) asthmatic subjects sensitised to A. fumigatus (including
patients with allergic bronchopulmonary aspergillosis),
(iii) non-asthmatic control subjects
The majority were patients attending the Chest Clinic at the Royal
Victoria Dispensary (RVD), Edinburgh. In addition patients with
allergic bronchopulmonary aspergillosis were recruited with the co¬
operation of the consultant chest physicians in the Edinburgh area.
The control group consisted of non-asthmatic individuals, the majority
of whom were members of staff at the Institute of Occupational
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Medicine (IOM); some were patients attending RVD for follow-up of
other conditions. A total of 58 people participated in this study.
The age distribution within the different groups is given in Table
2. 1.
2.2 Completion of Questionnaire
All participants in the study were asked to answer questions relating
to their age, smoking habit and medications (Fig. 2.1).
2.3 Skin Testing
All subjects were skin tested by the prick-test method using standard
Bencard allergy preparations (Bencard, Brentford, England). The
allergens used were: A. fumigatus, Dermatophagoides pteronyssinus,
grass-pollen, Penicillium sp: in addition a control solution (without
added allergen) was applied. The flexor aspect of the forearm was
used for testing and a ballpoint pen was used to label the patient's
arm adjacent to the test sites in order to identify the allergen and
control solutions. Using the applicator, one drop of each of the
allergen solutions was applied to the skin and a needle was used to
lightly puncture the skin below the solution; a fresh needle was used
for each of the allergens. After 15 min the arm was examined for a
wheal and flare reaction and the diameter of the wheal, if any, was
recorded. A response greater than that found with the control was
recorded as positive. All patients who gave a skin test positive
reaction to A. fumigatus were included in the asthma-sensitised group.
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TABLE 2.1 Age distribution of the people from each of the clinical
groups
CLINICAL GROUP

















Fig 2.1 The questionnaire completed for each subject participating
in the study
THE HOST DEFENCES AGAINST ASPERGILLUS FUMIGATUS
1. IDENTITY INFORMATION
CASE NO. (enter preceding zeros)
SAMPLE NO. (enter preceding zeros)
SURNAME
INITIALS
SEX (enter M = male or F = female)
DATE OF BIRTH (enter DDMMYY with preceding zeros)
DIAGNOSIS
NATURE OF SAMPLE (enter B = blood or L = lung lavage)
DATE SAMPLE TAKEN (enter DDMMYY with preceding
zeros)
now go to section 2 (smoking history)
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SMOKING HISTORY
[a) DO YOU SMOKE? (if yes enter Y and go
to question (b))
[if no enter N and go
to question (d))
(b) WHICH OF THE FOLLOWING DO YOU SMOKE REGULARLY?
CIGARETTES (if yes enter Y, if no enter N)
CIGARS (if yes enter Y, if no enter N)
PIPE (if yes enter Y, if no enter N)
[c) ON AVERAGE, HOW MANY DO YOU SMOKE PER WEEK?
CIGARETTES (enter preceding zeros for amount or
leave blank if not applicable)
CIGARS (enter preceding zeros for amount or
leave blank if not applicable)
OUNCES OF (enter preceding zeros for amount or
TOBACCO leave blank if not applicable)
for 1/4 oz. record 00.25
1/2 oz. record 00.50
3/4 oz. record 00.75 etc)
now go to section 3 (medication & skin test results)
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SMOKING HISTORY (continued)
(d) HAVE YOU EVER SMOKED AS MUCH AS ONE CIGARETTE A DAY
(OR ONE CIGAR A WEEK OR ONE OUNCE OF TOBACCO A MONTH)
FOR AS LONG AS A YEAR?
(if yes enter Y and go to question (e))
(if no enter N and go to section 3)
(e) IS IT LESS THAN A YEAR SINCE YOU STOPPED SMOKING?
(if yes enter Y and go to section 3)
(if no enter N and go to question (f))
(f) HOW MANY YEARS IS IT SINCE YOU STOPPED SMOKING?
(enter with preceding zero)
now go to section 3. (medication & skin tests results)
3 MEDICATION
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(g) ARE YOU TAKING ANY MEDICINES?
(if yes enter Y and go to question (h))
(if no enter N and go to section 4)
(h) WHICH MEDICINES ARE YOU TAKING?







ADDITIONAL TESTS (please specify)
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2.4 Collection of Blood
A 30 ml sample of blood was withdrawn from an antecubital vein.
Twenty five millilitres of blood were transferred into a plastic
universal container (Nunc, Gibco Europe Ltd, Paisley, Scotland)
containing the anticoagulant ethylenediaminetetra-acetic acid,
dipotassium salt (EDTA-Sigma Chemical Co. Ltd., Dorset, England) to
give a final concentration of 15 mg EDTA/1 ml blood. The remaining 5
ml of blood were transferred into a sterile glass tube (New Brunswick
Scientific Ltd., London) and allowed to clot at room temperature
(RTP). Sterile technique were used throughout.
2.5 Separation of Mononuclear and Polymorphonuclear Cells
The cells were isolated by density gradient centrifugation using
the basic method described by Ferrante and Thong . The principles
• • O "3 C
of this method were established by Boyum in 1968 . A sterile
plastic Pasteur pipette (Sterilin Ltd, Middlesex, England) was used to
layer gently 3.5 ml of the anticoagulated blood onto 3 ml of Mono/Poly
resolving medium density 1.114 +_ 0.002 (Flow Labs., Irvine, Scotland)
in a plastic sterile conical centrifuge tube (Sterilin). This was
centrifuged in a MSE Mistral 400 centrifuge for a total of 40 min at
room temperature. For the first 30 min the blood was spun at 300g
followed by 10 min at 400 g. This technique allows cells to be
separated according to their densities illustrated in Fig 2.2. The
top layer which contained the mononuclear cells was removed first
followed by the second layer which contained the polymorphonuclear
(PMN) cells. Cell yield was increased by using a sterile plastic
Pasteur pipette and a circular motion of the hand around the cell
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Figure 2.2 Mono/Poly resolving medium separation of human peripheral
blood in a conical tube following centrifugation for 40
min. From the top down; straw-coloured layer is plasma,
first white band contains the mononuclear cells, second
white band contains the granulocytes. The bottom dark
layer contains the red blood cells.
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TABLE 2.2 The number of mononuclear cells and granulocytes isolated





Total Cells x 10
PMN
6
Control 15 20.96 ( 6.2 1 18.14 ( 9.7)
Asthma
non-sensitised 14 24.17 ( 8.6) 25.82 (12.9)
Asthma
sensitised 13 22.05 (10.9) 27.2 (15.!
1 Mean (SD)


























































TABLE 2.4 White blood cell count of subjects divided by clinical
group
q
Clinical Group Number in Group WBCC x 10/1
Mean (SD)
Control 15 6.74 (2.01)
Asthma
Non-sensitised 14 7.17 (1.55)
Asthma
Sensitised 13 7.49 (1.98)
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layer interface. The cell layers were transferred into ice-cold
conical centrifuge tubes (Sterilin) and washed twice in phosphate
buffered saline (PBS) [without calcium (Ca++) or magnesium (Mg++)]
centrifuging each time at 350 g for 10 min at 4°C. EDTA anticoag-
ulates by chelating calcium ions. The PBS was, therefore, Ca++ and
Mg++ free in order to prevent clot formation in the mononuclear cell
layer. As the PMN layer usually contained red blood cells (RBC) it
was treated with RBC lytic buffer as follows:- the PMN were resus-
pended in 7 ml of the lytic buffer (NH^CL 8.28 g, NaHCO-^ 0.4 g, EDTA-
disodium salt 0.0336 g, made up to one litre in distilled water) and
the tube kept on ice for 6 min. The cells were then washed twice in
PBS (Ca++ and Mg++ free) and the cell pellets resuspended in 2 ml of
Hanks' balanced salt solution (HBSS) ready for counting. The number
of cells obtained using this technique, isolated from the patients in
the 3 clinical groups is shown in Table 2.2. The purity of the cell
populations is shown in Table 2.3.
2.6 Cell Counts and Cell Viability
2.6.1 White blood cell counts
Cell suspensions were diluted 1:20 in Turk's fluid (2% acetic acid
plus trace gentian violet), mixed and left for 5 min before being
counted in an improved Neubauer counting chamber . The peripheral
white blood cell counts from the blood of the people in the 3 clinical
groups is shown in Table 2.4.
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2.6.2 Cell viability
A cell viability was assessed using the trypan blue exclusion
method*^. The cells were diluted 1:2 with 0.4% trypan blue (Gibco)
and 100 cells were counted. The viable cells, those that excluded
trypan blue were expressed as a percentage of the total.
2.7 Preparation of Cytocentrifuge Smears
A monolayer of cells was prepared by adding 50 til of 5 x 10^/ml cell
suspension to 0.3 ml saline in a cytocentrifuge cup and spinning at
375 g for 5 min in a cytocentrifuge (Shandon Southern Products Ltd,
Cheshire). The slide was then removed and allowed to dry before being
fixed. Preparations of the cells are illustrated in Figs 2.3, 2.4.
2.8 Cell Staining and Differential Counts
All slide preparations (cytocentrifuge smears, blood films) were fixed
for 5 min in methanol (BDH Chemicals Ltd, Poole, England) before being
stained using the following May-Grunwald Giemsa staining method. The
slides were stained in May-Grunwald stain (0.6 g into 100 ml of
methanol warmed to 60°C and then left overnight and filtered for 10
min) and then in Giemsa stain (diluted 1:15 in 0.066 M Sorensen's
buffer) for 10 min rinsed 2x5 min in pH 6.8 buffer and allowed to
dry. The number of different leukocyte types in one hundred cells
were counted and the result expressed as a percentage and in absolute
numbers^®. The cell differentials of the white blood cells from
patients in the clinical groups are given in Table 2.5.
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Figure 2.3 Cytocentrifuge smear of human mononuclear cells isolated
by density gradient centrifugation. The cells
illustrated are monocytes (->) and lymphocytes .
Original magnification x 400.
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Figure 2.4 Cytocentrifuge smear of human granulocytes isolated by
density gradient centrifugation. The preparation
contains >92% PMN. Original magnification x 400.
TABLE2.5Differentialwhi ebloodc lountsfsubjectsdivid dycli i algroup DIFFERENTIAL% ClinicalNumberPMNLymphocyteMo ocytEosin philBas p StatusinGroup Control1559.07( 2.7)133.211.0)4.8( 97300) Asthma Non-sensitised1456.21(11.3)33 994.76074.0.0 ! Asthma Sensitised1356.46(11.7)33 0816.1524(4 200) 1Mean(SD)
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2.9 Serum Separation and Treatment
Clotted blood was spun at 400 g for 20 min in an MSE super minor
centrifuge at room temperature. The serum was then removed and
divided into three samples which were treated in the following way:
(i) stored at 4°C,
(ii) heated at 50°C in a water bath for 20 min
(iii) heated at 56°C in a water bath for 30 min
The sera were used in the assay systems within one hour of treatment.
Heat inactivation is conventionally used to examine the effects of
complement in phagocytosis/killing assay systems. Storage at 4°C for
short periods preserves heat labile complement components. Heating
for 20 min at 50°C destroys factor B which is involved in the alter¬
native pathway of complement activation. Heating at 56°C for 30 min
destroys all other heat labile complement components including those
which are involved in the classical as well as the alternative pathway
23Q
of complement activation .
2.10 Detection of Serum Antibody to A. fumigatus
The presence of serum antibody to A. fumigatus was estimated using
counter immunoelectrophoresis (CIEP) which detects mainly IgG precip¬
itating antibodies, and the radio-allergosorbent test (RAST) for the
determination of circulating specific IgE antibodies.
2.10.1 CIEP
The method used was based on an established procedure2^®. Agarose
(1% Sigma) was dissolved in 0.05 M sodium barbitone buffer pH 8.6
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(10.31 g sodium barbitone, 12 ml N HCL into one litre of distilled
water). A volume of 8 ml of 1% agar in sodium barbitone buffer was
added to glass plates (3 x A in) and the plates allowed to set at A°C
for 6 h. The wells were punched and the agar allowed to settle
overnight. The test sera were added to the top wells while the
A. fumigatus antigens and control added to the lower wells. The
plates were electrophoresed at a constant voltage of 150 Volts for 1.5
h using a Shandon (Shandon Southern Products Ltd, Runcorn, Cheshire)
power pack. After this time the plates were removed and put into a
moist box and left at room temperature for 18 h. The plates were put
into saline for one hour to remove non-bound protein, then rinsed in
distilled water, and allowed to dry with a piece of filter paper on
top. The plates were stained using Amido Schwartz stain (50 g
mercuric fluoride was dissolved in 950 ml distilled water by gentle
heating, 5 g Napthalene black was added to 50 ml of glacial acetic
acid and shaken for 30 min and then added to the mercuric chloride
solution and filtered through filter paper to remove any deposit) for
30 min and then cleared using methanol acetic acid (9:1) until
background staining was removed. Positive staining came up as a sharp
blue line between the sera and the antigen preparation. Positive and
negative controls were included in each run. A typical example is
illustrated in Fig 2.5.
2.10.2 RAST
This test was kindly carried out by Dr Hugh McFarlane of the
Department of Dermatology, University of Edinburgh using the Phadebas














rigure 2.5 An example of the precipitation lines that occur when
serum containing specific antibody to A. fumigatus is
electrophoresed against A. fumigatus antigens when
compared with control solution (negative control).
Direction of current (+).
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principle of the test involves incubating the patient's serum with
special discs coated with A. fumigatus antigen. Any specific IgE
antibodies in the patient's serum bind to the disc to form a disc-
allergen-IgE complex. Sepharose beads coated with radio-labelled
anti-human IgE sera are then incubated with the discs and any specific
A. fumigatus IgE antibody present in the patient's sera will bind to
the radio-labelled sepharose beads to form a disc-allergen-IgE-radio-
labelled-anti-IgE complex which is measured in a gamma counter ^.
2.11 Animals Used in the Study
The rodents used in the study were an important source of cells
and serum. The animals used were syngeneic C57B1/6 mice and
syngeneic PVG hooded rats. The animals were obtained from the
IOM Animal Breeding Unit, Bush House Estate.
2.12 Animal Maintenance
The animals were housed in the Animal Unit at the City Hospital,
Edinburgh. They were maintained in plastic cages on grade 6 sawdust
bedding. The animals were fed standard laboratory rat and mouse diet
and tap water ad libitum. The animal house was mechanically vent¬
ilated and illuminated on a 12 h photoperiod at an average temperature
of 22°C.
2.13 Intraperitoneal Injection of Mice
Peritoneal exudate cells were obtained from the peritoneal cavity of
untreated naive mice or following intraperitoneal injection of
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thioglycollate, a non-specific macrophage eliciting agent27*2 or
Corynebacterium parvum which has been shown to actiiiAjiemacrophages as
well as having immunomodulatory effects27*2. In addition mice were
challenged with suspensions of fungal spores. All animals were used
at between 12 and 20 weeks of age at the time of injection.
Thioglycollate was prepared by boiling 3 g of thioglycollate medium
(Gibco Europe Ltd) in 100 ml of distilled water. The solution was
then autoclaved at 15 lb/in2 at 121°C for 3 min. After cooling the
thioglycollate was put into aliquots in sterile containers and stored
in the dark for 3 months prior to use. Storage renders the
thioglycollate more effective in increasing the yield of peritoneal
macrophages27*2. A volume of 0.5 ml was used for injection and the
animals left for 4 days prior to harvesting.
A volume of 200 yil (1.4 mg) of heat killed C. parvum (Wellcome Bio¬
technology Ltd) was used for injection and the animals left for 5 days
prior to harvesting. All animals were injected in the mid-peritoneal
cavity beneath the line of the liver and above the bladder.
2. 14 Harvesting of Peritoneal Exudate Cells
When required the mice were killed by ether overdose and the
peritoneal exudate cells harvested. An incision was made into the
midline of the peritoneal cavity of the mouse, the fur pulled back and
5 ml of HBSS usually containing 10 units/ml heparin (preservative-
free) were injected into the peritoneal cavity. The peritoneum was
then gently massaged and the mouse left for one minute. An incision
was made into the middle of the skin covering the peritoneal cavity
and the animal flipped over a cold glass filter funnel which was
placed in a plastic universal container in an ice bucket. This was a
convenient method which allowed the peritoneal fluid to drain from the
peritoneal cavity without requiring the use of a syringe or multiple
washes. The washouts containing the c&lts were kept on ice and spun at
4°C at 400 g for 8 min. All cells were washed once in HBSS prior to
counting. The differential cell counts obtained are shown in Table
2.6.
2.15 Mouse Model of Immunisation
To obtain an animal model of systemic sensitisation to A. fumigatus an
antigenic extract of A. fumigatus was used. The extract was obtained
from Dr J Edwards, MRC, Sully Hospital, Penarth who provided a sensi¬
tisation schedule. The A. fumigatus extract was prepared by Dr
Edwards as follows: (Method description written by Dr J Edwards) "An
A. fumigatus strain No. 1355 was grown by the double dialysis
method^^ with added glucose at 10 g/1 for 7-10 days at 30°C. The
mat was removed and washed (saline/azide) and extracted by Hughes
Press or equivalent. Hughes Press entailed freezing and squeezing
through a small orifice to give a decompression rupture. After cent-
rifuging, the debris was removed and the supernatant dialysed against
running tap water. Concentration to 25-40 mg/ml (dry weight) was by
air dialysis and storage was at -20°C. The extracellular material
was dialysed against running tap water, concentrated by air dialysis
and centrifuged. The soluble material was concentrated to 25-40
mg/ml and kept at -20°C. The extract used contained 50:50 somatic and
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TABLE 2.6 Differential cell counts of mouse peritoneal exudate
cells following injection with thioglycollate or
C. parvum
Differential %
Treatment Macrophage PMN Lymphocyte Eosinophil
Mast Cell
None 93.2 ( 2.0)1 0.8 ( 1.0) 3.8 (1.5) 2.2 (1.5)
Thioglycollate 92 ( 1.4) 2.3 ( 1.4) 3.3 (2.5) 2.3 (2.1)
C. parvum 63 (10.9) 34.2 (11.4) 2.6 (1.8) 0.5 (0.8)
1 Mean (SD) of counts from a pool of 6 mice from 6 separate exper¬
iments
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culture filtrate having been thawed, spun and filtered through a <450
my filter. Dry weight was determined before dispensing and the volume
adjusted to 20 mg/ml."
The animals were injected intramuscularly into the hind leg with 0.05
ml of 0.5 mg of A. fumigatus antigen in 0.25 mg Freund's complete
adjuvant. After 2 weeks the animals were boosted subcutaneously at
the scruff of the neck with 0.5 mg A. fumigatus extract. After a
further one, 2 and 3 weeks blood was obtained by cardiac puncture and
the sera tested for specific antibody using CIEP.
2.16 Intratracheal Instillation of Rats
This procedure was performed by Dr K Donaldson of the I.O.M. PVG
rats were anaesthetised with ether and the trachea exposed by blunt
dissection. A small incision was made into the trachea and a blunt
ended needle was introduced down to the carina. A volume of 0.1 ml
containing 1.4 mg of heat killed C. parvum was injected and the skin
closed with metal clips. To obtain an acute PMN-rich exudate the
rats were sacrificed 16 h later. The- cell population comprised >90%
PMN.
2.17 Lung Lavage Technique
PVG rats were sacrificed by intraperitoneal injection of
pentobarbitone sodium. The rats were dissected to expose the lungs
and the trachea. The trachea was raised slightly and a small hole
made between the cartilage rings. A cannula made from a blunted 16 g
needle was inserted and the needle tied in position with fishing line.
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The lungs, heart, trachea and needle were carefully removed from the
thoracic cavity and the lungs slowly inflated with 10 ml of warm
saline (37°C). The saline was then slowly withdrawn from
the lungs and decanted into plastic tubes which were kept on ice.
This procedure was repeated four times. The cells were centrifuged
at 350 g for 10 min at 4°C and the pellet resuspended in ice cold HBSS
prior to counting as previously described.
2.18 Isolation of Human Pulmonary Macrophages
Human pulmonary macrophages were obtained from fresh surgically
resected lung specimens. Sections of peripheral lung tissue were
taken by Dr K Kerr of the Department of Pathology, from macro-
scopically 'normal' areas when available, in non-diseased lobes and
always avoiding areas of collapse, infection or endogenous lipoid
pneumonia. The tissue was scissored into small fragments and filtered
through a 60 m wire mesh with ice cold HBSS. The cell suspension was
spun at 375 g for 10 min and the cells resuspended in medium (RPMI-
Flow Laboratories, Irvine, Scotland). A cytocentrifuge smear was
prepared and a differential cell count performed. A typical smear is
illustrated in Fig 2.6.
2. 19 Purification of Macrophages by Adherence
One hundred microlitres of a cell suspension containing 5 x 10^/ml
macrophages were added to flat-bottomed Removawells (Dynatech) or
glass coverslips 6 x 22 mm (Chance Propper Ltd, Warley, England).
The cells were allowed to adhere at 37°C in a 5% CO2 incubator for one
hour. After this time the cells were washed twice in warm (37°C)
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Figure 2.6 A photomicrograph of a cytocentrifuge smear of human
pulmonary macrophages, obtained from human lung tissue.
Original magnification x 400.
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RPMI prior to use.
2.20 Fungal Spores
All fungal spores used in the study were prepared and maintained by Dr
L.J.R. Milne, Mycology Unit, Western General Hospital, Edinburgh.
2.20.1 Aspergillus fumigatus
The principal strain of A. fumigatus used was an isolate grown from
the sputum of a patient with allergic bronchopulmonary aspergillosis
(Fig 2.7). In addition, for some of the work, multiple isolates of
A. fumigatus obtained from the sputum of a patient with aspergilloma
were used. A batch of A. fumigatus was prepared by culturing the
spores for two weeks at 37°C on 4% malt-peptone-agar (40 g malt
extract (The Boots Company, Nottingham, England), 5 g bacteriological
peptone (Oxoid, Basingstoke, England), 15 g agar (Gibco) dissolved in
one litre of distilled water (pH 5.6) and autoclaved at 121°C for 15
min). The spores were obtained from the cultures by tapping the
plates gently to release the spores which were then distributed into
sterile glass bijoux and kept at room temperature until required.
Once a week spores were removed from the stock supply and cultured at
28°C on malt-peptone-agar slopes to obtain spores for use in the
experiments.
2.20.2 Penicillium ochrochloron
The strain of P. ochrochloron was IMI 61531 (Fig 2.8). The freeze-
dried sample was put into distilled water, divided into aliquots in
sterile dry glass bijoux and stored at 4°C. Once a week, an aliquot
of the suspension culture of P. ochrochloron was removed from the
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Figure 2.7 A colony of A. fumlgatus (the strain used in this study)
grown at 28°C for 5 days on malt-peptone agar.
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Figure 2.8 A colony of P. ochrochloron (the strain used in this
study) grown at 28°C for 5 days on malt-peptone agar.
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stock supply and cultured at 28°C on malt-peptone-agar slopes to
obtain spores for use in the experiments.
2.21 Harvesting of Fungal Spores
Fungal spores were removed from the agar slopes using a sterile swab
(Medical Wire and Equipment Co. Ltd, Corsham, England) and transferred
into 5 ml of HBSS-0.01% bovine serum albumin (BSA). The spores were
dispersed manually using a glass homogeniser (Gallenkamp, East
Kilbride, Scotland). The dispersed spores were filtered through
nylon mesh which had a pore size of 5 pm. Filtration removed any
mycelial fragments, chains of spores or spore clumps to yield a spore
suspension containing only single spores. The spores were diluted
1:200 in HBSS-0.01% BSA and counted in an improved Neubauer chamber.
All spores were freshly prepared before each experiment and kept on
ice until required.
2.22 Spore Diffusates
Single spore suspensions were prepared as previously described (2.21)
In addition spores were prepared in distilled water or HBSS alone.
O
All spores were adjusted to a concentration of 10 /ml and incubated at
37°C for up to 3 h. After incubation the tube containing the spores
was spun at 500 g for 5 min and the supernatant containing the
diffusate filtered through a 0.22 Mm sterile filter (Flow
Laboratories). The diffusate was stored at -70 C until required.
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2.23 Preparation of Zymosan
Zymosan (Sigma) a cell wall extract of the yeast, Saccharomyces
cerevisiae was used as an additional control for some of the assays.
Zymosan was prepared by dissolving 5 g in PBS which was then boiled
for 5 min. The boiled zymosan was washed x 2 in HBSS by centri-
fugation at 400 g for 10 min and adjusted to 20 mg/ml in HBSS.
Aliquots were stored at -70°C until required.
2.24 Opsonisation of Spores and Zymosan
The spores and zymosan were opsonised in 5% sera for 30 min at 37°C
immediately prior to use. For some of the assay systems (production
of reactive oxygen intermediates) the spores were washed in HBSS, by
centrifugation at 400 g for 10 min and then resuspended in HBSS alone.
This step was required in order to remove the excess serum which is
thought to interfere with these particular assays. For the phago¬
cytosis/killing assay, spores were opsonised in RPMI-5% sera and then
used directly in the assay (without washing). All opsonised spores
were kept on ice until required.
2.25 Estimation of Cell Association of Fungal Spores
A volume of 50 KL of human PMN or mononuclear cells (1 x 10 /ml in
RPMI-5% serum) was added to flat bottomed microtitre plates (Gibco).
Wells containing 5 x 10^ adherent macrophages were prepared as
previously described (2.19). At the same time control wells
containing 50 nl of RPMI-5% serum alone were set up. One hundred
microlitres of opsonised spores (10^/ml in RPMI-5% serum) were added
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to give a final spore:phagocytic cell ratio of 2:1 or 1:1. The
results of a standardisation experiment to determine optimum
spore:cell ratio is illustrated in Fig 2.9. To increase contact
between spores and cells the microtitre plates were centrifuged at 125
g for 5 min and then incubated at 37°C for one hour. After this time
the sedimented non-cell associated spores were resuspended by gently
mixing and an aliquot of supernatant (50 pi) was removed and diluted
1:2 in saline/Trypan blue (W/V 1:1) and the number of free spores
present counted using an improved Neubauer counting chamber. Total
spores were estimated from the number of spores in the supernatant of
the control wells containing spores alone, and this was used as a
baseline to determine the percentage of spores becoming cell-
associated using the following formula:
% of spores
cell-associated = (total spores - spores non-cell-associated) x 100
total spores
All experiments were carried out in triplicate. The basic procedure
used in this technique is illustrated in Fig 2.10.
2.26 Phagocytosis of Radiolabelled Antibody Coated Sheep Red
Blood Cells
This method of phagocytosis was used to discriminate between attached
and ingested sheep red blood cells (srbc). All non-ingested srbc are
removed by lysis, thereby permitting an accurate estimation of
ingestion.
245
The method used was based on that described by Shaw and Griffin







































Figure 2.10 Illustration of the basic procedure used for the
estimation of phagocytic cell-association of fungal
spores.
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England) were washed x 3 in PBS. The washed packed srbc were radio-
[T -I C I O
labelled by incubation in 3 sodium chromate (D Cr) 10 (Amersham
p
International PLC, Aylesbury, England). A volume of 10 srbc/100 y
CI O R 1
Ci Cr were incubated for one hour at 37 C. The J Cr srbc were washed
Q S 1
once in PBS and adjusted to 10y J Cr srbc/ml. This suspension was then
divided into two aliquots and the following added:
(i) Irrelevant antibody (mouse IgG; Sigma) at 10 pg/10'
srbc
(ii) Monoclonal antibody to srbc (mouse IgG anti-srbc, Sera-
7
Lab Ltd, Crawley Down, England) at 10 pg/10 srbc.
These mixtures were incubated for 15 min at 37°C then washed twice in
ice-cold PBS by centrifuging at 300g for 10 min. The antibody coated
C 1J Cr srbc were then suspended in RPMI-20% heat inactivated foetal calf
serum (Gibco) at a concentration of A x 10 /ml. C. parvum stimulated
mouse peritoneal exudate cells was added to flat-bottomed Removawells
at a concentration of 2 x 10"7ml in 100 Pi of RPMI-10% heat
inactivated foetal calf serum. The cells were left to adhere for 3 h
at 37°C in 5% CO2 and then washed twice in warm HBSS (37°C). Five
separate treatments were used and so 50 Pi of one of the following
solutions were added to Removawell cultures.
(i) HBSS alone
(ii) HBSS alone
(iii) A. fumigatus diffusate,
(iv) P. ochrochloron diffusate,
(v) a known inhibitor of phagocytosis - cytochalasin B at 25
Pg/ml (Sigma).
To treatment (i) 50 Pi of ^1Cr srbc coated in irrelevant antibody
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C 1
was added whilst treatments (ii) - (v) 50 pi of J Cr srbc coated
with mouse IgG anti-srbc was added.
The Removawells were centrifuged for 5 min at 125 g to enhance contact
then incubated at 37°C in 5% CO2 for 1.5 h. The supernatant was
removed and 100 pi of ice-cold red cell lytic buffer added to lyse
non-phagocytosed srbc. After 5 min the lytic buffer was removed and
the cell washed x 3 in cold PBS. The Removawells containing cells
C 1
with phagocytosed Cr srbc were counted in a gamma counter (LKB-Rack
Gamma II). For each experiment 5 replicates were performed.
2.27 Spore Killing Assay
This assay is based on the estimation of colony forming units
following incubation of fungal spores with phagocytic cells for 3 h at
37°C illustrated in Fig 2.11. A volume of 50 pi of human PMN or
7
mononuclear cells (1 x 10 /ml) in RPMI-5% autologous serum) were added
to flat bottomed Removawells. Removawells containing 5 x 10 adherent
macrophages were prepared as previously described (see sections 2.19 &
2.25). At the same time control wells containing 50 pi of RPMI-5%
serum alone were set up. A volume of 100 pi of appropriately
opsonised spores (5 x 10 /ml in RPMI-5% serum, see section 2.24) were
added to all wells to give a final spore:phagocytic cell ratio of 2:1
and 1:1. The results of standardisation experiments to determine
optimum spore:cell ratios are illustrated in Fig 2.12. To increase
contact between spores and cells the Removawells were centrifuged at
125 g for 5 min. The cells plus spores were then incubated in a
humidified chamber for 3 h at 37°C. After this time the wells were















Figure 2.11 Illustration of the basic procedure used for the
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(Sterilin) containing distilled water-0.1% Triton-X (Sigma) which were
mixed by vortexing on a Whirlimix. This process causes disruption of
the cells allowing release of the cell-associated fungal spores.
After 5 min a 50 |il aliquot was transferred to a sterile bijou
containing 3.95 ml of PBS-0.01% BSA from which a 125 nl sample was
plated out using a sterile inoculating loop (Nunc) on to a Petri dish
of Sabouraud dextrose agar (65 g of Sabouraud dextrose agar (Oxoid)
dissolved in one litre of distilled water and autoclaved at 121°C for
15 min - Sabouraud plates were kindly prepared by the Bacteriology
Department at the City Hospital). The plates were incubated at 37°C
for 24-40 h (A. fumigatus-24 h, P. ochrochloron-40 h; optimum times
for colony growth). The colony forming units (CFU) were counted using
a semi-automated colony counter (Chiltern) and the results are
expressed as:
The percentage of spores killed = (Control CFU-cells/spores CFU) x 100
Control CFU
All experiments were set up in triplicate.
A considerable amount of time was spent on the development and stand¬
ardisation of this spore killing assay. Numerous technical problems
had to be overcome, the primary one being adaptations to take into
account the biological behaviour of the fungal spores. Initial
studies revealed that the ability of the phagocytic cells to kill
fungal spores was dependent upon the spore's state of germination,
prior to challenge. If spores were harvested (0 h spores) opsonised
and then incubated with mouse peritoneal exudate cells for one hour
instead of the spores being killed there was an increase in CFU (%
surviving) relative to the control spore suspension. However, if the
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spores were harvested then preincubated for 3 h at 37°C (3 h spores)
prior to opsonisation the percentage of spores surviving in relation
to the control spore suspension was substantially reduced (Table 2.7).
This result suggested that spores in early stages of germination (not
visible) are more susceptible to killing when compared with dormant
spores. In order to try to explain the reasons for this enhanced
germination the following experiments were carried out.
2.27.1 Effect of incubation time on CFU formation
The spores of A. fumigatus were obtained by shaking the free spores
from the culture as it was thought that these 'released' spores were
similar to those that would normally be inhaled by man. The possi¬
bility that these released spores would be in a fairly dormant phase
(thereby accounting for the low CFU in the control suspension),
and that incubation at 37°C in suspension, may bring them out of this
phase, was considered. Suspensions of spores of A. fumigatus and
P. ochrochloron were incubated at 37°C, samples were taken at set time
points, plated out, incubated overnight and CFU estimated. It can be
seen from Fig 2.13 that the CFU of both A. fumigatus and
P. ochrochloron increased by approximately 25%, although this increase
plateaued much earlier for P. ochrochloron (2 h) than for A. fumigatus
(5 h).
Although these results partially explained the increase in CFU found
between using 0 and 3 h spores another experiment was carried out to
test if cell products may also be contributing to the enhanced germ¬
ination.
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TABLE 2.7 Effect of preincubation at 37°C on the
percentage of opsonised spores of A. fumigatus
surviving after incubation with mouse peritoneal
exudate cells for one hour at a spore : cell
ratio of 1:1. The % is calculated from the CFU
of the control spores alone.
Preincubation (h) % Spores added surviving
0 152 (18.8)1
3 101 (16.1)
1 Mean (SD) of eight experiments
O
+30- +20- 10-
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2.27.2 Effect of cell products on numbers of CFU
Adherent mouse peritoneal exudate cells in medium containing 5% serum
were subjected to 3 treatments:
(i) Supernatants (containing resting cell products) were
obtained from cells which had been incubated at 37° for
one hour.
(ii) Supernatants were obtained from cells which had been
frozen, thawed and then spun.
(iii) Cells were treated with latex beads for one hour in order
to stimulate phagocytosis. The supernatants were then
removed.
The supernatants removed from these 3 treatments were incubated with 0
h spores for one hour at 37°C and CFU estimated. When compared with
control alone in medium containing serum it was found that these 3
treatments enhanced the germination of the 0 h spores by approximately
40% (see Table 2.8). Although it was only one experiment this result
indicated that cell products obtained from resting macrophages were
sufficient to enhance the germination of spores.
Further work was undertaken to see if phagocytic cells needed a longer
incubation period in which to kill the spores. The results shown in
Fig 2.14 demonstrate that incubating 0 h spores with mouse peritoneal
exudate cells for up to 4 h resulted in a time-dependent increase in
spore killing.
The overall results of these studies showed that in order to obtain
reproducible results it was very important to always have the spores
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TABLE 2.8 The effect on the germination of spores of
A. fumigatus following the addition of supernatants
of mouse peritoneal exudate cells, which had been
subjected to three treatments
Treatment Percentage difference from control CFU
(Supernatant) (Mean [SD])
None (resting cells) + 38 (2.5)
Frozen and thawed + 45 (2.3)
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in the same phase of growth at the beginning of each assay (see 2.20).
It was also decided that a 3 h incubation period would be used for all
spore-killing experiments.
2.28 Preparation of Cell/Spores for Microscopy
Phagocytic cells (200 pi of 5 x 10^/ml in RPMI-5% autologous serum)
were allowed to adhere to glass microchamber slides (LAB-TEK, Miles
Laboratories) or glass coverslips (13 mm diameter) for one hour at
37°C in 5% CC^- The cultures were then gently rinsed twice in warm
HBSS (to remove non-adherent cells). Opsonised spores in RPMI-5%
autologous serum were added to the adherent phagocytic cells at a
spore:cell ratio of between 2:1 and 1:1 and the cultures incubated at
37°C and 5% CO2 for 1.5 h. Spores alone were added to coverslips
which had been pre-treated with 1% alcian blue (Sigma) to increase the
surface charge of the glass, which results in increased attachment of
particles. After this period, excess spores were removed by gently
washing 3 times in warm HBSS the slides were fixed in methanol and
stained in May Grunwald Giemsa as previously described. For examin¬
ation by either Phase contrast or Nomarski differential interference
optics (Carol Zeiss, West Germany), the slides were mounted in HBSS.
The coverslips were processed for scanning electron microscopy
(SEM)^^1 by fixing at 37°C for 30 min in 2.5% glutaraldehyde (Sigma)
in 0.1M cacodylate buffer containing 0.1M sucrose (Sigma) followed by
two rinses in the buffer. The cells were then dehydrated with
increasing concentrations (25, 50, 75 and 100%) of acetone in
distilled water, by incubating for 10 min in 2 changes of each concen¬
tration. The fixed cells were taken to the Western General Hospital,
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Edinburgh where they were Critically Point Dried using liquid CC>2 by
the staff of the Electron Microscopy Suite of the MRC Population
Cytogenetics Unit, Edinburgh. The cells were mounted on stubs and
coated with gold using a gold sputter coater (Nanotech, England) prior
to examination on a scanning electron microscope (Cambridge Stereoscan
250 Mark II, Cambridge Instruments Ltd, England).
2.29 Preparation of Cells/Spores Following Challenge with Spores
in vivo
C57B1/6 mice which had received an intraperitoneal injection of 3%
thioglycollate (0.5 ml) 4 days previously, were challenged intra-
peritoneally with 10® spores in 0.5 ml HBSS. After 1.5 h the
peritoneal cavity was lavaged with 5 ml of HBSS; the lavaged cell
population with attached or ingested spores was allowed to adhere to
coverslips for one hour at 37°C and was then prepared for light and
scanning electron microscopy.
2.30 Chemiluminescence
This assay is based on the finding that stimulated phagocytes generate
light detected as chemiluminescence®^''' following contact with surface
activating agents. The chemiluminescent responses of PMN and mono¬
nuclear cells were amplified by the addition of 5-amino-2, 3-dihydro-
O A Q
1, 4-phthalazinediane (luminol, Sigma) , whilst that of macrophages
was amplified by bis-n-methylacridinium nitrate (lucigenin, Sigma 1®^^.
Luminol was made up by dissolving 17.7 mg in a minimal volume of
dimethyl sulphoxide (Sigma) and making up to a concentration of 4 x
-8 o
10 M in HBSS. Aliquots of stock solution were stored at -70 C until
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required. Lucigenin was prepared by dissolving 51.0 mg into 10 ml
HBSS to give 10~^M. Aliquots were stored at -70°C until required.
Chemiluminescence was measured directly in mV in an automated 24
sample carousel LKB 1251 luminometer interfaced to an Apple lie
computer with disc storage. Phagocytic cells were prepared at 5 x
£
10 /ml in cold HBSS and maintained on ice until required. Optimal
spore:cell ratios for the assay systems were determined (Figs 2.15
a,b and 2.16) and the following concentrations used: PMN 10:1,
monocytes 50:1, macrophages 100:1. Zymosan was used as a positive
control. Standardisation experiments showed that a concentration of
5 mg gave good responses for both PMN and monocytes (Table 2.9). A
volume of 200 yl of opsonised spores or zymosan was placed in poly¬
styrene cuvettes (LKB) followed by 200 yl of the appropriate
amplifier. Luminol for PMN and mononuclear cells and lucigenin for
macrophages. Five hundred microlitres of cells were then added (2 x
10^/ml) and the cuvettes immediately placed into the carousel of the
luminometer and kept at 37°C with regular mixing. The chemilumines-
cent responses were measured in mV and automatically recorded at timed
intervals until the chemiluminescence had peaked. All results were
stored on disk for subsequent analysis. A typical chemiluminescent
response of both PMN and mononuclear cells to zymosan is illustrated
in Fig 2.17. As the number of samples which could be tested at any
*
one time was governed by the availability of cells and the capacity of
the machine it was decided that each treatment would be measured once
only. This decision was based on the results of experiments which
showed that the technique gave highly reproducible results within
replicates. An example of the reproducibility of the measurements of































































Theeffectofincreasingsporerc llratio(5:1100:1)nthlucig inamplifi d chemiluminescentresponsesofmop ritonealexudatc lltowards o ef A.fumigatusandPochrochloron,opso isedin5%autologo sse .Resultsxpressed aspeakchemiluminescenceinmV.
-87-
TABLE 2.9 The effect of increasing concentrations of zymosan,
from 0.5-20 mg, on the production of chemilumin-
escence by human monocytes and PMN
Zymosan* PMN Monocytes
mg Peak (mV) Time (sec) Peak (mV) Time (sec)
0.5 554.9 1235 71.81 1495
2.5 770.4 845 100 1430
5.0 995.6 780 106 975
10.0 1103 650 109.1 650
20.0 1166 585 90.79 520
* Zymosan preopsonised in 5% human AB serum
TIME(min)
Figure2.17Typicalprofileothluminol-amplifiedchemilumin scentresponsesfu aPMNa d monocytes(1x106cell ),towardzymosan(5mgonitoredver5itiperio .
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exudate cells are shown in Table 2.10. The coefficient of variation
of this experiment was estimated at 1.5%.
2.31 Hydrogen Peroxide Assay
Hydrogen peroxide was measured according to the method of Pick and
250
Keisari . The assay is based on the horseradish peroxidase
mediated oxidation of phenol red by hydrogen peroxide, which results
in the formation of a compound demonstrating increased absorbance at
610 nm. Phenol red (Sigma) was made up to 0.028 M in distilled water
(1 g/100 ml). This solution was kept at 4°C for up to 6 months.
Horseradish peroxidase Type II salt-free powder (Sigma) was dissolved
in 0.05 M potassium phosphate buffer pH 7.0 at a concentration of 5
mg/ml divided into one millilitre volumes and kept frozen at -70°C
until required. Hydrogen peroxide was obtained as a 30% solution
(Sigma) and 102 yl of this was diluted with 100 ml distilled water
(0.01 M) just before use. Catalase was obtained as a purified powder
from bovine liver (Sigma) and was diluted in 0.1 A M sodium chloride
just prior to use. The buffered phenol red solution (PRS) used in all
assays contained 140 mM sodium chloride, 10 mM potassium phosphate
buffer pH 7.0, 5.5 mM dextrose, 0.28 mM phenol red and 50 ug/ml
horseradish peroxidase.
The reaction mixture (1 ml) containing 5 x 10^ phagocytic cells,
phenol red solution and appropriate treatments, (for example, spores
or spore diffusates) were added to 30 mm petri dishes (Sterilin). As
an additional control, opsonised zymosan was added to the reaction
mixture at a concentration of 1 mg/ml. All experiments on human cells
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TABLE 2.10 Reproducibility of eight separate estimations of the
chemiluminscent responses of lucigenin amplified mouse
peritoneal exudate cells to zymosan opsonised in 5%
autologous serum
Chemiluminscence










were set up in duplicate and whilst those on animal cells were carried
out in triplicate; the dishes were incubated at 37°C for 2 h. After
this time the supernatants were transferred into RT30 tubes which were
spun at 400 g for 10 min at 4°C, to sediment cells/spores. The super¬
natants were then read at 610 nm using a spectrophotometer (Pye Unicam
SP 400). A hydrogen peroxide standard curve was made by diluting the
hydrogen peroxide stock solution to give concentrations of 10 pM to 10
mM. Ten microlitres of these hydrogen peroxide concentrations were
added to RT30 tubes (Sterilin) containing 1 ml volumes of phenol red
solution, to give a final hydrogen peroxide concentration of 0.1-100
PM. The standards were incubated at the same time as the assay. A
typical standard curve is illustrated in Fig 2.18. The concentration
of hydrogen peroxide in the samples was determined from the standard
curve.
2.32 Superoxide Anion Assay
23 1
Superoxide anion was measured according to the method of Johnston
which relies on the reduction of cytochrome C, a reaction charact¬
erised by an increase in spectrophotometric absorbance of cytochrome C
at a wavelength of 550 nm. The reduction of cytochrome C is not
specific for superoxide anion and the required specificity is achieved
by the use of superoxide dismutase, an enzyme for which superoxide
anion is the only known substrate. This assay was run with
and without superoxide dismutase and only the portion of the reduced
cytochrome C which could be inhibited by superoxide dismutase was
considered to reflect the nmol of superoxide anion released. The
reaction mixture (total volume 1.5 ml) which contained 80 pmol cyto-
Figure2.18Theffectofaddingincreasinconcent atio shydrogp rox de(H2O2)t spectrophotometryabs rbance610nmofthehorseradishperoxidase-ph nolr solution.
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chrome C (Sigma) 2 mg/ml dextrose (Sigma), appropriate treatments (eg
spores or spore diffusates) followed by 5 x 10 phagocytic cells were
added to 30 mm Petri dishes. As an additional control, opsonised
zymosan was added to the reaction mixture at a concentration of 1
mg/ml. To determine the portion of reduced cytochrome C that could be
inhibited by superoxide dismutase identical dishes with added
superoxide dismutase (25 ug/ml; Sigma) were prepared at the same time.
The experiments were set up in either duplicate or triplicate and
incubated at 37°C for 2 h. The supernatants were transferred into
RT30 tubes and spun at A00 g for 10 min and 4°C. The peak absorbance
at 550 nm, of the supernatant, was determined using the scan mode of
the spectrophotometer (SP8/400 Pye Unicam). The portion of the
reduced cytochrome C that could be inhibited by superoxide dismutase
was then used to estimate the nmol of superoxide anion released.
2.33 Chemotaxis
In the chemotaxis experiments the basic procedure described by
232
Snyderman J for blindwell chambers was followed except that PMN were
used. The chemoattractant, zymosan activated serum was prepared by
incubating 1 mg of zymosan with 1 ml of serum in a shaking water bath
for 30 min at 37°C. The zymosan was spun out of the serum by centri-
fuging at 500 g for 15 min. The serum was then heat inactivated at
56°C for 30 min. Aliquots were stored at -70°C until required. The
working solution used for the experiment was RPMI - 10 mM Hepes
(Gibco) - 1% BSA.
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A volume of 200 pi of chemoattractant was placed in the lower
compartment of the blindwell chamber which was separated from the top
compartment by a 3 pm nuclepore filter (Nuclepore Corporation Inc,
Pleasanton, California USA). Prior to adding the cells (200 pi 1 of 3 x
10^ human PMN per ml) to the top compartment, the following solutions
(200 pi) were added: (i) HBSS or (ii) A. fumigatus diffusate, or
(iii) P. ochrochloron diffusate. For the experiments on random
migration additional treatments were included. Instead of zymosan
activated serum, 200 pi of HBSS or 200 p1 of A. fumigatus diffusate
were added to the lower compartment followed by 200 pi HBSS or 200 pi
A. fumigatus diffusate to the top compartment. The chambers were
incubated in a humidified incubator containing 5% CC>2 for 45 min at
37°C. After this time the filters were washed twice in PBS and
stained in Diff Quick (Merz and Dade AG, Switzerland) and the number
of migrated cells per five high power fields (magnification x 1000)
were counted. All tests were carried out in duplicate. The basic
procedure for this assay is illustrated in Fig 2.19.
2.34 Macrophage Spreading Assay
This assay was carried out according to the method of Donaldson ert
ai253. Fifty Pi of the following solutions was added to 6 x 22 mm
glass coverslips:
i) control HBSS, or
ii) A. fumigatus diffusate, or
iii) P. ochrochioron diffusate.
c;













NUMBER OF CELLS MIGRATED
COUNTED
Figure 2.19 Illustration of the basic procedure used to estimate the
effect of spore diffusates in the chemotaxis of human
PMN towards zymosan activated serum using a blindwell
chamber.
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mouse peritoneal exudate cells in RPMI-1640 20% foetal calf serum
which had been heat inactivated at 56°C for 30 min. After a one hour
incubation at 37°C in 5% CO2 the coverslips were rinsed gently twice
in saline and stained in Diff Quick. When dry the coverslips were
inverted and mounted on a microscope slide using DPX (BDH Chemicals
Ltd, Poole, England). The greatest diameter of 200 cells was
measured using a microcomputer-assisted digitising system (DDSI
Graphic Information Systems Ltd, Scotland). With this system a pin¬
point of light on the cursor is superimposed on the image of the
stained macrophage preparation using a camera lucida attachment to a
Nikon FE optical microscope. Before measuring each assay the system
was calibrated using a graduated graticule which enabled the cell
measurements to be expressed directly in microns. All tests were
carried out in triplicate. Typical size distributions of resting and
activated (C. parvum elicited) peritoneal exudate cells are
illustrated in Figs 2.20 a,b.
2.35 Techniques to Detect a Possible Scavenging Effect of
Diffusates on Reactive Oxygen Intermediates
The following methods were used to test for a possible scavenging
effect of diffusates on reactive oxygen intermediates.
2.35.1 Superoxide anion
A cell-free superoxide anion generation system generally based on the
254
method described by Rosen and Klebanoff was used . Approximately 6
nmol of superoxide anion was generated by incubating xanthine oxidase
(20 wg/ml, Sigma) with acetaldehyde (40 nmol, Sigma) for 5 min at
37°C. To this superoxide anion generating system one millilitre of
100-



















Figure2.20bTypicalsizedistributionsofthediameterfC.parvumst ulat dm speriton al exudatecellsfollowingincubationng assiRPMI-10%foet lcalfs rum(h inactivated)for1ht37°C
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the following was added: (a) HBSS (control); (b) superoxide dismutase
(25 ug) (c) diffusate (1:4 dilution). Each of the 3 treatments was
set up in triplicate and incubated for 10 min at 37°C. The reaction
mixture, used to detect superoxide anion (see section 2.32), was then
added and after a further incubation for 10 min at 37°C the absorbance
at 550 nm measured.
2.35.2 Hydrogen peroxide
Hydrogen peroxide (Sigma) was diluted to give concentrations ranging
from 1-20 nmol. To the hydrogen peroxide 1 ml of the following was
added: (a) HBSS (control); (b) catalase (Sigma) 100 ug/ml, an enzyme
which catalyzes the degradation of hydrogen peroxide to oxygen and
water, and (c) diffusate (1:4 dilution). Each of the 3 treatments
was prepared in duplicate and incubated for 30 min at 37°C. The
reaction mixture used to detect hydrogen peroxide (see section 2.31)
was added to the tubes which were then incubated for a further 30 min
at 37°C; the absorbance at 610 nm of the mixture was read.
2.36 Techniques to Determine Molecular Weight of Spore Diffusates
To determine whether the spore diffusate was of a low molecular weight
the diffusate was dialysed against HBSS for 16 h at 4°C using dialysis
tubing 8/32 ins. (The Scientific Instrument Centre Ltd, London,
England). As the activity of the diffusate appeared to decrease on
storage at 4°C, an aliquot of the diffusate was put into dialysis
tubing and kept in a sealed tube for 16 h at 4°C, as a control. The
treated diffusate was then tested in the superoxide anion and hydrogen
peroxide assay systems. The diffusate was also put through Amicon
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filters (Stonehouse, UK) with exclusion limits of >1,000 MW, >5,000 MW
and >10,000 MW.
2.37 Techniques to Assess the Time taken for Release of Spore
diffusate
In order to find out at what stage the diffusates were released into
O
the supernatant, spores (10 /ml) were added to HBSS. This suspension
was divided into 3 aliquots, and the following treatments carried out:
(i) the spores were incubated for 2 min immediately removed
and supernatants filtered; hereafter referred to as 2
min incubation or washings;
(ii) the washed spores were resuspended in HBSS and incubated
for 3 h at 37°C before spinning them out obtain the super¬
natant; hereafter referred to as washed + 3 h incubation;
(iii) the spores were incubated in HBSS for 3 h and the super¬
natant removed and filtered = 3 h incubation.
The spore diffusates were then tested in the superoxide anion and
hydrogen peroxide assay systems.
2.38 Assessment of Cell Viability Following Treatment with Spore
Diffusates
2.38.1 Trypan blue exclusion
To determine if the spore diffusates were having a toxic effect on the
cells, 5 x 10^ cells were incubated for 2 h at 37°C in 1 ml of control
HBSS or spore diffusates (1:4 dilution). After this time the percent-
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age viability was determined by the trypan blue exclusion method.
S 1
2.38.2 Chromium release assay for detection of cytotoxicity
Human lung macrophages were added to flat-bottomed microtitre plates
at a concentration of 1 x 10^ cells per well in RPMI-2% BSA. Ten
microlitres of ^1Cr (100 KBq) was added to the wells and the cells
left to become radio-labelled for 18 h at 37°C in 5% C02. The cells
were washed x 3 in PBS and 200 pi of the following added: (i) HBSS - a
measure of spontaneous release (ii) A. fumigatus diffusate diluted 1:2
in HBSS, (iii) A. fumigatus diffusate diluted 1:4 in HBSS. The cells
were incubated for a further 3 h at 37°C in 5% C02. A sample of 100
ul of the supernatant was taken and counted in the gamma counter. A
C 1
total measure of the amount of J Cr taken up by the cells was made by
adding distilled water-0.1% triton-X to wells containing the cells and
HBSS; the cell lysates were then counted in the gamma counter.
Cytotoxicity was determined by comparing the counts in the super-
natants of the cells treated with diffusates, with those counts
obtained by the addition of HBSS alone (spontaneous release) .
2.39 Enzyme Treatment to Strip Spores from Cell Surfaces
In an attempt to quantify the number of intra and extracellular spores
an enzyme stripping technique was adopted. Opsonised spores of
A. fumigatus were incubated with mouse peritoneal exudate cells in
either medium plus 5% autologous serum alone (see section 2.25) or
containing known inhibitors of phagocytosis; cytochalasin B (25
pg/ml) and sodium azide (0.02%). After one hour incubation at 4°C or
37°C the cells/spores were washed to remove excess non-cell-associated
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spores and the cells treated with pronase (0.15%), an enzyme which is
known to strip cell receptors and, therefore, the attached spores.
The cells were then disrupted to release the remaining (ingested)
spores (see section 2.27). The spores removed by stripping and
obtained by breaking up the cells were then counted (see section
2.25).
2.40 Statistical Analyses
The majority of the statistical analyses was carried out by Mr W
McLaren and Miss H P R Collins of the Statistical Branch at the IOM.
The type of statistical analyses used depended on the nature of the
experiments. Most of the work for the patient study was carried out
on one occasion only. An analyses of co-variance was used to
estimate the possible differences in the phagocytosis/killing assays.
For standardisation work using the animals each experiment was carried
out in triplicate and performed on 2-5 separate occasions. For
individual experiments a different group of animals and spores or
spore diffusates prepared from fresh cultures was used. Therefore,
day to day variation in spontaneous release of ROI, killing of fungal
spores and strength of diffusate did occur. The statistical analyses
were designed to take into account this variation between experiments
and treatments so that the analyses of treatment effect would be
independent of inter-experimental variation. Initially the raw data
were subjected to analysis of variance using a randomised block
design; each day/experiment constituted a block. Student's-t tests
were used to compare treatment means using the residual error obtained
256
from the analysis of variance .
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3. RESULTS
The mechanisms involved in the interactions of phagocytic cells with
fungal spores were primarily assessed by measuring the processes of
phagocytosis, killing and reactive oxygen intermediate production.
The results of the experiments are presented in the order in which
the research evolved. I thought this would give the reader a
clearer understanding of the rationale behind the development and,
therefore, the reasons for the experimental sequence. These general
results are followed by the results of comparisons of fungal handling
by phagocytic cells from asthmatic patients sensitised and non-
sensitised to A. fumigatus and non-asthmatic control subjects.
3.1 Morphological Examination of the Interaction between
Phagocytic Cells and Fungal Spores
This work began by examining morphologically what happens when fungal
spores are added to phagocytic cells. The ability of phagocytic
cells to bind fungal spores was assessed by estimating the number of
spores which become cell-associated following incubation in vitro for
one hour at 37°C. Following these initial estimations of cell-
association the next step was to distinguish between attached and
ingested spores using Nomarski differential interference contrast
optics, scanning electron microscopy and also enzyme stripping
techniques.
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3.1.1. Association of fungal spores with phagocytic cells
The results in Table 3.1 show that most (>77%) of the opsonised
spores of both A. fumigatus and P. ochrochloron became cell-
associated with both human monocytes and PMN after one hour incub¬
ation at 37°C. Similarly, approximately 65% of opsonised spores
became cell-associated with mouse peritoneal exudate cells (Table
3.2). No significant differences were found between spore or cell
type.
Examination by light microscopy of slide preparations of the cell-
spore interactions also confirmed that a substantial number of spores
had become cell-associated (Figs 3.1 a-d). It was not possible,
however, to distinguish between attached and ingested spores.
Adherent cultures of thioglycollate elicited mouse peritoneal exudate
cells challenged with'spores of A. fumigatus were unable to fully
inhibit spore germination. Phase contrast micrographs at two hours
show that the spores had become cell-associated (Fig 3.2a). At nine
hours, however, the spores had become swollen and germ tubes were
beginning to emerge (Fig 3.2b) and by 12 h hyphal branching was
evident (Fig 3.2c).
3.1.2 Discrimination between intracellular and extracellular spores
i) Examination of spores/cells using Nomarski Optics
Examination of the interaction of phagocytic cells from humans and
mice with opsonised fungal spores after incubation for three hours at
37°C using Nomarski differential interference contrast optics
revealed that a substantial number of spores appeared to be bound to
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TABLE 3.1 The percentage of spores opsonised in autologous serum
which became cell-associated with human monocytes and
PMN after one hour in vitro
Fungal spore Cell type % of cell-associated spores
A. fumigatus Monocyte 87.8 (3.2)*
A. fumigatus PMN 00 o (9.5)
P. ochrochloron Monocyte 80.7 (4.7)
P. ochrochloron PMN 77.5 (6.4)
* Mean (SEM) of the results from 6 subjects
-106-
TABLE 3.2 The percentage of spores opsonised in autologous serum
becoming cell-associated with thioglycollate elicited
mouse peritoneal exudate cells after 1 h in vitro












Figure 3.1 a-b Photomicrographs of the cell-association of human
monocytes and PMN with spores of A. fumigatus
(opsonised in 5% autologous serum) following
incubation in vitro for 1 h at 37°C. (a) monocytes
and A. fumigatus Tb) PMN and A. fumigatus; spores







Figure 3.1 c-d Photomicrographs of the cell-association of human
monocytes and PMN with spores of P. ochrochloron
(opsonised in 5% autologous serum) following incub¬
ation in vitro for 1 h at 37°C (c) monocytes and
P. ochrochloron (d) PMN and P. ochrochloron: spores
indicated with arrows. Light microscopy original
magnification x 400.
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Figure 3.2 a-c Phase contrast micrographs of thioglycollate elicited
mouse peritoneal exudate cells challenged with spores
of A. fumigatus and incubated at 37°C for up to 12 h;
(a) 2 h Tbj 9 h germ tube indicated with an arrow
(c) 12 h : original magnification x 400
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the surface of the cell and not internalised. The spores which are
seen as silhouettes against the cell surface are illustrated in Figs
3.3 a,b (with mouse macrophages), Figs 3.3 c,d (with human monocytes),
Figs 3.3 e,f (with human PMN).
ii) Scanning electron microscopy of fungal spores with human
phagocytic cells
The next stage was to examine the cell/spore interaction using
scanning electron microscopy (SEM), which shows fungal spores as
small rounded bodies closely associated with the phagocytic cell
membrane. The degree to which the spore became cell-associated has
been arbitrarily divided into three phases: (1) attached - spore
lying on the cell surface; (2) partially ingested - the cytoplasm of
the cell enclosing the spore yet not fully covering it; and (3)
ingested - the outline of the spore being seen under the cytoplasm of
the cell.
Using SEM a substantial number of spores of A. fumigatus were found
to be attached to the surface of the human phagocytic cell and not
internalised after incubation at 37°C for 1.5 h (Figs 3.4 a,b).
Although spores of P. ochrochloron were present on the surface of the
cell they appeared to be less numerous (Figs 3.4 c,d). Opsonisation
of fungal spores in sera containing specific antibody did not appear
to alter this finding.
iii) Examination of Fungal Spore Interactions with Mouse Phagocytic
Cells using SEM
A mouse model was used to examine whether the finding (substantial
number of extracellular spores) obtained by in vitro experimentation
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Figure 3.3 a-b Photomicrographs, using Nomarski differential inter¬
ference contrast optics, of the cell-association of
spores of A. fumigatus and P. ochrochloron opsonised
in autologous serum with mouse peritoneal exudate
cells following incubation at 37°C for 3 h; (a)
A. fumigatus (b) P. ochrochloron, spores are
indicated with arrows : original magnification x 400
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Figure 3.3 c-d Photomicrographs using Nomarski differential
interference contrast optics of the cell-
association of spores of A. fumigatus and
P. ochrochloron opsonised in autologous serum,
with human monocytes following incubation at 37°C
for 3 h; (c) A. fumigatus (d) P. ochrochloron
spores indicated with arrows; original magnifi¬
cation x 250.
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Figure 3.3 e-f Photomicrographs using Nomarksi differential inter¬
ference contrast optics of the cell-association of
spores of A. fumigatus and P. ochrochloron, opsonised
in autologous serum, with human PMN following incub¬
ation at 37°C for 3 h; (e) A. fumigatus
(f) P. ochrochloron spores indicated with arrows;




Figure 3.4 a-b Scanning electron micrographs of the interaction of
spores of A. fumigatus, opsonised in autologous
serum, following incubation in vitro for 1.5 h at
37°C: (a) a human monocyte (b) a human PMN; spores
attached ( □ ) partially ingested ( O )
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Figure 3.4 c-d Scanning electron micrographs of the interaction of
spores of P. ochrochloron, opsonised in autologous
serum, following incubation in vitro for 1.5 h at
37°C: (c) a human monocyte (d) a human PMN; spores
attached ( □ ) partially ingested ( O )
-116-
could be repeated i_n vivo. Examination of the interaction of opson-
ised fungal spores with thioglycollate elicited mouse peritoneal
exudate cells (PEC) in vitro gave results similar to those obtained
with human phagocytes (Figs 3.5 a-b). The in vivo experiments, in
which spores were injected into the peritoneal cavity of the mouse
followed by lavage 1.5 h later, gave similar findings. A substantial
number of A. fumigatus spores were seen to be bound to the surface of
the cells in vivo, while spores of P. ochrochloron were becoming
ingested (Figs 3.6 a-d).
(iv) Quantification of the number of spores ingested using enzyme
stripping techniques
Preliminary attempts, using enzyme stripping techniques to quantify
the number of intra and extracellular spores were unsuccessful.
Treatment with pronase dislodged substantially more spores from the
phagocyte cell surface when compared with treatment by medium alone
(Table 3.3). However, only 44% of the spores, which had become cell-
associated by prior incubation at 4°C were dislodged, by pronase
treatment even though the majority of these spores would have been
surface bound and not internalized.
Summary
The results of all these experimentssi^ggestthat although A. fumigatus
spores become cell-associated, the majority remain on the surface of
the cell. However this was based on qualitative as opposed
to quantitative data.
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Figure 3.5 a-b Scanning electron micrographs of the cell association
of fungal spores following incubation in vitro for
1.5 h of mouse peritoneal exudate cells and opsonised
(a) spores of A. fumigatus (b) spores of
P. ochrochloron. Spores : attached ( □ ) partially
ingested ( O ) fully ingested ( v ).
V
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Figure 3.6 a-b Scanning electron micrographs of the cell-
association of fungal spores following the inter¬
action in vivo for 1.5 h of mouse peritoneal
exudate cells and spores of A. fumigatus.
Spores:attached ( □ ).
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(d)
Figure 3.6 c-d Scanning electron micrographs of the cell-association
of fungal spores following the interaction in vivo
for 1.5 h of mouse peritoneal exudate cells and
spores of P. ochrochloron. Spores : attached ( □ )
partially ingested ( O ) fully ingested (V )•
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TABLE 3.3 The percentage of cell-associated spores of A
fumigatus becoming dislodged from mouse peritoneal
exudate cells following treatment of spore/cell
preparations with either medium (control) or pronase
(enzyme). Prior to treatment the spores/cells were










* Percentage of spores becoming dislodged
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3.2 Chemiluminescent Responses of Phagocytic Cells to Fungal
Spores
Chemiluminescence is a measure of the light emited by phagocytic
cells and is proportional to 'respiratory burst' activity. It
arises from the production of high energy compounds intimately
involved in the microbicidal activity of the cell.
A standardised chemiluminescence technique was used to answer the
following questions:
(i) Do the chemiluminescent responses of human or murine phago¬
cytic cells from A. fumigatus spores of differ from those to
P. ochrochloron?
(ii) Does the magnitude of the monocyte 'respiratory burst' in
response to fungal spores differ from that given by PMN?
iii) Are the chemiluminescent responses of phagocytic cells
different when spores are opsonised in autologous sera, in
untreated or heated inactivated sera or in standard AB serum?
The amount of chemiluminescence produced by phagocytic cells varies
from person to person and from day to day. Therefore, some of the
results were expressed as a percentage of the peak chemiluminescent
response of the phagocytic cells to zymosan on that day, which was
always included as a positive control.
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3.2.1 Chemiluminescent responses of phagocytic cells to spores
of A. fumlgatus compared with P. ochrochloron
The chemiluminescent responses of thioglycollate elicited mouse peri¬
toneal exudate cells to spores of A. fumigatus opsonised in auto¬
logous sera was significantly lower than that obtained in response to
P. ochrochloron (p<0.01, Table 3.4).
Spores of A. fumigatus (opsonised in AB sera) elicited a signif¬
icantly lower (p<0.001) chemiluminescent response from human PMN and
monocytes when compared with P. ochrochloron (Table 3.5). A typical
chemiluminescent profile of human PMN in response to challenge with
zymosan spores of A. fumigatus and P. ochrochloron is illustrated in
Fig 3.7. Further experiments using different strains of A. fumigatus
gave similar results. The peak chemiluminescent responses elicited
by six different strains of A. fumigatus isolated from the sputum of
a patient with aspergilloma are shown in Table 3.6. The peak chemi-
luminescence to A. fumigatus spores was in all cases substantially
lower than that elicited by either zymosan or spores of
P. ochrochloron.
3.2.2 Comparison of the chemiluminescent responses of PMN and
monocytes
The peak chemiluminescent responses of PMN to zymosan or to spores of
A. fumigatus or P. ochrochloron were substantially higher than those
elicited by monocytes (Table 3.7). However, when the results were
normalised by adjusting to the percentage of peak response to
zymosan; this finding is reversed with the chemiluminescent resp¬
onses of PMN to both A. fumigatus and P. ochrochloron falling to
approximately 63% of that elicited by monocytes (the analysis of
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TABLE 3.A Chemiluminescent responses of thioglycollate
elicited mouse peritoneal exudate cells to




A. fumip;atus 14.45 (5.2)
P. ochrochloron A6.28 (6.9)*
1 Hanks' balanced salt solution - measure of
the spontaneous release
2 Mean (SD) of 3 experiments
* Significantly greater than HBSS p<0.01
-124-
TABLE 3.5 Cherailuminescent responses of human PMN and monocytes to
spores of A. fumigatus and P. ochrochloron opsonised in
AB sera
Cell A. fumigatus P. ochrochloron
peak chemiluminescence (mV)
Monocyte 20.99 (5.82)1 69.2 (24.9)*
PMN 34.39 (6.59) 182.5 (69.7)*
1 Mean (SEM) of samples from 5 control subjects
* Significantly greater than A. fumigatus p<0.001
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TABLE 3.6 The peak chemiluminescent responses of human phagocytic

































1 Result of a representative experiment
2 Strain of A. fumigatus normally used in the study
All A. fumigatus strains elicited significantly lower responses















Figure 3.7 Typical profile of luminol amplified chemiluminescent
responses of normal human PMN to the following
triggers, opsonised in human AB sera : zymosan (5
mg), spores of A. fumigatus and spores of
P. ochrochloron at a spore:cell ratio of 10:1;
continuously measured in mV over a 20 min period.
TABLE3.7Chemiluminescentrespon esofmonocytesa dPMNtspor sA.fumigatu P.ochrochloronexpressedapeakchemiluminescence(mV)ndpercentageft individualzymos nresp nse. CellZymosanA.fumigatusPochr chlorof iochrochloron PeakchemiluminescencemV%ofzy osaresp nse Monocyte141.1(6.2)21 3.6)80.48( 0)14 9.3555 70 1 PMN612.7(15 .3)40.1 019458.1)8.82.9)34 2. ) 1Mean(SEM)ofpe kchemiluminescencellsfrivsubjects 2Mean(SEM)ofther sultswhexpressedaperc ntagetzymo nr sp nsef rach experiment
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variance Table used for the analysis is given in the Appendix, Table
A1).
3.2.3 Effect of Opsonisation of Fungal Spores
(i) Autologous versus AB serum
Opsonisation of spores in autologous serum compared with control AB
serum increased the chemiluminescent responses of both monocytes and
PMN (from controls) to P. ochrochloron, and PMN to A. fumigatus by
approximately 24% (p<0.05). It had no effect on the chemilumines-
cence produced by monocytes in response to spores of A. fumigatus
(Table 3.8)
(ii) Effect of heat inactivation
Opsonisation of spores of A. fumigatus and P. ochrochloron in auto¬
logous serum which had been heat treated for 30 min at 56°C signif¬
icantly reduced the chemiluminescent responses of monocytes and PMN
to both spore types. The chemiluminescence produced in response to
spores which had been opsonised in sera, heat treated for 20 min at
50°C generally fell between those obtained using non-treated serum
and serum heat treated at 56° for 30 min (Table 3.9).
Summary
The principal conclusion from this work is that spores of
A. fumigatus elicit significantly lower chemiluminescent responses
from phagocytic cells when compared with spores of P. ochrochloron or
with particles of zymosan.
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TABLE 3.8 A comparison of opsonisation of fungal spores in auto¬
logous versus AB serum on the chemiluminescent responses
of human monocytes and PMN
Spore Monocyte PMN
AB Autologous AB Autologous
A. fumigatus 14 (1.2) 15 (1.2) 7 (1.4) 9 (1.5)*
P. ochrochloron 46 (1.3) 56 (1.2)* 28 (1.3) 34 (1.3)*
1 Geometric mean (SEM)' of the percentage of the zymosan response
from 5 subjects
% Comparison between AB versus autologous p<0.05
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3.3 The Effect of Fungal Spores on the Production of Superoxide
Anion and Hydrogen Peroxide by Phagocytic Cells
The experiments using chemiluminescence suggested that spores of
A. fumigatus did not elicit a significant 'respiratory burst'; the
next step was to estimate the levels of the specific reactive oxygen
species, superoxide anion and hydrogen peroxide, which may become
release during cell-association with fungal spores.
The experiments were performed using C. parvum-stimulated mouse peri¬
toneal exudate cells, which are known to spontaneously release high
levels of reactive oxygen intermediates. In addition, the
production of superoxide anion, by human monocytes and PMN challenged
with fungal spores was measured.
3.3.1 Effects of fungal spores on release of superoxide anion
C. parvum-stimulated mouse peritoneal exudate cells released sign¬
ificantly less superoxide anion (p<0.001) in response to spores of
A. fumigatus than in response to zymosan or spores of P. ochrochloron
(Table 3.10). Both zymosan and P. ochrochloron spores were assoc¬
iated with a significant increase in release of superoxide anion that
was significantly greater than the spontaneous release by cells
(p<0.001). When the results from the individual spore:cell ratios
were combined, P. ochrochloron was seen to stimulate an increase in
superoxide anion release of about 50%, whilst zymosan, a potent
trigger of superoxide anion, stimulated a 300% increase. The
results are illustrated in Fig 3.8. The analyses of variance Table
is given in the Appendix (Table A2).
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TABLE 3.10 Release of superoxide anion by C. parvum stimulated
mouse peritoneal exudate cells to spores of
A. fumigatus, P. ochrochloron and zymosan opsonised in
autologous serum.
Treatment Spore:cell Superoxide anion
ratio nmol/5 x 10 cells/2 h
HBSS* - 12.89 C\Joeg
zymosan - 41.6 (0.60)*
A. fumigatus 10: 1 12.06 (0.20)
A. fumigatus 50: 1 11.07 (0.45)
A. fumigatus 100: 1 11.09 (0.84)**
P. ochrochloron 10: 1 14.62 (1.60)
P. ochrochloron 50: 1 20.12 (1.23)
P. ochrochloron 100: 1 18.4 (1.70)*
1 Treatment with Hanks' balanced salt solution (HBSS) is a
measure of the spontaneous release.
2 Mean (SEM) of three to five separate experiments
* Zymosan and P. ochrochloron (all spore:cell ratios combined)
elicited significantly more than HBSS p<0.001
** A. fumigatus (all spore ratios combined) elicited significantly
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3.3.2 Effects of fungal spores on release of hydrogen peroxide
Both zymosan and P. ochrochloron slightly reduced the spontaneous
release of hydrogen peroxide by Cj^parvum-stimulated mouse peritoneal
exudate cells (Table 3.11). Spores of A. fumigatus produced a
reduction of hydrogen peroxide release with increasing spore:cell
ratios (Fig 3.9). When the results from the individual spore:cell
ratios were combined the release of hydrogen peroxide was signif¬
icantly lower in response to A. fumigatus (p<0.001) than to zymosan
or P. ochrochloron. The analyses of variance Table is given in the
Appendix (Table A3).
3.3.3 Production of superoxide anion by human monocytes and PMN in
response to fungal spores
The production of superoxide anion by phagocytic cells to spores of
A. fumigatus, P. ochrochloron and to zymosan, opsonised in AB serum
was measured. The results in Table 3.12 show that the spontaneous
release of superoxide anion by PMN is significantly higher than that
produced by monocytes (p<0.001). Zymosan induced a significant
increase in superoxide anion production in both cell types (p<0.01).
Spores of P. ochrochloron had no significant effect on the release of
superoxide anion by PMN although a slight decrease in the amount
produced by monocytes was found. Spores of A. fumigatus caused a
significant decrease in the spontaneous release of superoxide anion
by monocytes and PMN (p<0.002) being considerably lower than that
produced in response to spores of P. ochrochloron (p<0.02). The
analyses of variance Table is given in the Appendix (Table A4).
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TABLE 3.11 The release of hydrogen peroxide by C. parvum
stimulated mouse peritoneal exudate cells to spores of
A. fumigatus, P. ochrochloron and zymosan, opsonised in
autologous serum.
Treatment Spore:cell Hydrogen peroxide
ratio nmol/5 x 10^ cells/2 h
HBSS ^ - 10.19 (1.57)
zymosan - 9.53 (1.53)
A. fumigatus 10: 1 8.63 (1.41)
A. fumigatus 25: 1 6.80 (0.35)
A. fumigatus 50: 1 5.15 (0.87)*
P. ochrochloron 10: 1 8.63 (1.18)
P. ochrochloron 50: 1 8.16 ( 1.88)
1 Treatment with Hanks' balanced salt solution (HBSS) is a measure
of the spontaneous release.
2 Mean (SEM) of three to five separate experiments
* A. fumigatus (all spore:cell ratios combined) elicited
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TABLE 3.12 Comparison of the production of superoxide anion by
human monocytes and PMN to spores of A. fumigatus and
P. ochrochloron (sporeicell ratio 50:1) and zymosan,
opsonised in AB sera.
Trigger Monocyte PMN
c
Superoxide anion nmol 5 x 10 cells/2 hr
HBSS ' 6.46 2.(1.7) 13.6 (4.4 )*
Zymosan 13.94 (2.9)** 15.53 (4.4 )**
P. ochrochloron 6. 18 (2.6) 13.30 (3.9 )
A. fumigatus 4.8 (1.3)*** 9.9 (2.25)***
1 HBSS - Hanks' balanced salt solution measure of spontaneous
release
2 Mean (SD) of results from five subjects
* PMN release significantly more than monocytes, p<0.001
** Responses to zymosan significantly greater than HBSS, p<0.01
*** Responses to A. fumigatus significantly less than HBSS, p<0.002
and to P. ochrochloron, p<0.02
-138-
Summary
The principal finding from these experiments is that spores of
A. fumigatus failed to elicit production of superoxide anion and
hydrogen peroxide by phagocytic cells.
3.4 Effects of Spore Diffusates on Release of Reactive Oxygen
Intermediates
To examine the possibility that A. fumigatus may produce a substance
that had a direct effect on cellular production of reactive oxygen
intermediates, the effect of spore diffusates on the spontaneous
release of reactive oxygen intermediates from C. parvum-stimulated
mouse peritoneal exudate cells were measured. Diffusates from
A. fumigatus greatly reduced (p<0.001) the spontaneous release of
superoxide anion and hydrogen peroxide (Table 3.13) whilst those from
P. ochrochloron did not. The analyses of variance Tables are given
in the Appendix (Tables A5 and A6).
Using bronchoalveolar lavage cells obtained from rats whose lungs had
been treated with C. parvum, this inhibitory effect was found to be
strikingly dependent on the concentration of diffusate (Fig 3.10).
Summary
The results of these experiments have shown that spores of
A. fumigatus release a substance which inhibits production of
reactive oxygen intermediates by phagocytic cells.
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TABLE 3.13 The effect of adding spore diffusates at a 1:4 dilution
on the spontaneous release of superoxide anion and
hydrogen peroxide by C. parvum stimulated mouse
peritoneal exudate cells
Treatment Superoxide anion Hydrogen peroxide










1 The addition of Hanks' balanced salt solution (HBSS) is a measure
of the spontaneous release.
2 Mean (SEM) of three separate experiments. Response to
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3.4.1 Direct effect of spore diffusates on superoxide anion and
hydrogen peroxide
In order to examine whether the diffusate was influencing production
of reactive oxygen intermediates or was scavenging the reactive
oxygen intermediates once produced, the diffusate at a 1:4 dilution
was added to a cell free superoxide anion generation system and to
hydrogen peroxide solutions.
(i) Superoxide anion
Superoxide anion was generated by the xanthine oxidase-acetaldehyde
system. The addition of spore diffusates of A. fumigatus to super¬
oxide anion did not affect the measurable amount of superoxide anion;
the amount present remained the same as that found with HBSS (Table
3.14). However, the addition of superoxide dismutase (which is used
in the conversion of superoxide anion to hydrogen peroxide) removed
the superoxide anion from the system. This result confirmed that
the diffusate was not scavenging superoxide anion.
(ii) Hydrogen peroxide
Similarly, the diffusates did not scavenge hydrogen peroxide. The
addition of control HBSS to a system containing hydrogen peroxide
resulted in a linear increase in absorbance at 610 nm (a measure of
hydrogen peroxide in the system) with increasing concentration of
hydrogen peroxide (1-20 nmol) shown in Fig 3.11. The addition of
the diffusate to hydrogen peroxide resulted in an increase in absorb¬
ance at 610 nm, the same as that given with HBSS. However, when
catalase, an enzyme which breaks down hydrogen peroxide, was added to
the system no increase in absorbance at 610 nm was obtained.
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TABLE 3.14 The effect of adding diffusates of A. fumigatus at a 1/4
dilution on superoxide anion generated by the xanthine
oxidase-acetaldehyde generation system when compared











1 Mean (SD) of results of two experiments
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The results of these experiments have shown that spore diffusates of
A. fumigatus do not scavenge the reactive oxygen intermediates super¬
oxide anion and hydrogen peroxide.
3.5 Time Course of Production of Spore Diffusates of A. fumigatus
In order to study the kinetics of diffusate release to the super¬
natant, the effect of time on the inhibition of reactive oxygen
intermediate production was examined. Table 3.15 demonstrates that
washings (2 min incubation) from the spores significantly reduced
reactive oxygen intermediate release (p<0.001) by C. parvum-
stimulated mouse peritoneal exudate cells. Therefore, the diffusate
is released immediately the spores are put into liquid. In addition
the spores, once washed, continued to release the diffusate. The
longer the spores were incubated, the greater was the inhibitory
capacity of the diffusate.
Summary
The component of the spore diffusate which inhibits the production of
reactive oxygen intermediates by phagocytic cells is released immed¬
iately the spores are put into solution.
3.6 Effect of Spore Diffusates of A. fumigatus on Cell Viability
3.6.1 Trypan blue exclusion
Viability studies using trypan blue exclusion established that the
spore diffusates were not having a toxic effect on the cells as the
percentage viability of the phagocytic cells (human monocytes, PMN,
alveolar macrophages and mouse macrophages) after an incubation
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TABLE 3.15 The effect of time on the diffusion, from A. fumigatus
spores, of activity which inhibits the production of
superoxide anion and hydrogen peroxide by C. parvum
stimulated mouse peritoneal exudate cells
Treatment Superoxide anion Hydrogen peroxide












3 hr incubation A.77 (0.15)* 3.3 (0.06)*
1 Hanks' balanced salt solution (HBSS) is a measure of the
spontaneous release.
2 Mean (SEM) of results from three experiments
* All treatment significantly inhibited the spontaneous release of
superoxide anion and hydrogen peroxide p <0.001
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period in spore diffusates for 2 h was the same as that found with
control HBSS (>95% viable).
S 1
3.6.2 Chromium release assay
C 1
The estimation of J Cr release is a sensitive technique for measuring
the potential toxicity of substances towards cells. The results in
Table 3.16 show that spore diffusates of A. fumigatus did not
6 1
increase the spontaneous release of Cr by human pulmonary macro¬
phages following incubation for three hours in vitro.
Summary
These results confirm that spore diffusates are not directly toxic to
phagocytic cells.
3.7 Preliminary Characterisation of Diffusates from
A. fumigatus spores
3.7.1 Molecular weight
The inhibitory effect of the diffusate on reactive oxygen inter¬
mediate release by C. parvum-stimulated mouse peritoneal exudate
cells was removed by dialysis (Table 3.17), indicating that the mole¬
cular weight of the active substance(s) in the diffusate is less than
14,000 daltons.
Further studies which involved passing the diffusate through special
filters with molecular weight exclusion limits of 1,000, 5,000 and
10,000 daltons were performed. The initial sample and the filtrates
were then tested for their capacity to inhibit the production of
superoxide anion by C. parvum stimulated mouse peritoneal exudate
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TABLE 3.16 The effect of spore diffusates of A. fumigatus














1 Hanks' balanced salt solution - a measure of the
spontaneous release
2 Mean (SD) of 5 replicates
R 1
3 Measure of the total J Cr taken up by the macrophages
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TABLE 3.17 The effect of dialysis on the capacity of A. fumigatus
diffusate to inhibit the production of superoxide anion
and hydrogen peroxide by C. parvum stimulated mouse
peritoneal exudate cells
Treatment Superoxide anion Hydrogen peroxide
nmol/5 x 10^ cells/2 h
HBSS 1 12.98 C\j00CO 21.3 (2.06)
diffusates 5.65 (0.57) 8.75 (1.07)
diffusates
4°C 18 h
incubated 9.95 (1.28) 13.86 (0.38)
diffusates
4°C 18 h
dialysed 13.76 (1.69)* 25.6 (1.82)
1 Hanks' balanced salt solution is a measure of the spontaneous
release.
2 Mean (SEM) of three experiments
* Statistical significance between means of diffusates incubated
4°C 18 h versus dialysed diffusate is p<0.0001
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cells. This experiment showed that the inhibitory component has a
molecular weight between 1,000 and 5,000 daltons (Table 3.18).
3.7.2 Biochemical characterisation
The biochemical characterisation of the spore diffusate, is being
carried out by Dr V Hearn of the Public Health Laboratories,
Colindale, London. Her preliminary results show that the diffusate
contains an aromatic compound which is eluted on high performance
liquid chromatography at 254 nm. Amino acids have been detected and
the predominant ones are arginine, serine, glutamine, aspartic acid,
glycine, alanine and valine. Further characterisation of the spore
diffusate is in progress.
Summary
The inhibitory component of spore diffusates of A. fumigatus has a
molecular weight of between 1,000 and 5,000 daltons. The exact
biochemical nature of the substance is still to be established.
3.8 The Effect of Spore Diffusates on the Phagocytosis of Sheep
Red Blood Cells'
The previous results have shown (section 3.1) that spores of
A. fumigatus appear to be resistant to ingestion. In an attempt to
assess accurately the effect of spore diffusates of A. fumigatus and
51
P. ochrochloron on phagocytosis of antibody coated Cr labelled
sheep red blood cells by C. parvum-stimulated mouse peritoneal
exudate cells was measured. This technique has the advantage that
all extracellular (non-ingested) sheep red blood cells, including
those attached to the cell surface, are removed by lysis with red
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TABLE 3.18 Effect of molecular sieving on the capacity of
A. fumigatus diffusate to inhibit superoxide anion
production by C.parvum-stimulated mouse peritoneal
exudate cells
Treatment Superoxide anion
nmol/5 x 10^ cells/2 h
HBSS1 7.33 (0.44)2
Spore diffusate 1.27 (0.43)
(before filtration)
Filtrate < 1,000 7.90 (0.58)
Filtrate < 5,000 1.43 (0.35)
Filtrate <10,000 2.41 (0.06)
1 Hanks' balanced salt solution a measure of the
spontaneous release
2 Mean (SD) of 3 replicates
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blood cell lytic buffer, thereby enabling an accurate measurement of
phagocytosis to be made. There was significantly more phagocytosis
(p<0.0005) of the sheep red blood cells coated in specific anti-sheep
red blood cell than of those coated with irrelevant mouse IgG (Table
3.19). This result established the validity of the technique. The
5 1
Cr labelled sheep red blood cells coated in specific anti-sheep red
blood cell antibody were used to assess the effects of the spore
diffusates. Diffusates of A. fumigatus inhibited phagocytosis by
about 63% (p<0.0025) whilst spore diffusates of P. ochrochloron had
no significant effect (Table 3.19). As a positive control cyto-
chalasin B (a known inhibitor of phagocytosis) was included; this
inhibited the phagocytosis of radiolabelled red blood cells coated
with specific antibody to sheep red blood cells by 44% (p<0.005) at a
concentration of 1.25 jjg.
Summary
Spore diffusates inhibit the phagocytosis of radiolabelled antibody
coated sheep red blood cells.
3.9 Effect of Spore Diffusates on Phagocytic Cell Movement
The effect of spore diffusates on the chemotaxis and cytoplasmic
spreading of phagocytic cells was measured.
3.9.1 Effect of spore diffusates on chemotaxis of PMN
Spore diffusates of A. fumigatus inhibited the number of cells migra¬
ting towards the chemoattractant (zymosan activated serum) by approx¬
imately 46% p<0.001). Spore diffusates of P. ochrochloron had no
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TABLE 3.19 The effect of spore diffusates at a 1:2 dilution on the
phagocytosis of antibody-coated radiolabelled-sheep red
blood cells by C. parvum stimulated mouse peritoneal





HBSS Mouse IgG 87.1 (10.OA)
2
HBSS tsrbc AA0.5 (36.6)
A. fumigatus
diffusate




cytochalasin B (1.25 ug) asrbc 2A7.8 (3A.2)*
1 Hanks' balanced salt solution
2 Means (+ SEM) of three separate experiments
Significantly less than HBSS asrbc
* p<0.005 ** p<0.0025
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inhibitory effect on the migration of the cells (Table 3.20) illus¬
trated in Figs 3.12 a-c. Further experiments which involved measuring
the random migration of the cells in HBSS alone in the top compart¬
ment versus A. fumigatus diffusates in the lower compartment (Table
3.21) confirmed that the spore diffusates of A. fumigatus were not
acting as a chemoattractant. A comparison of the effect of 8
different preparations of A. fumigatus diffusate from isolates of the
same strain on the chemotaxis of human PMN towards the known chemo¬
attractant, zymosan activated serum, showed that this inhibitory
activity was reproducible (p<0.001) (see Table 3.22). The analysis
of variance Table is given in the Appendix (Table A7).
3.9.2 Effect of spore diffusates on phagocytic cell spreading
Spore diffusates of A. fumigatus were seen to inhibit the spreading
of C. parvum-stimulated mouse peritoneal exudate cells when compared
with control HBSS and with spore diffusates of P. ochrochloron (Fig
3.13 a-c). Measurement of the mean diameters of the cells showed
that those cells treated with A. fumigatus diffusate were substant¬
ially less spread (by approximately 54%) than those with control HBSS
(Table 3.23). The differences between cells treated with
A. fumigatus diffusate and the controls were significant (both
p<0.001). The analysis of variance Table is given in the Appendix
(Table A8).
Summary
The results so far have shown that spores of A. fumigatus appear to
resist ingestion, inhibit the 'respiratory burst' and produce a sub¬
stance which also inhibits phagocytosis, production of reactive
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TABLE 3.20 The effect of spore diffusates of A. fumigatus and
P. ochrochloron on the migration of human
PMN towards zymosan activated serum through 3 jim
filters following incubation at 37°C for 45 min
1
Experiment HBSS A. fumigatus P. ochrochloron
control diffusate diffusate
1 68.5 (4.8)2 32.6 (3.4)* 68.4 (6.0)
2 62.9 (1.2) 36.2 (4.8)* 62.6 (0.0)
3 83.3 (7.6) 46.2 (4.7)* ND3
1 Hanks' balanced salt solution
2 Results of three separate experiments expressed as the mean
(SD) of the number of cells migrated per 5 high power fields.
3 ND = not done
* Significantly lower than HBSS p<0.001
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Figure 3.12 a-b Photomicrographs of the number of human PMN
which have migrated towards zymosan activated serum
following incubation at 37° for 45 min. The
effect of adding (a) HBSS, (b) A. fumigatus
diffusate (1/2 dilution). The cells which have
migrated are the darkly staining ones highlighted
by arrows. Original magnification x 400.
The small brown fringed circles are the 3pm
pores of the filter membrane.
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Flgure 3.12 c A photomicrograph of the number of human PMN
which have migrated towards zymosan activated
serum following incubation at 37°C for A5 min.
The effect of adding (c) P. ochrochloron
diffusate (1/2 dilution). The cells which have
migrated are the darkly staining ones high¬
lighted by arrows. Original magnification x
A00.
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TABLE 3.21 Effect of A. fumigatus diffusates on random migration
of human PMN cells in "a blindwell chamber incubated for
45 min at 37°C
Treatment
Top compartment Lower compartment
No. of cells migrated per












1 Hanks' balanced salt solution
2 Mean (SEM) of two experiments
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TABLE 3.22 The effect of 8 different preparations of A. fumigatus
diffusate on the migration of human PMN towards zymosan
activated serum through a 3 urn filter in a blindwell
chamber following incubation for 45 min at 37°C
A. fumigatus % of inhibition










Figure 3.13 a-b Photomicrographs of the spreading of C. parvum
stimulated mouse peritoneal exudate cells
following incubation at 37°C for 1 h in RPMI-10%
foetal calf serum containing (a) HBSS, (b)
A. fumigatus diffusate (1/2 dilution) Original
magnification x 600.
Figure 3.13 c A photomicrograph of the spreading of C. parvum
stimulated mouse peritoneal exudate cells following
incubation at 37°C for 1 h in RPMI-10% foetal calf
serum containing (c) P. ochrochloron diffusate (1/2
dilution) Original magnification x 600.
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TABLE 3.23 The effect of spore diffusates on the spreading of
C. parvum-stimulated mouse peritoneal exudate cells
Treatment Cell diameter
Mean (SD)







1 Hanks' balanced salt solution
2 Mean (SD) of three separate experiments
* Significantly less than HBSS p<0.001
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oxygen intermediates and cell movement.
3.10 Killing of Fungal Spores by Rat Alveolar Macrophages
In order to put of the above findings into perspective the next stage
was to examine the overall ability of phagocytic cells to deal with
spores of A. fumigatus by measuring their capacity to kill the
fungus.
The killing assay involved incubating spores of phagocytic cells for
3 h at 37°C. The spores were distrupted from the cells and the
colony forming units (CFU) measured. The results given in Table
3.24 show that spores of A. fumigatus opsonised in autologous sera
were significantly more resistant to killing _in vitro by rat alveolar
macrophages, than were similarly opsonised spores of P. ochrochloron
(p<0.01) even although the number of spores becoming cell-associated
was similar; percentage mean (+ SEM): A. fumigatus - 86.3 (+3.5)
P. ochrochloron - 83.6 (+ 2.9).
Summary
Spores of A. fumigatus opsonised in autologous sera are more resist¬
ant to killing by human pulmonary macrophages than similarly
opsonised spores of P. ochrochloron.
3.11 Interaction of Fungal Spores with Human Lung Macrophages
The previous results have shown that macrophages from mice and rats
are less efficient at killing spores of A. fumigatus than spores of
P. ochrochloron. The next stage was to see if these differences
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TABLE 3.24 Killing of fungal spores, opsonised in autologous serum,
by rat alveolar macrophages incubated at 37°C for 3 h
Experiment A. fumigatus P. ochrochloron
% killed
1 11.5 (0.60)1* 16.5 (1.5)
2 25. 1 ( 1.52)* 33.5 (5.5)
3 15.9 (0.78)* 34.2 (0.41)
1 Mean (SD)
* % of A. fumigatus killed significantly less than
P. ochrochloron p<0.01
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could be found using human pulmonary macrophages.
3.11.1 Cell-association
More than 60% of the opsonised fungal spores became cell-associated
with human pulmonary macrophages following incubation for one hour at
37°C (Table 3.25). There were no significant differences in the
percentage of spores of A. fumigatus becoming cell-associated when
compared with spores of P. ochrochloron.
3.11.2 Killing
Spores of A. fumigatus opsonised in 5% pooled normal sera, were
significantly more resistant to killing by human pulmonary macro¬
phages than similarly opsonised spores of P. ochrochloron (p<0.02,
Fig 3.14). Approximately 46% more spores of P. ochrochloron were
killed by the macrophages than were spores of A. fumigatus.
3.11.3 Effect of serum treatment on spore killing
The ability of pulmonary macrophages to kill spores which had been
opsonised in heated sera was examined. Sera which had been heated to
50°C for 20 min prior to opsonisation had no significant effect on
macrophage killing of fungal spores. However, sera which had been
heated to 56°C for 30 min prior to opsonisation significantly
increased by (approximately 74%) the ability of pulmonary macrophages
to kill spores of A. fumigatus when compared with non-heat-treated
sera (p<0.001, Table 3.26). The percentage killing of
P. ochrochloron remained the same. The analyses of variance Table
is given in the Appendix (Table A9).
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TABLE 3.25 The percentage of spores opsonised in pooled normal
serum which were cell-associated with human pulmonary
macrophages after incubation at 37°C in vitro
Fungal spore % of cell-associated spores
A. fumigatus 62.7 (3.7)^
P. ochrochloron 65.3 (A.5)
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TABLE 3.26 The effect of heating the opsonising sera on the killing
of fungal spores by human pulmonary macrophages after
incubation at 37°C for 5 h
Spore Serum Treatment % of spores killed
A. fumigatus None 27.09 (3.23) 1*
A. fumigatus 50°C, 20 min 30.01 (4.16)
A. fumigatus 56°C, 30 min 47.02 (4.35) **
P. ochrochloron None 39.7 (3.29)
P. ochrochloron 50°C, 20 min 42.56 (3.32)
P. ochrochloron 56°C, 30 min 39.83 (7.64)
1 Mean (SEM) of results from 10 subjects
* A. fumigatus significantly more resistant to killing than
P. ochrochloron p<0.02
** Significantly more spores of A. fumigatus killed when
opsonised in 5% heat-treated serum (56°C 30 min) compared
with 5% untreated sera p<0.001
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3.11.b Effect of increasing concentration of serum on spore killing
Spores of both A. fumigatus and P. ochrochloron were opsonised in
concentrations of pooled normal sera ranging from 1-25%. Serum was
used both untreated and after heating for 30 min at 56°C.
(i) Opsonisation in untreated serum
The results (Fig 3.15) show that increasing concentrations of
untreated sera significantly reduced (p<0.001) the ability of human
pulmonary macrophages to kill spores of A. fumigatus. Human
pulmonary macrophages were unable to kill spores of A. fumigatus
opsonised in 10% sera and even appeared to enhance the germination of
spores opsonised in 25% sera when compared with control spores alone.
Decreased killing with increasing concentrations of opsonising sera
was also found with spores of P. ochrochloron, the largest decrease
falling between the 1% and 5% serum concentrations (p<0.025). How¬
ever, unlike A. fumigatus spores of P. ochrochloron were still being
killed, by human pulmonary macrophages at a serum concentration of
25%, (20% killing occurred).
\
(ii) Opsonisation in heat treated serum
In contrast to the results found using untreated serum, opsonisation
of fungal spores in increasing concentrations of serum, which had
been heat-treated, had no effect on the killing of A. fumigatus by
human pulmonary macrophages (Fig 3.16). Similarly, no real differ¬
ences in the killing of P. ochrochloron opsonised in heat-treated
serum were found except a decrease in killing between the 1% and 5%
concentration, an effect which paralleled that found with












































Theeff ctofincreasingconcentrationspooledn rmals rum,whi hhadb nt- treated(30min56°C)ohkilli gfsporesA.fu igatunPochr chloronby humanpulmonarymacrophagesfollowinginc batiot37°Crsp re:c llra of1:1.Resultsshownaretmea(SEM)fwoexp riments.
-171-
Therefore, serum contains a heat labile component which enables
spores of A. fumigatus to resist killing by human lung macrophages.
No such effect was found with spores of P. ochrochloron.
3.12 Effect of Opsonisation in Sera Containing Specific
Antibody on the Killing of A. fumigatus by Mouse
Macrophages
Sera and peritoneal macrophages obtained from naive mice and mice
specifically sensitised to A. fumigatus were used for this experi¬
ment. Although sera containing specific antibody to A. fumigatus
appeared to enhance the ability of mouse peritoneal macrophages from
naive animals to kill spores of A. fumigatus the effect was not stat¬
istically significant (Table 3.27). The cells from mice specif¬
ically sensitised to A. fumigatus killed slightly more spores, opson-
ised in naive sera (36.4%), when compared with the percentage killing
found with naive cells (32.7%). Opsonisation in specific antibody
did not result in increased killing by cells from sensitised animals.
The effect of opsonising in sera, heat treated at 56°C for 30 min,
once again significantly increased phagocytic cell killing of
A. fumigatus by approximately 30% (p<0.05, Table 3.27). Opson¬
isation in sera containing specific antibody which had been heat
treated for 30 min at 56°C resulted in significantly enhanced killing
of A. fumigatus by macrophages both from naive and specifically sens¬
itised animals (p<0.005).
Summary
Opsonisation of spores of A.fumigatus in serum containing specific
antibody did not significantly increase mouse peritoneal exudate
cell killing of A.fumigatus
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TABLE 3.27 The effects of opsonisation in naive sera and sera
containing specific antibody on the killing of spores
of A. fumigatus by macrophages from naive mice and



























1 % killing of A. fumigatus Mean (SEM)
2 Sera from animals sensitised to A. fumigatus containing specific
antibody
* Significantly more killing than untreated serum p<0.05
** Significantly more killing than untreated naive serum p<0.005
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3.13 Examination of the Cell Association and Killing of Fungal
Spores by Phagocytic Cells from People with Asthma Compared to
Normal Controls
Phagocytic cells were obtained from 42 people evenly distributed
between the three clinical groups:
(i) 15 non-asthmatic controls
(ii) 14 asthmatic patients non-sensitised to A. fumigatus
(iii) 13 asthmatic patients sensitised to A. fumigatus
Examination of the ability of monocytes and PMN to handle fungal
spores was carried out in order to answer the following questions:
(i) Does the number of spores of A. fumigatus which are bound and
killed by human monocytes and PMN differ from that of the
control spore P. ochrochloron?
(ii) Is the number of fungal spores killed by monocytes different
from that killed by PMN?
(iii) Does opsonisation in heat treated serum have an effect on the
phagocytic killing of fungal spores?
(iv) Are there differences between the clinical groups in their
phagocytic handling of A. fumigatus, either alone, or
compared with P. ochrochloron?
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3.13.1 Cell-association and killing of fungal spores by human PMN
and monocytes from control subjects
(i ) Cell-association
The cell association of fungal spores with both monocytes and PMN
was generally very high (>86%). No significant differences between
spore type were found. The individual results with mean (SEM) are
shown in Fig 3.17.
(ii) Spore killing
Spores of A. fumigatus, opsonised in autologous serum, were signif¬
icantly more resistant to killing by monocytes (p<0.025) and PMN
(p<0.001) than were similarly opsonised spores of P. ochrochloron.
The results are shown in Fig 3.18 and the means (SEM) given in Table
3.28.
3.13.2 A comparison of the handling of fungal spores by monocytes
versus PMN from control subjects
Human monocytes were significantly more efficient than PMN at killing
spores of A. fumigatus (p<0.001) and P. ochrochloron (p<0.002) see
Table 3.28.
Summary
Although the cell association of the fungal spores to the phagocytic
.cell was generally very high, spores of A.fumigatus appeared to be
more resistant to killing than spores of P.ochrochloron. In addition







































PMN MONO PMN MONO
Figure 3.17 The percentage (Mean + SEM) of spores of A. fumigatus
and P. ochrochloron, opsonised in 5% autologous serum,
becoming cell-associated with human polymorphonuclear
leukocytes (PMN) and monocytes (MONO) following incub¬








































MONO PMN MONO PMN
Figure 3.18 The percentage of spores of A. fumigatus and
P. ochrochloron, opsonised in 5% autologous serum,
which were killed by human monocytes (MONO) and
polymorphonuclear leukocytes (PMN) following incubation
at 37°C for 3 h.
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TABLE 3.28 The percentage killing of spores of A. fumigatus and
P. ochrochloron opsonised in autologous serum by human
monocytes and PMN incubated for 3 h at 37°C in vitro
Cell A. fumigatus P. ochrochloron
% killed
Monocyte 63.3 (4.42)1 * 73.8 (3.46)
PMN 35.8 (3.87)** 60.5 (3.1)
1 Mean (SEM) of the results from 15 subjects
Significantly less killed than P. ochrochloron
* p<0.025 ** p<0.001
Monocytes significantly more efficient than PMN
at killing A. fumigatus p<0.001 and P. ochrochloron
p<0.002
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3.13.3 A comparison of the handling of spores of A. fumigatus and
P.ochrochloron by phagocytes from asthmatic patients~~
sensitised and non-sensitised to A. fumigatus versus control
subjects
(i) Cell-association
The cell association of monocytes and PMN with spores of A. fumigatus
and P. ochrochloron was generally very high. However, fewer spores
bound to monocytes and PMN from the control group when compared with
binding to cells from asthmatic patients sensitised and non-
sensitised to A. fumigatus (Table 3.29).
(ii) Spore killing in autologous serum
People with asthma sensitised to A. fumigatus showed significant
differences in their handling of A. fumigatus in vitro when compared
with the control group. Monocytes from these patients were signif¬
icantly less efficient at killing spores of A. fumigatus whilst their
PMN were significantly more efficient, when compared with the cells
from the control group (p<0.05 Table 3.30). Therefore, unlike the
results found with the control group no significant differences were
found in the killing of A. fumigatus by PMN and monocytes from these
patients. The results for the group of non-sensitised asthmatic
patients generally fell between those obtained from the control group
and the sensitised asthmatic patient group (Table 3.30) except for
PMN killing of P. ochrochloron which was decreased.
(iii) Spore killing in heat-treated sera
Opsonisation with sera which had been heated at 56°C for 30 min once
again significantly increased the killing of spores of A. fumigatus
by monocytes and PMN from all of the patient groups (p<0.002, Fig


























































1Mean(SEM)of%sporeskilled *Monocyteskillsignificantlylessa dPMNllsig if cantlymore A.fumigatuswhencomparediththntrolgro pp<0.05
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3.19). No such effect was found for P. ochrochloron; the means (SEM)
are given in Table 3.31.
(iv) Comparison between the killing of fungal spores by asthmatic
patients sensitised to A. fumigatus subdivided into two
clinical groups
To determine what contributions the cells and serum from patients
diagnosed as having allergic bronchopulmonary aspergillosis may have
to these findings, the group of asthmatic patients sensitised to
A. fumigatus (n = 13) was divided into two subgroups (i) simple
asthmatics sensitised to A. fumigatus (n = 5), (ii) patients
diagnosed as having allergic bronchopulmonary aspergillosis (n = 8).
The comparison between these two groups with regard to the phagocytic
killing of spores of A. fumigatus and P. ochrochloron, opsonised in
autologous and heat-treated sera was made. The results illustrated
in Fig 3.20 show that there were no differences between the two
groups in the killing of A. fumigatus. Although there appear to be
some differences between the groups in the killing of
P. ochrochloron, especially after opsonisation in heat treated serum,
they are not statistically significant. The analyses of variance
Table is given in the Appendix (Table A10).
Summary
Patients sensitised to A. fumigatus showed significant differences in
the ability of their cells to kill spores of A. fumigatus which had
been opsonised in autologous serum. However, these differences were
not evident when the spores were opsonised in serum (autologous) which
had been heat-treated as this resulted in an overall increase in the
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Figure3.20Acomparisonfthepercentag ssporeso.fumi atuandPchrochlo onkill bymonocytesa dPMNfromtheasth aticpatientssensitisedA.fumiga uswh d beensubdividedintotwgroups:-(i)mpla thmaticss nsit sedA.fumigatus n=5(OO)iipat entsdiagnosedh vi gllergicbronchopulmonary aspergillosisn=8(••).Thesporw reop onis di5%autolo ouerumich hadbeenuntreated(—)orheat-tr atf30mi56°C(HI).R sultsexpressed meanperc nt ges.
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found for spores of P. ochrochloron.
3.14 Effect of Corticosteroid Treatment on the Phagocytic Killing
of Fungal Spores
To determine if corticosteroid treatment affected phagocytic cell-
association and killing of fungal spores, patients from the asthmatic
group sensitised to A. fumigatus were again subdivided into two
groups (i) patients not on corticosteroids (n = 7), (ii) patients on
corticosteroid treatment (n = 6); three on intramuscular
triamcinolone acetonide - two on 40 mg per month, one on 60 mg per
month: the other three on oral prednisolone 10 mg per day.
The results in Table 3.32 show that corticosteroid treatment had no
effect on the association of fungal spores with phagocytic cells.
No differences between the two groups were found in the ability of
phagocytic cells to kill spores of A. fumigatus opsonised in
untreated serum. Although patients on corticosteroids appeared to
show increased killing of spores of P. ochrochloron, it was not stat¬
istically significant (Table 3.33). A comparison between opsonising
in serum with and without heat treatment is illustrated in Fig 3.21.
The analysis of variance Table is given in the Appendix, Table All.
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TABLE 3.32 The effect of corticosteroid treatment on the cell-
association of fungal spores with monocyte cells from



















1 % of spore becoming cell-associated - Mean (SD) after 1 h at
37°C in vitro
















































































Figure3.21Theffectofcorticosteroidtreatmentnthk lli gfsporesfA.u iga usa d P.ochrochloronbym nocytesa dPMNfr masth aticpatientsensiti edt A.fumigatussubdividedintotwroups:-( )pati ntsncorticosteroids=7(O—O),ii)patientsocor icosteroidsn=6(••).Thesporesw reps nised in5%autologousserumwhichhadb enuntreated(—)rh at-treatedf30int56°C(HI).Resultsexpressedam anpercentages.
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3.15 Comparison between Clinical Groups on the Production of
Reactive Oxygen Intermediates by Phagocytic Cells in Response
to Fungal Spores
3.15.1 Chemiluminescence
Blood was taken from a total of 16 people who were subdivided into
the three clinical groups:
(i) Five non-asthmatic controls
(ii) Five with asthma but not sensitised to A. fumigatus
(iii) Six with asthma sensitised to A. fumigatus
Chemiluminescent responses to monocytes and PMN was assessed to
determine if there were any differences between the clinical groups.
No significant differences were found between clinical groups in the
chemiluminescent responses of monocytes and PMN to spores of
A. fumigatus and P. ochrochloron opsonised in 5% autologous serum
(illustrated in Fig 3.22).
Opsonisation in autologous serum (when compared to control AB serum,)
increase the chemiluminescent responses to P. ochrochloron of both
monocytes and PMN from patients with asthma sensitised to
A. fumigatus, by approximately 45% as opposed to the 20% increase
found with the control group (Table 3.34).
Opsonisation of A. fumigatus in serum which was heat-treated (56° 30
min) had no effect on the chemiluminescent responses of PMN from
asthmatic patients sensitised to A. fumigatus; whilst the PMN from
the control group showed a significant decrease p<0.05, see Table
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inescent responses is illustrated in Fig 3.23. The analyses of
variance Table for this work is given in the Appendix (Table A1).
The effect of specific antibody was not examined using this assay
system as only one of the patients showed evidence of precipitating
antibodies.
3.15.2 Superoxide anion
Phagocytic cells were obtained from a total of 26 people who were
subdivided between the clinical groups as follows:
(i) 5 non-allergic controls
(ii) 10 with asthma non-sensitised to A. fumigatus
(iii) 11 with asthma sensitised to A. fumigatus - as well as
positive Type I skin test reactions. Ten of these patients
had either precipitating antibodies and/or specific IgE anti¬
body to A. fumigatus
A comparison between patient groups in the amount of superoxide anion
produced by phagocytic cells in response to spores of A. fumigatus,
spores of P. ochrochloron and zymosan was measured. In addition the
effects of opsonisation on the production of superoxide anion by
phagocytic cells in response to A. fumigatus was estimated.
No significant differences in the production of superoxide anion by
phagocytic cells were found between clinical groups (Table 3.36).
Even although the spontaneous release of superoxide anion by mono¬
cytes in the two groups of patients with asthma, appeared to be
increased when compared with the control group; it was not statist¬
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of variance Table is given in the Appendix (Table A4).
There were no differences in the amount of superoxide anion released,
in response to spores of A. fumigatus, opsonised in AB sera compared
with autologous sera. Similarly opsonisation of A. fumigatus in
autologous sera which had been heat-treated at 56°C for 30 min had no
effect (see Table 3.37).
Therefore, opsonisation in specific antibody did not affect the
release of superoxide anion by phagocytic cells. In addition opson¬
isation in heat treated serum did not alter the amount of superoxide
anion produced in response to spores of A. fumigatus.
Summary
The principal conclusions arising from comparison between the three
clinical groups are that cells from asthmatic patients, sensitised to
A. fumigatus, show significant differences in their ability to kill
spores of A. fumigatus opsonised in autologous serum. No such
differences were found for spores of P. ochrochloron. Cortico¬
steroid treatment (maintenance dose) had no effect on fungal killing
by phagocytic cells. Phagocytic cells from all three clinical groups
failed to elicit a 'respiratory burst' to spores of A. fumigatus even
when opsonised in specific antibody.





















1. Although a substantial number of spores of A. fumigatus
become cell-associated the majority remain on the surface
of the cell without becoming ingested.
2. Opsonised spores of A. fumigatus fail to elicit a
'respiratory burst' from phagocytic cells.
3. Spores of A. fumigatus release a substance which,
although not cytotoxic, interferes with phagocytic cell
function including phagocytosis, production of reactive
oxygen intermediates, chemotaxis and spreading.
4. The inhibitory component of the spore diffusate is
released immediately the spores are put into solution,
and has a molecular weight of between 1,000 and 5,000
daltons. The exact biochemical nature of the substance
has still to be established.
5. Spores of A. fumigatus, opsonised in autologous serum are
significantly more resistant to killing by phagocytic
cells from humans and rodents than similarly opsonised
spores of P. ochrochloron.
6. Serum contains a heat labile component which inhibits
phagocytic cell killing of spores of A. fumigatus. No
such effect was found with spores of P. ochrochloron.
7.
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Human monocytes are more efficient than PMN at killing
fungal spores.
8. Comparisons between the three clinical groups showed that
patients sensitised to A. fumigatus gave significant
differences in the ability of their phagocytic cells to
kill spores of A. fumigatus, opsonised in autologous serum,
when compared with the control group.
9. The presence of specific antibody in the opsonising serum
did not significantly increase the phagocytic killing of
A. fumigatus.
10 Corticosteroid treatment (maintenance dose) had no effect
on fungal killing by phagocytic cells.
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4. DISCUSSION
What is so special about A. fumigatus as opposed to many other air
spora which enables it to cause ill-health in man and animals? An
intriguing aspect of the biological behaviour of A. fumigatus is its
ability to initiate so many disease processes. Thus it may,
depending on the appropriate circumstances, provoke asthma, extrinsic
allergic alveolitis, allergic bronchopulmonary aspergillosis, form
into a mycetoma or act as a true opportunistic pathogen by becoming
2 2
invasive ' .
Mullins and Seaton in 1978 found that A. fumigatus could be isolated
from post mortem human lung specimens more frequently than would have
been anticipated from the prevalence of its spores in the air. This
led to the suggestion that as well as having an optimum growth temp¬
erature of 37°C and a spore size which enabled it to penetrate deep
into the lung the fungus may also be particularly resistant to the
1 Kp
host defence network J . This hypothesis was the starting point of
this Thesis, leading to an investigation of phagocytic cells, a key
component of the network. Though clearly important in host defences
against invading microorganisms, the' precise role of these cells in
the handling of A. fumigatus remained undefined.
4.1 Phagocytosis
Phagocytosis is often an important step in the killing of most micro¬
organisms and it has often been assumed that spores of A. fumigatus
PP1 PPP
are phagocytosed prior to becoming killed However, the
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results of this study have shown that spores of A. fumigatus are
relatively resistant to phagocytosis by human and mouse phagocytes.
Whilst initial studies using light microscopy did not allow differ¬
entiation of ingested and surface-bound spores, further work using
Nomarski optics revealed that a substantial number of spores of
A. fumigatus appeared to be on the surface of the cell; in
contrast spores of P. ochrochloron appeared to be phagocytosed more
readily although they also were seen, in smaller numbers, on the cell
surface. These observations proved difficult to quantitate but were
supported by further observations using scanning electron microscopy,
which showed that a high proportion of spores of A. fumigatus (and a
lower proportion of spores of P. ochrochloron) were not taken into
the cell, remaining bound to the surface. These findings appeared
not to be artefacts of _in vitro experimentation since similar results
were obtained when spores were injected directly into peritoneal
cavities of mice and the cells subsequently removed by lavage.
Since these observations were subjective attempts were made to
quantify the ratio of extracellular to intracellular spores by means
of enzyme stripping technique, but it proved very difficult to remove
spores from the cell surfaces. Further efforts, using transmission
electron microscopy, also failed, as it proved impossible to differ¬
entiate between ingested spores and those sectioned between folds of
the phagocyte cell membrane. The difficulties involved in discrim¬
inating between attached and ingested particles have previously been
discussed by van Furth and Diesselhoff-den Dulk who stated that:
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"Even the application of electron microscopy to thin sections cannot
solve this problem, because particles trapped between folds of the
cell membrane can seem in tangential sections to lie inside the
cell"257.
In spite of this, Levitz and Diamond, using transmission electron
microscopy of peroxidase-stained sections of spores of A. fumigatus
which had been incubated with PMN at a sporetcell ratio of 10:1 in
PBS for 30 min, apparently found that phagosome-lysosome fusion had
occurred and that >95% of the cell-associated spores of A. fumigatus
were intracellular; it is difficult to assess the validity of these
findings since no examples of this work were actually given in the
238
paper . In contrast the suggestion that spores of A. fumigatus
may be resistant to phagocytosis is supported by the work of Kurup
who, using rabbit alveolar macrophages in vitro could show no
evidence of phagosome-lysosome fusion following phagocytosis of
227
A. fumigatus . This may also be the explanation of the finding of
Lehrer and Jan who showed that apparently phagocytosed spores (as
judged by light microscopy) were nevertheless resistant to
killing226.
A.2 'Respiratory burst'
An important feature of the microbicidal action of phagocytic cells
20 1
is their capacity to undergo a 'respiratory burst' . This can be
detected by measuring the amount of chemiluminescence or specific
reactive oxygen intermediates (for example superoxide anion and
hydrogen peroxide) produced by phagocytic cells following challenge
with microorganisms in vitro.
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In addition to their apparent resistance to ingestion, spores of
A. fumigatus also failed to induce a significant respiratory burst by
human and rodent phagocytic cells. The chemiluminescence produced in
response to spores of A. fumigatus was minimal when compared with
that obtained following challenge with either zymosan or spores of
P. ochrochloron.
When the specific reactive oxygen intermediates superoxide anion and
hydrogen peroxide were measured, using phagocytic cells from
C. parvum-stimulated mice, it was found that spores of A. fumigatus
failed to trigger an increase in superoxide anion release while both
zymosan and spores of P. ochrochloron triggered a substantial
increase. Similarly, the amount of superoxide anion produced by
human PMN and monocytes in response to spores of A. fumigatus was
significantly less than that produced in response to zymosan or
spores of P. ochrochloron; indeed even opsonisation in specific anti¬
body had no effect. This suggested that spores of A. fumigatus were
failing to trigger the primary component of the respiratory burst.
The normal sequence of events in release of reactive oxygen intermed¬
iates by phagocytic cells is the production of superoxide anion,
which can then either spontaneously or with the help of superoxide
dismutase form hydrogen peroxide^-^. If spores of A. fumigatus fail
to trigger an increased release of detectable amounts of superoxide
anion, it might be expected that hydrogen peroxide levels would also
be low, unless rapid dismutation of superoxide anion was occurring.
Spores of A. fumigatus as well as failing to trigger superoxide anion
release also, at a spore:cell ratio of 25:1 and above, suppressed
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hydrogen peroxide production by C. parvum stimulated mouse peritoneal
exudate cells when compared with either spores of P. ochrochloron or
zymosan. The response of stimulated peritoneal exudate cells to
triggering with zymosan, by releasing increased amounts of superoxide
anion without an increase in the release of hydrogen peroxide has
P AD
been reported previously both from our laboratory and by Karnovsky
PA 1
and Badwey . Apart from the slight decrease found in the product¬
ion of superoxide anion by human monocytes, the release of reactive
oxygen intermediates in response to spores of the control fungus
P. ochrochloron generally paralleled those released in response to
zymosan. A similar trend has also recently been reported by Levitz
and Diamond who found that spores of A. fumigatus induce human PMN to
release significantly less superoxide anion, hydrogen peroxide, and
hypochlorous acid than do Candida albicans or zymosan^®. However,
the amount of superoxide anion generated by PMN in response to spores
of A. fumigatus in that study was still significantly more than the
spontaneous release by PMN alone (A. fumigatus 15 nmol, spontaneous
release 1 nmol). Although they used the same basic method of meas¬
uring superoxide anion as that used in this Thesis, namely, determin¬
ation of the portion of reduced cytochrome C which was inhibitable by
superoxide dismutase, the differences between the two studies in the
amount of superoxide anion produced either spontaneously or in
response to spores of A. fumigatus may possibly be accounted for by
different times and methods of incubation. It is known that the
phagocytic cell 'respiratory burst' can be induced following the
pertubation of the membrane which occurs when the cells come into
1 of\ p
contact with 'foreign' substances '. Chari-Bitron et al who
followed the uptake of opsonised zymosan by alveolar macrophages,
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found that the intensity of chemiluminescence was related to the
number of particles becoming attached, both reaching a peak at the
PA P
same time . Levitz and Diamond incubated their cells/spores for
10 minutes in a shaking water bath, the continual mixing of spores
with cells would result in constant membrane pertubation of the cell
by the particle thereby increasing non-specific release of superoxide
anion. This was indicated by their results which showed2-'® that the
combination of specific and non-specific triggering by zymosan using
the shaking method induced the PMN to release three times the amount
(45-1 nmol) of superoxide anion in 10 minutes, compared with the
amount (15.5 nmol) produced by PMN after a two hour incubation with
no shaking in the present study. It may be that if Levitz and
Diamond2®® had not shaken the cells with the spores they would have
found less superoxide anion produced in response to A. fumigatus.
It was curious, therefore, that even though a high percentage of
spores of A. fumigatus were becoming attached and presumably inducing
membrane pertubation, this was not sufficient to elicit a significant
'respiratory burst.
A.3 Spore Diffusates of A. fumigatus
The work discussed above led to the hypothesis that spores of
A. fumigatus may produce a substance which interferes with the
production of reactive oxygen intermediates and phagocytosis.
Studies carried out to test this hypothesis showed that diffusates
from spores of A. fumigatus significantly suppressed the spontaneous
release of reactive oxygen intermediates by C. parvum-elicited rodent
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phagocytic cells and that this inhibitory effect was dose-dependent.
No corresponding effect was found with diffusates from spores of
P. ochrochloron. The inhibitory component of the spore diffusate of
A. fumigatus was released immediately the spores were put into sus¬
pension and continued to be released after the spores had been
washed. The spore diffusates were shown to be affecting the
production of reactive oxygen intermediates and not simply scavenging
them once they had been produced. In addition it was confirmed
using two separate assay systems (trypan blue exclusion^''' and ^1Cr
266
release ) that the diffusates were not cytotoxic.
Further investigations of the effects of the diffusate from
246
A. fumigatus spores using an assay of quantitative phagocytosis
showed that the diffusates had a significant inhibitory effect:
diffusates from P. ochrochloron had no such activity. This observ¬
ation which supported the earlier microscopical findings is consist¬
ent with a recent report by Mullbacher et_ al who found that gliotoxin
isolated from 3-day culture supernatants of A. fumigatus had an
inhibitory effect on the phagocytosis of carbon particles by mouse
O A /
peritoneal exudate cells . This same group in another study just
published have also shown that gliotoxin inhibited the basal rate of
hydrogen peroxide production by human PMN. However, unlike the
results reported in this Thesis using spore diffusates of
A. fumigatus, gliotoxin could not inhibit phorbol myristate acetate
266
triggered production of hydrogen peroxide . The difference
between gliotoxin and the diffusate described in the present study is
that gliotoxin could not be isolated until the spores had been in
culture for at least three days, at which time mycelial growth would
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be expected to have been abundant. In contrast the diffusate
described here diffuses from the respirable sized spores as soon as
they are put into suspension and its quick release suggests that it
is a constituent present on or close to the surface of the spore
rather than a metabolite which is produced as a result of germin¬
ation. The inhibitory component of the diffusate has a molecular
weight of between 1,000 and 5,000 daltons and preliminary biochemical
analysis indicates that it is an aromatic compound.
In an attempt to pinpoint the effector mechanism of the inhibitory
component of the spore diffusate of A. fumigatus, its effect on cell
movement, a fundamental aspect of phagocytic cell activation, was
examined. In order for a phagocytic cell to become activated there¬
by enhancing its phagocytic ability, a rearrangement of the cell
PDV
membrane must occur ' . This involves a complex process which
requires a co-ordinated interaction of the plasma membrane with
pz: <7 OAQ
contractile elements in the cytoplasm ' . The changes are
reflected in the enhanced ability of the cell to spread over a
surface and to migrate in response to chemical stimuli. Such
functions are readily measured in vitro, and it was found that both
these aspects of phagocyte activity were inhibited by spore
diffusates of A. fumigatus. In contrast, spores diffusates of
P. ochrochloron had no effect.
Thus it appears that A. fumigatus spores release a diffusable sub¬
stance that has several effects of considerable biological importance
in ensuring their survival in the lung and therefore enhancing their
pathogenic potential. Possibly the diffusate is the first mechanism
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by which the spore reduces the efficiency of the phagocyte while
gliotoxin, which is produced once germination has taken place, may be
a second line of anti-phagocytic defence used by A. fumigatus to
establish itself and remain within the lung.
The actions of the A. fumigatus diffusate appear to be similar to
those of a group of fungal metabolites called cytochalasins (Greek:
cytos-a cell, chalasis-relaxation)2^9>270^ Cytochalasin B, the most
extensively studied of these metabolites, has a molecular weight of
less than 500 daltons and has been shown to inhibit phagocytosis,
271 272
cell spreading and chemotaxis ' and like the diffusate, is not
directly toxic to the cells. Cytochalasin B has been shown to act by
affecting the orientated microfilaments of the substratum-associated
272
regions of the plasma membrane '. It also affects re-ordering of
the lipid membrane causing depolarisation of the plasma
membrane2^>^75. p^g regi0n Qf the plasma membrane on which the
spore diffusate of A. fumigatus exerts its influence has still to be
established. Other studies on A. fumigatus have shown that a water
soluble substance (molecular weight >10,000 daltons), obtained from
seven day cultures, could interfere with complement activation2^,
whilst Chaparas et a_l found that three day-old culture supernatants
of A. fumigatus could inhibit mitogen-induced lymphocytic transform¬
ation^'''.
It is perhaps important to remember at this point that the patho¬
genicity of A. fumigatus should be regarded as incidental to its
P7 ft
normal saprophytic life cycle in nature . These biological proper¬
ties of the fungus may have evolved as a defence mechanism in its
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natural habitat, the soil, in order to protect itself against phago¬
cytosis by its natural enemies, the amoebae. Support for this hypo¬
thesis comes from the work of Old and Derbyshire who, whilst conduct¬
ing feeding trials to assess the ability of the giant vampyrellid
amoeba (Arachnula impatiens cienk), to attach and lyse fungal spores,
found that spores of a few fungal species were resistant to
27Q
ingestion; among those was A. niger .
4.A Killing of A. fumigatus Spores
These investigations lead to the conclusion that spores of
A. fumigatus are able to resist phagocytosis at least in part by
interfering with cell membrane movement. The biological relevance
of this anti-phagocytic property was assessed by looking at the
ability of phagocytic cells to kill spores of A. fumigatus as
compared to the control spores of P. ochrochloron. Again spores of
A. fumigatus proved more resistant to killing than did spores of
_______________
P. ochrochloron, whether the phagocytic cells were mouse peritoneal
macrophages, rat alveolar macrophages, human peripheral blood mono¬
cytes and PMN, or human pulmonary macrophages. The percentage kill¬
ing of A. fumigatus ranged from 17% with rat alveolar macrophages to
63% with human monocytes, but in all experiments spores of
A. fumigatus were more resistant to killing than were spores of
P. ochrochloron.
Although there are difficulties in extrapolating the findings of this
study to those of others because of differences in experimental
procedure, such as spore:cell ratios, incubation periods and methods
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of estimating germination, a reasonable amount of agreement can be
found. The percentage killing of A. fumigatus found using rat
alveolar macrophages was similar to that found by Kurup who used
227
rabbit alveolar macrophages and by Waldorf who used mouse alveolar
ppo
macrophages . Although human alveolar macrophages appear to be more
efficient at killing spores of A. fumigatus than do the rat alveolar
macrophages this may be related to differences in their state of
functional activation. The alveolar macrophages from rats used in
the work reported in this Thesis were obtained from specific
pathogen-free animals and were usually in a resting state whereas the
human pulmonary macrophages were obtained from lungs of people
(mainly city-dwellers who would have been constantly exposed to
normal environmental agents) and would perhaps have been more
activated. Previous studies have shown PVG rat alveolar macrophages
which had been activated by quartz inhalation to be more efficient at
killing spores of A. fumigatus than alveolar macrophages from the
PRO
non-stimulated animals . The levels of killing of A. fumigatus
spores by mouse peritoneal exudate cells in the present study are
222
substantially higher than those obtained by Schaffner e_t al
These authors used CF1 mice, whilst the results reported in this
Thesis were obtained using C57 Bl/6 mice. The differences in
results between the two studies may to some extent be attributed to
the strain of mouse as it is well known that some strains are more
PR 1
efficient at killing particular microorganisms than others . The
o o r
results of the study by Lehrer and Jan , who showed that a mixture
of monocytes and neutrophils was incapable of killing spores of
A. fumigatus in vitro after a 3 h incubation, are in contrast to the
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findings of the present study where both human PMN and monocytes were
found to kill spores of A. fumigatus. However, PMN were not nearly
as efficient as monocytes at killing spores of A. fumigatus, a
OpT
finding which is in keeping with the results of others . Schaffner
et al have previously shown that mononuclear phagocytes are important
in the killing of spores whilst PMN were more important in the erad-
223
ication of hyphae . Moreover, it is clear from clinical evidence
that the PMN plays an important part in preventing invasive asper¬
gillosis, in that the disease occurs particularly in patients with
OA Q£ QQ Q -| PP9
neutropenia and chronic granulomatous disease ' '' '' ' .
A.5 Mechanisms of Resistance
The pathogenicity of certain microorganisms has been shown to be
related to their possession of antiphagocytic properties. A number
of bacteria including Pseudomonas aeruginosa, Salmonella typhae, and
Mycobacterium tuberculosis can inhibit chemotaxis of phagocytic
pip pop
cells '. Similarly Streptococcus pneumoniae, Escherichia coli
and Neisseria gonorrhoeae (and many others) can attach to phagocytic
pO A
cells yet resist ingestion . The resistance of some microorganisms
to killing is inversely related to the phagocytic cell's ability to
release reactive oxygen intermediates2®®>286^ Nathan and
Nakagawara2®^ have postulated that the pathogenicity of micro¬
organisms, in general, may be related to their possession of anti¬
oxidant defences and to their capacity to avoid triggering the
release of reactive oxygen intermediates by macrophages. It would
appear from this study that A. fumigatus has evolved such mechanisms.
This may be in part responsible for its pathogenicity to certain
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individuals, in that it might explain why it acts as an opportunistic
pathogen in immunocompromised individuals, by overcoming an already
defective host defence network. It may also explain why A. fumigatus
can establish itself and form a mycetoma in old disease cavities of
the lung. However, it does not explain why the organism has a
prediliction for asthmatic airways.
4.6 Comparisons of Fungal Handling by Asthmatic Patients
Experiments were carried out to try to establish whether the phago¬
cytic cells of asthmatic patients sensitised to A. fumigatus are
deficient at handling and, therefore, more susceptible to spores of
A. fumigatus. The interaction of spores and phagocytes from
asthmatic patients, both sensitised and unsensitised to A. fumigatus
and from non-asthmatic subjects were compared. Phagocytes from people
with asthma sensitised to A. fumigatus showed significant differences
in their ability to kill A. fumigatus than did those from the control
group. Monocytes from these sensitised patients killed significantly
fewer spores of A. fumigatus (20%) while their PMN killed signif¬
icantly more (42%). No such differences were found for
P. ochrochloron. The percentage killing of fungal spores by phago¬
cytic cells from the non-sensitised asthmatic patients generally fell
between that obtained with the control and the sensitised asthmatic
patient groups.
As corticosteroid treatment has been shown to depress phagocytic cell
ICO IC/j
killing of A. fumigatus J ' J the possibility that these drugs may
have been contributing to the altered handling of A. fumigatus by
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asthmatic patients sensitised to A. fumigatus was considered.
Steroid treatment at a maintenance dose appeared to have no effect on
the ability of the phagocytic cells to kill either A. fumigatus or
131
P. ochrochloron. Earlier studies by Turner et al showed that the
degree of susceptibility of corticosteroid treated animals to
infection by A. fumigatus could be related to the dose of cortico¬
steroids; these workers suggested that animals on low dose cortico¬
steroids could limit infection by A. fumigatus but treatment with
IKK
high doses resulted in a high rate of mortality . Similarly,
patients who are on high dose corticosteroids to induce immune supp-
07
ression are particularly susceptible to infection by A. fumigatus .
The only other reports, of which I am aware, of studies on phagocytic
killing of A. fumigatus by cells from patients with aspergillus
infections are on two patients with invasive aspergillosis. Both
were found to have a selective defect in phagocytic killing of
PPQ ppf)
A. fumigatus even in the presence of specific antibody 7'.
4.7 Role of Opsonins
From the results of the comparisons of the clinical groups it appears
that PMN from patients sensitised to A. fumigatus may be compensating
for the poor handling of the fungus by the monocytes. It may well
have been that the presence of specific antibody in opsonising serum
of these patients was augmenting this effect. Normally opsonisation
of a particle with specific antibody promotes 'immune phagocytosis'
via Fc receptors in the cell membrane which in turn leads to enhanced
killing1^>209. plasma membrane receptors for the Fc portion of
-214-
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IgG on mononuclear phagocytes have been extensively studied . As
well as an Fc receptor for IgG which is also found on PMN, mono-
2RQ
nuclear phagocytes possess Fc receptors for IgE . Melewicz et al
showed that human monocytes from allergic individuals possess Fc
receptors for IgE which are involved in mediating phagocytosis and
2RQ
lysis of IgE coated targets .
Monocytes and macrophages also secrete complement components
including C1q which has been found to act as a plasma membrane Fc
oq n
receptor for IgG . It, therefore, was unexpected given all these
receptors, that monocytes from patients sensitised to A. fumigatus,
showed decreased killing of A. fumigatus even in the presence of
specific IgG and/or IgE antibodies. The presence of specific anti¬
body did increase (by approximately 22%) the ability of mouse peri¬
toneal exudate cells from naive animals to kill spores of
A. fumigatus. However, specific antibody had no effect on the
killing of A. fumigatus by cells from animals specifically sensitised
(to A. fumigatus) as these cells showed increased killing of
A. fumigatus even when opsonised in naive serum. It has previously
been demonstrated that the opsonisation of spores in specific anti-
227
body does not enhance killing of A. fumigatus by phagocytic cells .
The study reported in this Thesis goes no further in clarifying what,
if any, role specific antibody plays in the killing of A. fumigatus.
To assess further the effect of opsonins in the eradication of
A. fumigatus the role of complement was investigated. It is gene¬
rally considered that Fc receptors promote both binding and ingestion
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of particles which have been coated with immunoglobulin, whereas
complement receptors mediate attachment of complement coated
29 1
particles by ingestion 7 . However, it has been shown that activated
mononuclear phagocytes can ingest particles via complement
292
receptors 7 .
When spores of A. fumigatus were opsonised in serum which had been
heat treated to remove complement (56°C, 30 min) the ability of
phagocytic cells to kill spores of A. fumigatus was substantially
increased by as much as 75%, in the case of human lung macrophages.
No increased killing of similarly opsonised spores of P. ochrochloron
was found. Thus instead of promoting killing the presence of heat-
labile serum components actually enhanced the resistance of
A. fumigatus to attack by phagocytic cells. The other serum
component which is destroyed by heating at 56°C for 30 min is IgE.
However, as increased killing of A. fumigatus was also found using
heat-treated serum which did not contain high levels of IgE it seems
unlikely that IgE was causing this effect. I have shown in
unpublished experiments that spores of A. fumigatus do activate
complement via the alternative pathway and also bind C3b to their
surface. It, therefore, seems possible that A. fumigatus may be
using complement opsonisation to its advantage in that binding via
complement receptors may enable the diffusate to have more intimate
contact with the cell membrane, thereby enhancing its inhibitory
potential. If, however, exogenous heat labile complement components
are removed the binding to phagocytic cells will be via other
receptors, lectin-like receptors could be involved2*^ and it may be
that the position of binding within the cell membrane as well as the
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degree of avidity of the spores to these other receptors does not
permit the diffusate to exert such an inhibitory effect on phagocyte
function. Other examples of microorganisms using complement
components to their advantage exist. The protozoa Babesia rodhaini
utilises C3b to gain access via C3b receptors to the erythrocyte
O Q A
cytoplasm where it multiplies 7 . It, therefore, seems possible
that complement or other heat labile serum components, may paradox¬
ically enhance the ability of A. fumigatus spores to survive and,
therefore, germinate. In addition the results of preliminary work
suggest that germination of A. fumigatus spores in culture is
enhanced by the addition of serum or the products of macrophages
incubated for one hour in tissue culture. Thus it appears that
substances which are likely to be present in the airways of asthmatic
patients may be of positive advantage to inhaled spores of
A. fumigatus and enhance their germination in situ. Why this is of
advantage to the organism in its natural habitat is still a matter
for speculation.
A. 8 Conclusions
The results of this study have shown that spores of A. fumigatus are
resistant to phagocytosis and killing by both human and mouse phago¬
cytic cells. This property seems to be due to the ability of spores
to produce a low molecular weight diffusate that inhibits phago¬
cytosis, production of reactive oxygen intermediates, phagocyte
migration and macrophage spreading. It is speculated that this
property of the fungus may have evolved as a mechanism of defence
against its natural enemies in the soil, the amoebae. These results
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may explain why A. fumigatus can overcome the already defective host
defences of the immunocompromised individual and also why it is the
predominant fungus associated with the development of mycetomas. It
has been shown that 'paradoxically' killing of A. fumigatus by human
lung macrophages is inhibited by serum which is rich in protein and
enhanced if the serum is heated to temperatures that inactivate heat
labile serum components including complement. This has led me to
hypothesise that A. fumigatus is able not only to resist phagocytosis
but can also turn the protein rich exudate within asthmatic airways
to its own advantage for the purposes of survival and growth.
This work has led to the proposal of the following hypothetical
sequence of events in allergic bronchopulmonary aspergillosis: first
the atopic patient becomes sensitised to A. fumigatus as a result of
normal day to day exposure to the organism. This then results in
the development of an IgE-mediated bronchial response, with the
typical asthmatic, protein-rich exudate. A. fumigatus spores not
only resist phagocytosis, but also use the components of the exudate
to enhance their ability to germinate and grow. The increased anti¬
genic load thus produced intensifies the immune response and may be
sufficient to provoke an IgG mediated reaction also. These
responses, rather than controlling fungal growth, tend to enhance it;
however, if the bronchial reactions are suppressed by cortico¬
steroids, the proliferation of the fungus can be brought under
control as the exudate subsides.
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4.9 Further Studies
The sequence of events outlined above makes no mention of the role of
inflammatory cells characteristic of the asthmatic exudate. The
eosinophil, in particular, but also neutrophils, macrophages and mast
cells play important roles in the asthmatic reaction, and their
interactions with Aspergillus spores may result in more rapid elimin¬
ation (or, conceivably, enhancement of germination). A further
research programme has now commenced the purpose of which is to
answer the following questions.
( i) What effect do cells characteristic of the inflammatory
exudate of the asthmatic lung have on the germination of
spores of A. fumigatus?
( ii) Do complement components enhance the ability of
A. fumigatus to resist killing by phagocytic cells?
(iii) What is the biochemical nature of the inhibitory component
of the spore diffusate?
It is hoped that this work will lead to a better understanding of the
mechanisms of allergic bronchopulmonary aspergillosis and will aid
the development of more rational methods for its management and for
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6. APPENDIX I
Analyses of Variance Tables
Analyses of variance,for the principal results,which were obtained by
the Statisticians Mr W M McLaren and Miss H P R Collins using
pqc
Genstat (statistical programme). These Tables were used to
assess the significance of the different treatment effects in the
data.
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TABLE A1 Analysis of variance on the amount of chemilumin-
escence elicited by human monocytes and PMN in
response to fungal spores, expressed as a percen-
tage of the zymosan response
Source of variation Sum of Degrees of Mean Variance
Square f reedom Squares Ratio
Allergy 7.99 2 A.00 4.06
Residual (between 12.79 13 0.98
patients)
Total 20.78 15 1.39
Cell 5.64 1 5.64 25.70
Serum 0.93 1 0.93 4.23
Spore 57.62 1 57.62 262.70
Allergy Cell 0.95 2 0.48 2. 18
Allergy Serum 0.07 2 0.04 0. 16
Allergy Spore 1.29 2 0.65 2.95
Cell Serum 0.02 1 0.02 0. 10
Cell Spore 0. OA 1 0.04 0. 18
Serum Spore 0.22 1 0.22 1.01
Allergy Cell Serum 0.02 2 0.01 0.05
Allergy Cell Spore 0. 11 2 0.06 0.25
Allergy Serum Spore 0. 13 2 0.07 0.30
Cell Serum Spore 0.01 1 0.01 0.02
Allergy Cell Serum 0.00 2 0.00 0.01
Spore
Residual (between 18.86 86 0.22
patients)
Total 85.92 107
Grand Total 106.70 122
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TABLE A2 Analysis of variance on the results of the experiments
measuring the amount of superoxide anion produced by
C. parvum stimulated mouse peritoneal exudate cells in
response to fungal spores
Source of variation Degrees of Sum of Mean Variance
freedom Square Squares Ratio
Experiments (E) 2 866.8 433.4
Treatments (T) 7 5194 742.0 75.73
E x T 11 107.8 9.798
Residual 38 15.37 0.4045
Total 58 6184
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TABLE A3 Analysis of variance on the results of the experiments
measuring the amount of hydrogen peroxide produced by
C. parvum stimulated mouse peritoneal exudate cells in
response to fungal spores
Source of variation Degrees of Sum of Mean Variance
freedom Square Squares Ratio
Experiments (E) 2 367.44 183.72
Treatments (T) 6 414.63 69. 10
E x T 9 128.27 14.25
Residual 35 11.33 0.324
Total 52 921.67
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TABLE A4 Analysis of variance on the superoxide anion produced by
monocytes and PMN, in response to zymosan spores of
A. fumigatus and P. ochrochloron, from patients in the
three clinical groups including effect of serum treatment.
Source of variation Degrees of Sum of Mean Variance
freedom Square Squares Ratio
Subject Stratum
GRP1 3 0.7379 0.2460 0.274
Residual 22 19.7574 0.8981
Total 25 20.4953 0.8198
Subjects *Units '*Stratum
Treatment 5 27.4199 5.4840 51.631
Cell (Monocyte PMN) 1 19.0743 19.0743 179.581
GRP1 Treatment 15 0.4673 0.0312 0.293
GRP1 Cell 3 1.3500 0.4500 4.237
Treatment Cell 5 5.4776 1.0955 10.314
GRP1 Treatment Cell 15 0.6300 0.0420 0.395
Residual 221 (21) 23.4737 0.1062
Total 265 77.8928 0.2939
Grand Total 290 98.3881
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TABLE A5 Analysis of variance of the results of the experiments
measuring the effect of spore diffusates on the production
of superoxide anion by C. parvum stimulated mouse
peritoneal exudate cells
Source of variation Degrees of Sum of Mean Variance
freedom Square Squares Ratio
Experiment (E) 1 10.778 10.77
Treatment 1IT) 2 232.93 116.46 126.19
E x T 2 m00 0.92
Residual 11 3.018 0.274
Total 16 248.57
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TABLE A6 Analysis of variance of the results of the experiments
measuring the effect of spore diffusates on the production
of hydrogen peroxide by C. parvus stimulated mouse
peritoneal exudate cells
Source of variation Degrees of Sum of Mean Variance
freedom Square Squares Ratio
Experiments (E) A 1157 289.1
Treatments (T) 2 2207 1103 19.77
E x T 8 446.A 55.8
Residual 29 20.5 0.7068
Total 43 3830
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TABLE A7 Analysis of variance of the chemotaxis of human PMN
towards zymosan activated serum : effect of spore
diffusates
Source of variation Degrees of Sum of Mean Variance













TABLE A8 Analysis of variance of the spreading of C. parvum
stimulated mouse peritoneal exudate cells on glass :
effect of spore diffusates






















TABLE A9 Analysis of variance of killing of spores of A. fumigatus
and P. ochrochlorcn ty human pulmonary macrophages
including effect of serum treatment
Source of variation Degrees of Sum of Mean Variance
freedom Square Squares Ratio
Patient Stratum
Sex 1 71.11 71.11 0.028
Residual 8 20616.55 2577.07
Total 9 20687.66 2298.63
Patient *Units* Stratum
Spore 1 12965.40 12965.40 152.853
Heat 1 0.00 0.00 0.000
Sex.spore 1 1307.21 1307.21 15.411
Sex.heat 1 0.00 0.00 0.000
Spore.heat 1 0.00 0.00 0.000
Sex.spore.heat 1 0.00 0.00 0.000
Sex.spore.temp 1 0.00 0.00 0.000
Spore.heat.temp 1 0.00 0.00 0.000
Residual 41 3477.72 84.82
Total 50 17750.33 355.01
Grand Total 59 38438.00
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TABLE A10 Analysis of variance on the killing of spores of
A. fumigatus and P. ochrochloron by monocytes and PMN
from patients divided by clinical group including
effect of serum treatment
Source of variation Degrees of Sum of Mean Variance
freedom Square Squares Ratio
Subject stratum
GRPNew 3 7888.9 2629.6 0.314
Residual 38 318353.4 8377.7
Total 41 326242.3 7957.1
Subject *Units* Stratum
Spore 1 3618.6 3618.6 12.282
Cell 1 0.0 0.0 0.000
Serum 1 0.0 0.0 0.000
GRPNew.Spore 3 3195.6 1065.2 3.615
GRPNew.Cell 3 10.2 3.4 0.012
Spore.Cell 1 25.7 25.7 0.087
GRPNew.Serum 3 25.2 8.4 0.028
Spore.Serum 1 337.1 337. 1 1. 144
Cell.Serum 1 0.0 0.0 0.000
GRPNew.Spore.Cell 3 52.6 17.5 0.060
GRPNew.Spore.Serum 3 74.8 24.9 0.085
GRPNew.Cell.Serum 3 0.0 0.0 0.000
Spore.Cell.Serum 1 0.0 0.0 0.000
GRPNew.Spore.Cell.Serum 3 5.8 1.9 0.007
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Suppression of host defences by Aspergillus fumigatus
MAURA D ROBERTSON. A SEATON. L J R MILNE, J A RAEBURN
From the Institute of Occupational Medicine and the Western General Hospital. Edinburgh
abstract An important feature of the microbicidal action of phagocytic cells is their ability to
produce reactive oxygen intermediates. In an attempt to identify the mechanisms by which the
fungus Aspergillus fumigatus resists normal host defences the effect of spores and spore diffusates
of A fumigatus on the production of superoxide anion and hydrogen peroxide by primed rodent
phagocytic cells has been measured. For comparison we have used the non-pathogenic fungus
Penicillium ochrochloron. Production of these reactive oxygen intermediates in response to A fumi¬
gatus was significantly lower than that in response to P ochrochloron. A similar reduction was
achieved by diffusate prepared from freshly washed spores. The inhibitory component was of low
molecular weight (less than 14 000) and its effect was dose dependent. These results suggest that
spores of A fumigatus fail to trigger and also inhibit the production of reactive oxygen intermediates
by phagocytic cells.
The opportunistic fungus Aspergillus fumigatus is of
special interest to respiratory physicians because of its
ability to cause several distinct pulmonary diseases. It
may cause sensitisation in asthmatic subjects, leading
in some instances to chronic symptoms and recurrent
episodes of pulmonary infiltration.' It may also
colonise lung cavities to produce aspergillomas2 and
invade lung tissue after infarction3 or influenza4 to
produce a fatal necrotising pneumonia, or cause pul¬
monary and systemic infection in the immuno-
suppressed.5 The frequency with which it may be asso¬
ciated with lung disease suggests that the organism
may be relatively resistant to the lung's defences.
While spores of A fumigatus occur commonly in the
air, especially in winter, when dead leaves are avail¬
able as a substrate, they are not among the most
abundant.6 Moreover, studies of postmortem lung
specimens have shown A fumigatus to be present and
viable more frequently than would be expected from
its prevalence among the fungal spores normally
found in the air, the aerospora, thus supporting the
idea that it may have properties that protect it from
the lung's defences.7 Such properties could ensure its
survival in the lung long enough to initiate allergic and
infective reactions in appropriate hosts.
Two factors that enhance the pathogenicity of A
fumigatus in man are the organisms' ability to grow
Address for reprinl requests Mrs MD Robertson. Institute of
Occupational Medicine. 8 Roxburgh Place, Edinburgh EH8 9SU.
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optimally at 37' C and the small spore size that enables
it to penetrate to the alveolar level. To survive and
germinate in the lung the spores must also be resistant
to the phagocytic defences of the lung. In this paper
we report the results of in vitro investigations of the




In an attempt to identify the mechanisms used by this
fungus to resist killing by phagocytic cells we have
examined the effects of spores and spore diffusate of
A fumigatus on the ability of the cell to produce
oxidising agents (reactive oxygen intermediates) that
can be used by the phagocyte for the destruction of
microorganisms.8 We have compared the release by
phagocytic cells from mice and rats of the reactive
oxygen intermediates superoxide anion and hydrogen
peroxide in response to challenge by A fumigatus and
by the non-pathogenic fungus Penicillium ochro¬
chloron.
phagocytic cells
Since resting phagocytic cells release minimal
amounts of reactive oxygen intermediates, we used
phagocytic cells obtained from mice and rats that had
been previously primed in vivo with Corynebacterium
parvum. This is a procedure that has been shown to
increase the ability of phagocytic cells to release reac¬
tive oxygen intermediates,9 as well as generally to
20
increase their microbicidal capacity.10" For each
experiment about 4 x 1(T peritoneal exudate cells,
which comprise 32% polymorphonuclear leucocytes
and 63% macrophages, were harvested from six male
C57B1 6 mice five days after intraperitoneal injection
of l-4mg C parvum (heat killed, Wellcome Bio¬
technology Ltd) About 2 x 101 bronchoalveolar
lavage cells (90% of which were polymorphonuclear
leucocytes) were obtained from the lungs of male PVG
rats 16 hours after intratracheal instillation of 0 7 mg
C parvum
FUNGAL SPORES AND DIFFUSATES
A single strain of A fumigaius was isolated from the
sputum of a patient with allergic bronchopulmonary
aspergillosis The strain of P ochrochloron was 1MI
61271. Spores of A fumigaius and P ochrochloron were
obtained from cultures that had been grown for seven
days at 29 C on malt agar Spore suspensions contain¬
ing only single spores were prepared in Hanks' bal¬
anced salt solution (HBSS) containing 0 01% bovine
serum albumin (Sigma Chemical Co Ltd), after gentle
homogenisation followed by filtration through nylon
mesh to remove mycelial fragments and chains of
spores Spore counts were performed with improved
Neubauer chambers. For the sporeicell experiments
the spores were opsonised in 5% autologous serum
for 30 minutes at 37'C. then washed in HBSS by
centrifugation at 400g for 10 minutes The spores
were then resuspended in HBSS and kept on ice until
required To obtain diflTusates, spores were incubated
at a concentration of 108/ml in HBSS at 37'C for up
to six hours The soluble diffusates in the supernatant
were passed through 0 22 pm sterile fillers. For the
assay systems the diffusates were used at a 1:4 dilution
in HBSS The number of spores require to obtain this
concentration of diffusate was equivalent to the num¬
ber derived from a sporeicell ratio of 50:1.
SUPEROXIDE ANION ASSAY
Superoxide anion was measured according to the
method of Johnston.12 Production of superoxide
anion can be delected by the reduction of cytochrome
C, a reaction accompanied by an increase in spectro-
photometnc absorbance at a wave length of 550 nm.
The reaction mixture (1-5 ml), containing 5 x 10s
peritoneal exudate cells, 80 jimol cytochrome C
(Sigma), 2mg/ml dextrose, and opsonised spores at a
spore:cell ratio of 10:1, 50:1, and 100:1 or spore
diffusaies at a 1:4 dilution, was added to 30 mm Petri
dishes (Falcon Plastics Ltd). For the diffusate dose-
effect experiments a total reaction mixture of 1 3 ml
containing 2 5 x 105 bronchoalveolar cells was used
As an additional control, zymosan (Sigma), a cell wall
extract of the yeast Saccharomyces cerevisiae and a
potent trigger of superoxide anion release, was
Robertson. Seaton. Milne. Raehurn
opsonised and added to the reaction mixture at a
concentration of I mg ml. To determine the portion of
reduced cytochrome C that could be inhibited by
superoxide dismutase. identical dishes with the addi¬
tion of superoxide dismutase (Sigma) 25/ig ml were
prepared at the same time. All experiments were set up
in triplicate and the mixtures incubated at 37 C for
two hours. The supernatants were harvested and the
peak absorbance at 550 nm. a measure of reduced
cytochrome C, was determined by using the scan
mode on a spectrophotometer (SP8 400 Pye Unicam).
The reduction of cytochrome C is not specific for
superoxide anion The required specificity is achieved
by the use of superoxide dismutase. for which super¬
oxide anion is the only known substrate Therefore
the assay was run with and without superoxide dis¬
mutase and only the portion of the reduced cyto¬
chrome C that could be inhibited by superoxide dis¬
mutase was used to estimate the nanomols of
superoxide anion released
HYDROGEN PEROXIDE ASSAY
Hydrogen peroxide was measured according to the
method of Pick and Keisari.13 The assay is based on
the horseradish peroxidase mediated oxidation of
phenol red by hydrogen peroxide, which results in the
formation of a compound showing increased absorb¬
ance at 610nm The reaction mixture (1 ml), contain¬
ing 5 x 105 peritoneal exudate cells. lOnmol phenol
red solution (Sigma). NaCl (!40nmol). dextrose
(5 5nmol). and horseradish peroxidase (50/igml)
(Sigma) in lOnmol potassium phosphate buffer, and
opsonised spores at a spore:cel! ratio of 10.1.25 1. and
50:1 or spore diffusates at a 1:4 dilution was added to
30 mm Petri dishes For the diffusate dose-effect
experiments a total reaction mixture of 1 -3 ml contain¬
ing 2-5 x 10' bronchoalveolar cells was used As an
additional control, opsonised zymosan was added to
the reaction mixture at a concentration of I mg ml
All experiments were set up in triplicate and incubated
at 37CC for two hours. The supematants were then
harvested and alkalised by the addition of 30 p] of
IN NaOH The absorbance of the solution at 610 nm
was measured in a spectrophotometer and converted
to hydrogen peroxide equivalent by means of a stan¬
dard curve.
TECHNIQUES USED TO DETECT A POSSIBLE
SCAVENGING EFFECT OF DIFFUSATES ON
REACTIVE OXYGEN INTERMEDIATES
To test for a possible scavenging effect of the
diffusates on reactive oxygen intermediates, we used
(a) a cell free superoxide anion generation system gen¬
erally based on the method described by Rosen and
Klebanoff.14 Superoxide anion was generated by
incubating xanthine oxidase 20jig'ml (Sigma) with
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acetaldehyde 40nmol for five minutes at 37°C. This
resulted in the generation of about 6nmol. To this
superoxide anion 1 ml of the following was added: (a)
HBSS (control); (b) superoxide dismutase (25 pg),
which catalyses the destruction of superoxide anion to
oxygen and hydrogen peroxide; (r) diflfusate (1 ;4 dilu¬
tion). Each of the three treatments was set up in trip¬
licate and incubated for 10 minutes at 37CC. The reac¬
tion mixture, used to delect superoxide anion
(described above), was then added and after a further
incubation for 10 minutes at 37'C the absorbance at
550 nm was measured; (ii) hydrogen peroxide (Sigma)
was diluted to give concentrations ranging from I to
20 nmol To the hydrogen peroxide 1 ml of the follow¬
ing was added: (a) HBSS (control); (b) catalase
(Sigma) lOOpg'ml. an enzyme that catalyses the
degradation of hydrogen peroxide to oxygen and
water; and (r) diffusate (1:4 dilution). Each of the
three treatments was prepared in duplicate and incu¬
bated for 30 minutes at 37CC The reaction mixture
used to detect hydrogen peroxide (described above)
was added to the tubes, which were then incubated for
a further 30 minutes at 37CC. The absorbance of the
mixture was read at 610 nm
DIFFUSATE DIALYSIS
To determine whether the active constituent of the
diffusate was of low molecular weight the diffusate
was dialysed against HBSS for 16 hours at 4CC. As we
had observed that the activity of the diffusate
decreases on storage at 4CC, an aliquot of the diffusate
was put into dialysis tubing and kept in a sealed tube
for 16 hours at 4°C. as a control.
DIFFUSATE RELEASE
To discover at what stage the diffusates were released
into the supernatant we added spores (108/ml) to
HBSS, divided this suspension into three aliquots. and
carried out the following treatments. (1) The spores
were incubated for two minutes and immediately
removed and the supernatants filtered ("two minutes
incubation (washings)" in table 4). (2) The washed
spores were resuspended in HBSS and incubated for
three hours at 37 °C before the spores were spun out
to obtain the supernatant, which was filtered
("washed + three hours incubation"). (3) The spores
were incubated in HBSS for 3 hours and the super¬
natant removed then filtered ("three hours incu¬
bation").
CELL VIABILITY
To determine whether the spore diffusates were hav¬
ing a toxic effect on the cells, 5 x 10s cells were
incubated for two hours at 37°C in 1 ml of control
HBSS or spore diffusates (1:4 dilution). After this time
the percentage viability was determined by the trypan
blue (Gibco) exclusion method.
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EXPERIMENTAL DESIGN AND STATISTICAL
ANALYSIS
Each experiment was carried out in triplicate and per¬
formed on two to five separate occasions. For individ¬
ual experiments a different group of animals and
spores or spore diffusates prepared from fresh cultures
were used. Therefore day to day variation in sponta¬
neous release of reactive oxygen intermediates and
strength of diffusates did occur. The statistical analy¬
ses were designed to take into account this variation
between experiments and treatments so that the analy¬
ses of treatment effects would be independent of inter-
experimental variation. Initially the raw data were
subjected to analysis of variance with a randomised
block design in which each day experiment consti¬
tuted a block. Student's / tests were used to compare
treatment means, using the residual error obtained
from the analysis of variance.
Results
EFFECTS OF SPORES ON RELEASE OF SUPEROXIDE
ANION
C parvum stimulated mouse peritoneal exudate cells
released significantly less superoxide anion (p <
0 001) in response to spores of A fumigaius than in
response to zymosan or P ochrochloron (table 1). Both
zymosan and P ochrochloron were associated with a
release of superoxide anion that was significantly
greater than the spontaneous release by cells (p <
0 001). When the results from the individual spore:cell
ratios were combined. P ochrochloron was seen to
stimulate an increase in superoxide anion release of
about 50%, while zymosan, a potent trigger of super¬
oxide anion, stimulated a three fold increase.
EFFECTS OF SPORES ON RELEASE OF HYDROGEN
PEROXIDE
Both zymosan and P ochrochloron slightly reduced the
spontaneous release of hydrogen peroxide by C pur-
Table 1 Effect of opsonised zymosan and opsonised fungal
spores on the release of superoxide anion by peritoneal
exudate cells
Treatment Spore cell ratio
Superoxide anion
(nmol mean (SEM
HBSS* 12 89(1 20)
Zymosan — 41 6 (0 60»
A fumigaius 10 1 1206(020)
A fumigatus 50. 1 1107(0 45)
A fumigaius 100 1 11 09(0 84)
P ochrochloron 10: 1 1462(1 60)
P ochrochloron 50 1 20 12(1 23)
P ochrochloron 100 1 18 4 (1 70)
•Treatment with Hanks' balanced sail solution (HBSS) gives a
measure of the spontaneous release
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Table 2 Effect of opsomsed zymosan and opsonized fungal
spores on the release of hydrogen peroxide by peritoneal
exudate cells
Treatment Spore cell ratio
Hydrogen peroxide
(nmol mean iSEM'j
HBSS' 10 19(1 57)
Zvmosan — 9 53(1 53)
A fumigatus 10 1 8-63(1 41)
A fumigatus 25 1 6 80(0 35)
A fumigatus 50: 1 5 15(0 87)
P ochrochloron 10 1 8 63(1 18)
P ochrochloron 50 1 8 16(1 88)
•Treatment with Hanks' balanced salt solution (HBSS) gives a
measure of the spontaneous release
yum stimulated mouse peritoneal exudate cells
(table 2). A fumigatus produced a reduction of hydro¬
gen peroxide release and this effect was more pro¬
nounced with increasing sporexell ratios When the
results from the individual sporexell ratios were com¬
bined the release of hydrogen proxide was
significantly lower in response to A fumigatus (p <
0 001) than to zymosan or P ochrochloron.
EFFECTS OF SPORE D1FFUSATES ON RELEASE OF
REACTIVE OXYGEN INTERMEDIATES
To examine the possibility that A fumigatus may pro¬
duce a substance that has a direct effect on cellular
production of reactive oxygen intermediates, we mea¬
sured the effect of diffusates obtained from spores of
A fumigatus and P ochrochloron on the spontaneous
release of reactive oxygen intermediates from C par-
vum stimulated mouse peritoneal exudate cells.
Diffusates from A fumigatus greatly reduced (p <
0 001) the spontaneous release of superoxide anion
and hydrogen peroxide (table 3) while those from P
ochrochloron did not
Using bronchalveolar lavage cells obtained from
rats whose lungs had been treated with C parvum. we
found that this inhibitory effect was strikingly
dependent on the concentration of diffusate (fig I).
STUDIES OF THE DIFFUSATE FROM SPORES OF
A FUMIGATUS
(1) Viability studies established that the spore
diffusates were not having a toxic effect on the cells, as
the percentage viability of the cells after an incubation
period of two hours in spore diffusate was the same as
that found with control HBSS (>95% viable).
(2) To find out at what stage the diffusates were
released into the supernatant, we looked at the effect
of time on the diffusion, from spores of the factor that
inhibited reactive oxygen intermediates production.
Table 3 Effect of spore diffusates on the spontaneous




t nmol mean fSEM>t
Hxdrogen peroxide
tnmol mean SEW
HBSS' 14 38(0 26) 18 82(1 63)
A fumigatus
diffusates 6 73(0 43) 4 16(052)
P ochrochloron
diffusates 14 40(0 67) 19 43(2 25)
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Dilutions
Effect of increasing dilution of
spore diffusates of Aspergillus
fumigatus on the spontaneous
release of superoxide anion '02~ J
and hydrogen peroxide < H202 ) by
phorbol myristate acetate triggered
Corynebacterium parvum induced
rat bronchoalveolar lavage cells
(2-5 x JO5 cellsj when compared
with the cells alone (two hour
incubation period j: means with
standard deviations.
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Table 4 shows that washings (2 min incubation) from
the spores significantly reduced release of reactive
oxygen intermediates (p < 0 001) by Cparvum stimu¬
lated mouse peritoneal exudate cells. Therefore the
diffusate is released immediately the spores are put
into liquid. In addition, the spores, once washed, con¬
tinue to release the diffusate The longer the spores
were incubated the greater was the inhibitory capacity
of the diffusate.
(3) To examine whether the diffusate was affecting
production of reactive oxygen intermediates by the
phagocytic cell or scavenging the reactive oxygen
intermediates once produced, or both, we looked at
the effect of adding the diffusale at a 1:4 dilution to a
cell free superoxide anion generation system and to
hydrogen peroxide We found that the amount of
superoxide anion present after the addition of the
diffusates (5 84nmo!) was the same as that found after
the addition of control HBSS (5-86 nmol). The addi¬
tion of superoxide dismutase (which is used in the
conversion of superoxide anion to hydrogen per¬
oxide). however, removed the superoxide anion from
the system This result confirmed that the diffusate
does not scavenge superoxide anion as generated by
the xanthine oxidase acetaldehyde system Similarly,
we found that the diffusates did not scavenge hydro¬
gen peroxide The addition of control HBSS to a sys¬
tem containing hydrogen peroxide results in a linear
increase in absorbance at 610 nm (a measure of hydro¬
gen peroxide in the system) with increasing concen¬
tration of hydrogen peroxide (1-20 nmol) The addi¬
tion of the diffusate to the hydrogen peroxide resulted
in an increase in absorbance at 610 nm. the same as
that given with HBSS When catalase. an enzyme that
breaks down hydrogen peroxide, was added to the
system, however, no increase in absorbance at 610 nm
was obtained.
(4) The inhibitory effect of the diffusate on release of
reactive oxygen intermediates by Cparvum stimulated
mouse peritoneal exudate cells was removed by
dialysis (table 5). indicating that the molecular weight
of the active substance in the diffusate is less than
14000 daltons
Discasskw
The key role played by phagocytic cells in the eradi¬
cation of microorganisms is well documented 8 ,s"17
Several studies have, however, reported apparently
conflicting results concerning the interaction of
these cells with A fumigatus. Rabbit alveolar
macrophages'8 and human blood monocytes" have
been found to be capable of killing A fumigaius in
vitro Schaffner etal. who compared natural immu¬
nity to A fumigatus in vivo with the actions of phago¬
cytes against the organisms in vitro, suggested that
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Tabic 4 Eftet I of time on the diffusion from A funngatus
spore s of at liMts that inhibits the produi lion of supcrtmdi
anion and hydrogen peroxide hi peritoneal exudate cells
Treatment
Superoxtdi an it m
inmnl mean St W
H\ drogen piroxid-
nmol mean St.W
HBSS* 13 43 (0 421 ■c ■> <
2 min intubation
(washings i 6 93(0 25) K 6 (0 36.
washed spores -»
3 h incubation 5 13(0 IK) 4 43(0 14,
3 h incubation 4 ^7(0 15) 3 3 (0 06.
"Treatment with Hank- balanced vail solution (HBSSi goes a
measure of the spontaneous release
Table 5 Effect of diafins on the capatin of the diffusate
to inhibit the production of superoxide anion and hydrogen
peroxide
Superoxidi anion Hydrogen pero x idt
Treatment (nmol mean SEM t nmoi mean SEM
HBSS* 12 9Kt 1 381 21 3 (2 06.
Diffusates 5 65(0 57) 8 75(1 0">)
Diflusates incubated
4 C 1K h 9 95(1 28) 13 86(0 38)
Diffusates dialvsed
4 C IK h 13 76(1 69)+ 25 6 (1 82)+
"Treatment with Hanks' balanced salt solution (HBSSi gives a
measure of the spontaneous release
tp < 0 0001 for incubated versus dialvsed diffusale
monocytes may be concerned with killing spores while
polymorphonuclear leucocytes may be responsible for
the eradication of hyphae. apparently in the absence
of a specific immume response. Other workers, how¬
ever. have been unable to show either in vitro killing
of A fumigatus by human monocytes or poly¬
morphonuclear leucocytes2' or killing in vivo by
mouse or rabbit alveolar cells.2223 Nevertheless, the
potential importance of reactive oxygen inter¬
mediates. and of hydrogen peroxide in particular, in
the eradication of spores and hyphae has been
demonstrated with cell free systems of myelo-
peroxidase-hydrogen peroxide-halide24 and ferrous
iron-hydrogen peroxide-halide.23 both of which arc
capable of killing A fumigatus
Our study, using phagocytic cells from mice and
rats, shows that spores of A fumigatus fail to trigger an
increase in superoxide anion release while zymosan
and control spores of P ochrochloron trigger a sub¬
stantial increase This suggests that spores of A fumi¬
gaius are failing to trigger the primary component of
the "respiratory burst " The normal sequence of
events in the release of reactive oxygen intermediates
by phagocytic cells is the production of superoxide
anion, which can either spontaneously or with the
help of superoxide dismutase form hydrogen per¬
oxide 16 If. as we have found. A fumigatus does not
trigger an increased release of detectable amounts of
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superoxide anion 11 mighi be expected thai hydrogen
peroxide concentrations would also be low. unless
rapid dismutation of superoxide anion were occur¬
ring We have shown that spores of A f.umigaius. as
well as failing to trigger superoxide anion release, also
at a spore cell ratio of 25 I and above suppress hydro¬
gen peroxide production by comparison with either
spores of P ochrochioron or zymosan The responses
of stimulated peritoneal exudate cells to triggering by
zymosan with the release of increased amounts of
superoxide anion without an increase in the release of
hydrogen peroxide have been previously reported
both from this laboratory® and by others3" In gen¬
eral. the release of reactive oxygen intermediates in
response to spores of the control fungus P och¬
rochioron parallels the response to zymosan
We have previously noted that spores of A fumi-
goius become attached to phagocytic cells3" in vitro
and in vivo, it is therefore interesting that binding of
spores to the cell does not trigger release of reactive
oxygen intermediates The studies reported here
explain this to the extent that we have shown that the
spores release a substance that interferes with the
production of those oxidants, and that this substance
is released immediately the spores are put into sus¬
pension Furthermore, it continues to be released after
the spores have been washed and is of low (less than
14 000 daltons) molecular weight Thus the physical
interactions of spores of A fumigatus with the phago¬
cytic cells appear to produce an immediate respiratory
burst similar to that produced by cells alone The
enhanced production of superoxide anion seen in
respose to the controls P ochrochioron and zymosan
is. however, suppressed in response to release of the
diffusate by A fumigatus These findings are consistent
with our previous observations that, in vitro, a large
number of spores of A Jumigatus appear to remain
bound to the surface of phagocytic cells without
becoming fully ingested 31 This potential anti¬
phagocytic effect of A fumigatus has also recently been
described by Mullbacher rial2' who found that a
metabolite called gJiotoxin. isolated from three day
culture supernatants of A fumigatus. had an inhibitory
effect on the phagocytosis of carbon particles by
mouse peritoneal exudate cells The difference
between this gliotoxin and the diffusale described in
the present study is that the gliotoxin could not be
isolated until the spores had been in culture for at least
three days, at which time mycelial growth would be
abundant In contrast, the diffusate described here
diffuses from the respirable sized spores as soon as
they are put into suspension The quick release of the
diffusate from the spores suggests that it may be
located on or dose to the surface of the spore Possibly
the diffusate is the first mechanism by which the spore
reduces the efficiency of the phagocyte while the glio-
toxin. which is produced once germination has taker
place, may be a second line of anliphagocyte defence
used by A lumigaius to establish itself and remain
within the lung
Our findings may also be relevant to the results of
those studies thai have indicated that the resistance o!
some microorganisms to killing is inversely related io
the phagocytic cell's ability to release reactive oxygen
intermediates 3° 30 Nathan and Nakagawara'" have
postulated thai the pathogenicity of microorganism-
may. in general, be related to their possession of anti¬
oxidant defence and to their capacity to avoid trig¬
gering the release of reactive oxygen intermediates by
macrophages A fumigaius would appear from our
study to have evolved such mechanisms and this may
in pan be responsible for its pathogenicity to the iung-
of certain individuals Probably normal individuals
have sufficient resources within their host defence net¬
work to overcome and remove these spores At the
other end of the scale A fumigaius can overcome the
defective host defences of immunocompromised indi¬
viduals. resulting in invasive aspergillosis Perhap-
some patients with asthma lie in the middle of this
hypothetical scale, where the fungus, although con¬
trolled to a certain degree is not efficiently removed
and therefore remains within the lung thus enabling
it to provoke an immune response with the resultant
allergic reactions
We would like to thank Miss HPR Collins and Mr V.
McLaren for statistical assistance This work is sup¬
ported by a grant from the Asthma Research Council
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Resistance of spores of Aspergillus fumigatus to
ingestion by phagocytic cells
MAURA D ROBERTSON. ANTHONY SEATON. L J R MILNE. JARAEBURN
From the Institute of Occupational Medicine and the Western General Hospital, Edinburgh
abstract Phagocytic cells are believed to have an important role in the eradication of fungal
spores from the lung. The ability of human and mouse cells to phagocytose the opportunistic fungus
Aspergillus fumigatus has been examined, spores of the non-pathogenic fungus Penicillium ochro-
chloron being used for comparison. Most spores became associated with cells. Those of A fumigatus
appeared to remain bound to the surface of the phagocyte rather than being ingested; in contrast.
P ochrochlorort spores appeared to be phagocytosed more readily, although they also were seen, in
smaller numbers, on the cell surface. In view of the subjective nature of these observations, the
effects of spore diffusates on phagocytosis were examined. Diffusates from spores of A fumigatus
were shown to inhibit phagocytosis of antibody coated radiolabeled sheep red blood cells by
primed mouse phagocytic cells. Diffusates of spores of P ochrochloron had no such effect. These
results suggest that when spores of A fumigatus become bound to the surface of phagocytes they are
able to release a substance that inhibits their ingestion while having little or no effect on surface
binding.
Inhalation of spores of the opportunistic fungus
Aspergillus fumigatus may lead to allergic disease in
man1 and in the immunosuppressed may cause life
threatening infection.2 While phagocytic cells are
clearly important in host defences against invading
microorganisms,3"5 their precise role in the killing of
A fumigatus remains undefined.6-" Phagocytosis is
often an important step in the killing of micro¬
organisms. and this has generally been assumed to be
the case with inhaled fungal spores. In one study,
however, no evidence of phagosome-lysosome fusion
was found in relation to phagocytosis of A fumi¬
gatus,'1 and recent studies from our laboratories have
shown that this organism is able to produce a
diffusate that significantly inhibits the respiratory
burst of phagocytic cells.13 A fumigatus spores more¬
over, as we have suggested in a preliminary report,
may be particularly resistant to phagocytosis.14
The process of phagocytosis can be divided into
two phases: (1) attachment of the particle to the cell
surface, followed by (2) ingestion. Steps I and 2 are
collectively referred to as cell association. Only when
a particle has undergone step 2 can it be said to be
Address for reprinl requests: Mrs M D Robertson, institute of
Occupational Medicine. 8 Roxburgh Place. Edinburgh eh8 9su.
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phagocytosed. Nevertheless, the term phagocytosis is
often used synonymously with cell association,
implying that the particle is phagocytosed when the
techniques used are unable to distinguish clearly
between attached and ingested particles. In this paper
we report further studies of the interactions between
spores of A fumigatus and phagocytic cells, w ith par¬
ticular reference to the two phases of the phagocytic
process.
Methods
The study was designed to assess, by light and elec¬
tron microscopy, the ability of phagocytic cells to
ingest spores of A fumigatus and. for comparison. P
ochrochhron. Since this assessment is necessarily sub¬
jective, a well established method of assessing the
number of ingested labelled sheep red blood cells
accurately has been used to investigate the effects of
diffusates of these spores on the phagocytic process.
phagocytic cells and sera
Human monocytes and polymorphonuclear leuco¬
cytes were isolated from the peripheral blood of six
healthy donors by density gradient centrifugation."
Autologous serum was obtained from a clotted blood
sample at the same time. Serum containing specific
antibody to A fumigatus was obtained from a patient
466
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with an aspergilloma, and this, produced about 10
precipitin lines when tested against a standard A fumi¬
gatus antigen preparation (Bencard Allergy Division).
Peritoneal exudate cells were harvested from 12
week old syngeneic C57BL6 mice by lavaging the
peritoneal cavity with isotonic saline. The mice were
pretreated by intraperitoneal injection of either 3%
thioglycollate broth (0-5 ml. Difco Products) four
days before harvesting or Corynebacterium parvum,
0-2 ml of 7 mg ml (Wellcome Biotechnology Limited)
five days before harvesting.
FUNGAL SPORES AND DIFFUSATES
The method used was that described previously.13
with the slight modification that after opsonisation
spores of A fumigatus and P ochrochloron were used
directly in the assays, suspended in RPMI-1640-5%
serum.
ESTIMATION OF CELL ASSOCIATION OF FUNGAL
SPORES IN VITRO
Fifty microlitres of human phagocytic cells (1 x
Iff/ml in RPM 1-5% autologous serum) were added
to microtitre plates. At the same time control wells
containing 50 p\ of RPM 1-5% serum alone were set
up To all wells 100 p\ of opsonised spores (5 x
I0fc/ml in RPM 1-5% serum) were added to give a
final spore:phagocylic cell ratio of 2:1 or 1:1. To
accelerate the contact process between spores and
cells microtitre plates were centrifuged at 125 g for
five minutes, then incubated at 37'C for one hour.
After gentle mixing to resuspend sedimented spores,
an aliquot of supernatant was removed and the num¬
ber of free spores present was counted with an
improved Neubauer counting chamber. Total spores
were estimated from the number of spores in the
supernatant of the control wells containing spores
alone; this was used as a baseline to determine the
percentage of spores becoming cell associated, the fol¬
lowing formula being used:
% of spores cell associaied =
total spores - spores oon-crll associated \
total spores "
All experiments were carried out in triplicate.
MICROSCOPY OF CEL L-SPOR E PRE P A R ATIONS
Phagocytic cells (200 p\ of 5 x 106/ml in RPM 1-5%
autologous serum) were allowed to adhere to glass
microchamber slides (LAB-TEK) or glass coverslips
(13 mm diameter) for one hour at 37°C in 5% carbon
dioxide. The coverslips were then gently rinsed twice
in warm Hanks' balanced salt solution (HBSS) to
remove non-adherent cells. Opsonised spores in
RPM 1-5% autologous serum were added to the
adherent phagocytic cells at a spore:cell ratio of
2:1-1:1 and the cultures incubated at 37GC in 5% car-
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bon dioxide for 1-5 hours. After this period excess
spores were removed by gently washing the cultures in
warm HBSS three times. The slides were fixed in
methanol and stained in May-Grunwald-Giemsa.
The coverslips were processed for scanning electron
microscopy17 by fixing at 37 C for 30 minutes in
2-5% glutaraldehyde (Sigma) in 01 mol 1 cacodylate
buffer containing 0 1 mol I sucrose (Sigma) followed
by two rinses in the buffer. The coverslips were then
dehydrated in graded series of acetone-water mixtures
and critically point dried with liquid carbon dioxide.
This method was used because lighl microscopy does
not differentiate between spores that have been
phagocytosed and those that remain on the surface of
phagocytes.
PHAGOCYTOSIS OF FUNGAL SPORES IN VIVO
C57B1.6 mice that had received an intraperitoneal
injection of 3% thioglycollate (0 5 ml) four days pre¬
viously were challenged inlraperitoneally with 10"
spores in 0 5 ml HBSS After I 5 hours the peritoneal
cavities were lavaged with 5 ml of HBSS; the lavaged
cell population with attached or ingested spores was
allowed to adhere to coverslips for one hour at 37 C
and was then prepared for light and scanning electron
microscopy.
PHAGOCYTOSIS OF R A DIOL A BEL LED ANTIBODY
COATED SHEEP RED BLOOD CELLS
The method was based on that described by Shaw and
Griffin.18 Sheep red blood cells in Alsever's solution
(Tissue Culture Service) were washed three times in
phosphate buffered saline (PBS). The washed packed
sheep red blood cells were radiolabeled by incubation
in 51Cr Na2 Cr04 (10s sheep red blood cells 100 pC\
!1Cr) (Amersham International) for one hour at
37"'C. The MCr labelled sheep red blood cells were
washed once in PBS and adjusted to 10" MCR
labelled sheep red blood cells/ml. This suspension was
then divided into two aliquots and the following were
added: (1) an irrelevant antibody, mouse immu¬
noglobulin (IgG) (Sigma) at 10 /ig 10" sheep red
blood cells and (2) monoclonal antibody to sheep red
blood cells (mouse lgG anti-sheep red blood cells
(Sera Laboratories) at 10 p% 107 sheep red blood
cells). These mixtures were incubated for 15 minutes
at 37"C then washed twice in ice cold PBS The anti¬
body coated 51Cr sheep red blood cells were then sus¬
pended in RPM 1-20% heat inactivated fetal calf
serum at a concentration of 4 x 107/ml C parvum
stimulated mouse peritoneal exudate cells were added
to flat-bottomed Removawells (Dynatech) at a con¬
centration of 2 x 105/well in 100 /al of RPM 1-10%
heat inactivated fetal calf serum. The cells were left to
adhere for three hours at 37°C in 5% carbon dioxide,
and then washed twice in warm HBSS. The experi-
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menl consisted of five separate treatments To the
adherent mouse peritoneal exudate cells 50 p] of one
of the following treatments was added: (1) HBSS plus
50 p\ of 51Cr labelled sheep red blood cells that had
been opsonised in mouse IgG; (2) HBSS alone; (3) A
fumigatus diffusate; (4) P ochrochloron diffusate: (5) a
known inhibitor of phagocytosis—cytochalasin B at
25 jig'ml (Sigma) To treatments 2-5 50 p\ of 5lCr
labelled sheep red blood cells opsonised in mouse IgG
anti-sheep red blood cells was added The
Removawells were centrifuged for five minutes at 125
g, then incubated at 37CC in 5% carbon dioxide for
1-5 hours. The supernatant was removed and 100 pA
of ice cold red cell lytic buffer (to lysc non-
phagocytosed sheep red blood cells) was added After
five minutes the lytic buffer was removed and the cells
were washed three times in cold PBS The
Removawells containing cells with phagocytosed
51Cr labelled sheep red blood cells were counted in a
gamma counter (LKB-Rack Gamma IT). For each
experiment five replicates were performed
STATISTICAL ANALYSES
The results of the cell association of the fungal spores
were analysed by a three way analysis of variance, the
data having been transformed on a logistic scale:
. / % cell associated \
\J00 — % cell associatedJ'
For the sheep red blood cells phagocytosis experi¬
ments a two way analysis of variance was used on the
log transformed data. Student's / tests were used to
assess the statistical significance of treatment con¬
trasts, estimates of residual error being obtained from
the analyses of variance.
Results
ASSOCIATION OF FUNGAL SPORES AND HUMAN
PHAGOCYTIC CELLS
Most (> 77%) of the opsonised spores of both A
fumigatus and P ochrochloron became cell associated
with both monocytes and polymorphonuclear cells
after incubation in vitro for one hour at 37CC (table
1). No significant differences were found between
Table 1 Percentage ofopsonised spores that became cell
associated after one hour in vitro (means (SEM) ofresults
from the six donorsJ
% ofcell
Fungal spores Cell type associated spores
Aspergillus fumigalus Monocyte 87 8 (3 2)
A fumigatus Polymorphonuclear 80 4 (9 5)
Penicillium ochrochloron Monocyte 80 7 (4 7)
P ochrochloron Polymorphonuclear 77 5(6 4)
spore or cell type. Examination by light microscopy
of slide preparations of the cell-spore interactions also
confirmed that a substantial number of spores had
become cell associated It was not possible, however,
to distinguish between attached and ingested cells by
means of light microscopy
SCANNING ELECTRON MICROSCOPY OF U NGAI
SPORES AND HUMAN PHAGOCYTIC CELLS
Scanning electron microscopy shows fungal spores as
small rounded bodies closely associated with the
phagocytic cell membrane The degree to which the
spore has become cell associated has been arbitrarily
divided into three phases: (1) attached—spore lying
on the cell surface: (2) partially ingested—the cyto¬
plasm of the cell enclosing the spore yet not fully cov¬
ering it: and (3) ingested—the outline of the spore
being seen under the cytoplasm of the cell.
IB)
Fig 1 Scanning electron micrographs of the interaction
after 15 hours in vitro between spores ofAspergillus
fumigatus and (A) a human monocyte and B a human
polymorphonuclear cell a—attached spore: p—partially
ingested spore.
Resistance ofspores of Asperigillus fumigalus to ingestion by phagocytic cells
With scanning electron microscopy a substantial
number of spores of A fumigalus were found to be
attached to the surface of the phagocytic cell and not
internalised after incubation at 37 C for 1-5 hours (fig
1). Although spores of P ochrochlnron were present
on the surface of the cell they appeared to be less
numerous. Opsonisation of the fungal spores in sera
containing specific antibody to A fumigatus did not
appear to alter this finding
CELL ASSOCIATION OF SPORES WITH MOUSE
PHAGOCYTIC CELLS
A mouse model was used to examine whether the
finding obtained by in vitro experimentation could be
repeated in vivo. We initially examined the inter¬
action in vitro of opsonised fungal spores with thio-
glycoliate elicited mouse peritoneal exudate cells and
found that this gave results similar to those obtained
with human phagocytes (fig 2). In vivo experiments,
in which spores were injected into the peritoneal cav¬
ity of the mouse followed with lavage I -5 hours later,
once again gave a similar result. A substantial number
of A fumigatus spores were seen to be bound to the
surface of the cells in vivo, while spores of P ochro-
chloron were in general becoming ingested (fig 3).
PHAGOCYTOSIS OF ANTIBODY COATED 51Cr
LABELLED SHEEP RED BLOOD CELLS BY MOUSE
PHAGOCYTES
We measured the effect of spore diffusates of A fumi¬
gatus and P ochrochloron on the phagocytosis by C
parvum stimulated mouse peritoneal exudate cells of
antibody coated 5lCr labelled sheep red blood cells.
This technique has the advantage that all extracellular
(non-ingested) sheep red blood cells, including those
attached to the cell surface, may be removed by lysis
with red blood cell lytic buffer, thereby enabling an
accurate measurement of phagocytosis to be made.
There was significantly more phagocytosis (p <
0 0005) of the specific anti-sheep red blood cells
coated cells than of those coated with irrelevant
mouse IgG (table 2). This result established the valid¬
ity of the technique. The "Cr labelled sheep red
blood cells coated in specific anti-sheep red blood
cells antibody were used to assess the effects of the
spore diffusate. Diffusates of A fumigatus inhibited
phagocytosis by about 63% (p < 0 0025) while spore
diffusates of P ochrochloron had no significant effect
(table 2). As a positive control we included in the
assay 1-25 pg of cytochalasin B, a known inhibitor of
phagocytosis; this inhibited the phagocytosis of
specific anti-sheep red blood cells coated labelled
sheep red blood cells by 44% (p < 0 005).
Discussion
An intriguing aspect of the biological behaviour of A
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Fig 2 Scanning electron micrographs of the interaction in
vitro for 1 5 hours ofmouse peritoneal exudate cells and (A )
spores ofAspergillus fumigatus and IB] spores of
Penicillium ochrochloron. a—attached spore, p—partially
ingested spore; i—fully ingested spore.
fumigatus is its ability to colonise the human bron¬
chopulmonary system under certain circumstances.
This has allowed it to become an important pathogen
in immunosuppressed patients.2 a cause of severe
postinfluenzal lung infection," and a coloniser of
lung cavities,20 as well as provoking asthma and aller¬
gic bronchopulmonary aspergillosis in some people.
This association with such a range of diseases makes
it unique among fungi pathogenic to man.
Some years ago it was found that A fumigatus could
be isolated from postmortem human lung more fre¬
quently than would have been anticipated from the
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Fig 3 Scanning electron micrographs of the interaction in vivo for 15 hours ofmouse peritoneal exudate cells and 'A and B
spores ofAspergillus fumigatus and IC and D) spores of Penicillium ochrochloron. a—attached spore, p—partially ingested
spore; i—fully ingested spore.
prevalence of its spores in the air.21 This led to the
suggestion that it might have a specific ability to resist
the natural defences of the lung: its small spore size
and optimal temperature for germination (37rC) were
other factors considered likely to be important. This
led us to study the interactions of spores with phago-
Table 2 Effect of spore diffusates on the phagocytosis of
antibody coated radtolabelled sheep red blood cells t"Cr







HBSS Mouse IgG 87 I (10 04)
HBSS Anti-srbc 440 5(36 6)
Aspergillus fumigatus
diffusate Anti-srbc 161 8 (29 4)
Penicilhum ochrochloron
diffusaie Anti-srbc 408 3 (516)
Cylochalasin B Anti-srbc 247 8 (34 2)
HBSS—Hanks' balanced salt solution
cytic cells in vitro. In a recent publication13 we
showed that spores of A fumigatus produce a difTusate
containing a low molecular weight factor that inhibits
the respiratory burst of neutrophils and macro¬
phages. This factor is given off by the spores after
only brief incubation, in contrast to another
inhibitory substance, named gliotoxin. shown by
others to inhibit phagocytosis by mouse peritoneal
exudate cells.22 Since gliotoxin is produced only after
three days' incubation of A fumigatus. by which time
mycelial growth would be profuse, it is probably a
mycelial rather than a spore derived product.
Our finding that A fumigatus spore products
inhibited the respiratory burst of phagocytic cells led
us to consider another important leucocyte function,
the process of phagocytosis. In this paper we have
shown that the spores of A fumigatus are relatively
resistant to phagocytosis by human and mouse
phagocytes. Initial studies, using light microscopy,
did not allow differentiation of ingested and surface
bound spores. Scanning electron microscopy did
Resistance of spares of Aspcrigillus fumigatus to ingestion by phagocytic cells
show thai a high proportion of spores of A fumigatus
(and a lower proportion of spores of P ochrochloron)
were not taken into the cell but remained bound to
the surface This remained true when cells first
encounterd spores in vivo in mice Attempts were
made to quantify this, by means of enzyme stripping
techniques: but it proved very difficult to remove
spores from cell surfaces. Further efforts, using trans¬
mission electron microscopy, also failed as it proved
impossible to differentiate between ingested spores
and those sectioned between folds of the phagocyte
surface membrane In view of these difficulties in
quantifying the effect, we used a reliable assay of
phagocy tosis, the ingestion of radiolabeled sheep red
blood cells coated with antibody. This allowed lysis of
any surface associated red blood cells and assay of the
numbers actually ingested Diffusates of A fumigatus.
unlike those of P ochrochloron. significantly inhibited
phagocytosis, thus confirming our microscopical
observations This may be the explanation of the
findings of Lehrer and Jan.23 who showed that appar¬
ently "phagocytosed" spores (as judged by light
microscopy ) were nevertheless resistant to killing
There is thus convincing evidence that A fumigatus
spores produce one or more substances that readily
diffuse from the spore surface and have an inhibitory
effect on phagocytosis. Similar mechanisms by which
potential pathogens may evade phagocytosis have
been shown to be important to the pathogenicity of
other microorganisms.24 25 It has been suggested that
evasion of phagocytosis may be a principal method
by w hich microorganisms escape macrophage defence
function.26 The capacity of A fumigatus to resist
phagocytosis may be an important factor con¬
tributing to its pathogenicity, and further studies are
now taking place to characterise the diffusate and to
examine other aspects of its effects on phagocytic cell
function
The authors would like to thank Mrs K Niven for
operating the scanning electron microscope. Mrs D
Lyster for printing the photographs, and Mr W Mac-
laren for the statistical analyses This work is sup¬
ported by the Asthma Research Council
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Previous studies have shown that spores of Aspergillus fumigatus
inhibit phagocytosis and killing by macrophages and polymorphonuclear
leucocytes. In order to identify the mechanisms of this interference
with host defences, we have examined the effects of A. fumigatus spore
diffusates on phagocytic cell function. For comparison, we have used
spore diffusates of the non-pathogenic fungus Penicillium ochrochloron.
The diffusates of A. fumigatus reduced the number of human
polymorphonuclear leukocytes migrating towards a known chemoattractant
by approximately 50% (p<0.001). In addition spore diffusates of A.
fumigatus significantly decreased (p<0.001) the capacity of primed
mouse peritoneal exudate cells to spread on glass. Spore diffusates
of JP. ochrochloron showed no comparable inhibitory effects. These
studies have shown that spore diffusates of A. fumigatus inhibit the
movement of the phagocytic cell membrane and are thus able to
interfere with a primary function of phagocytic cells.
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INTRODUCTION
Inhalation of spores of the opportunistic fungus Aspergillus fumigatus
may cause allergic disease in man (17) and may in the immunosuppressed
person lead to life-threatening lung infection (29). The mechanisms
by which this fungus persists in the lung and causes disease in
certain individuals is still unclear. It has been suggested that
spores of A. fumigatus may be particularly resistant to the actions of
the host defence network (20). Phagocytic cells are a primary
component of this network, playing an essential role in the
eradication of microorganisms (11,14). Previous studies have shown
that spores of A. fumigatus are relatively resistant to the actions of
phagocytic cells (15,16,25). In addition, we have shown that spores
of A. fumigatus release a substance which interferes with important
microbicidal functions of phagocytic cells (23,24). As the
microbicidal capacity of phagocytic cells is related to their state of
functional activation (1,21), we have, in this study, looked at the
effect of spore diffusates from A_^ fumigatus on two aspects of
phagocytic cell activation: chemotaxis and spreading. For





Human polymorphonuclear leukocytes (PMN) were isolated from the
peripheral blood of three healthy donors by density gradient
centrifugation (9). The cell populations used comprised >96% PMN
with a >95% viability by trypan blue exclusion.
Peritoneal exudate cells (PEC) were harvested from twelve-week old
syngeneic C57B1/6 mice by lavaging the peritoneal cavity with isotonic
saline. The mice were pretreated with intraperitoneal injection of
Corynebacterium parvum (1.4mg, Wellcome Biotechnology Ltd.), seven
days prior to harvesting. This procedure has been shown to increase
Q
the ability of phagocytic cells to spread on glass.
Fungal spores and diffusates
The strain of _A. fumigatus was an isolate obtained from the sputum of
a patient with allergic bronchopulmonary aspergillosis. The strain
of P. ochrochloron was IMI 61271. Spores of _A. fumigatus and
.P. ochrochloron were obtained from cultures which had been grown for
seven days at 29°C on malt agar. Spore suspensions containing only
single, unclumped spores were prepared by gentle homogenisation in
Hanks' balanced salt solution (HBSS) followed by filtration through
nylon mesh to remove mycelial fragments and chains of spores. Spore
counts were performed using improved Neubauer chambers. To obtain
diffusates, spores were incubated at a concentration of 10®/ml in HBSS
at 37°C for up to three hours. No visible evidence of germination
was present at this time. The spores were removed from the HBSS by
centrifugation and the soluble diffusates in the supernatant were
passed through 0.22|om sterile filters.
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Chemotaxis
In the chemotaxis experiments the basic procedure described by
Snyderman (26) for blindwell chambers was followed except that PMN
were used. The chemoattractant used was zymosan activated serum
which results in the generation of the potent leucotactic factor C5a.
Zymosan activated serum (ZAS) was prepared by incubating zymosan
(Sigma) with pooled human serum (lmg/ml) for 30 minutes at 37°C. The
zymosan was removed from the serum by centrifuging at 500g for 15
minutes and the serum then heated at 56°C for 30 minutes. Two
hundred microlitres of the chemoattractant (5% ZAS in RPMI-1640), were
placed in the lower compartment which was separated from the top
compartment by a 3)-im millipore filter. Prior to adding the cells
(200M1 of 3x10^ human PMN per ml of RPMI-20mm Hepes-2% bovine serum
albumin) to the top compartment, the following solutions (200pil) were
added (i) HBSS, or (ii) A. fumgatus diffusate, or (iii) ochrochloron
diffusate. For the experiments on random migration, additional treatments
were included, in order to determine the chemoattractant properties of the
spore diffusates. Instead of ZAS, 200|il of HBSS or 200p1 of A. fumigatus
diffusate was added to the lower compartment followed by 200^1 of HBSS or
200pil of A. fumigatus diffusate to the top compartment. The chambers were
incubated in a humidified incubator containing 5% CO2 for 45 minutes at
37°C by which time a reasonable number of cells have migrated. The
filters were then washed and stained and the number of migrated cells, per
five high power fields (magnification x 1000), were counted. All tests
were carried out in duplicate.
Macrophage spreading assay
Phagocytic cells, stimulated in vivo with _C. parvum were used as
indicator cells, as they have been shown to demonstrate increased
spreading on glass. Fifty microlitres of the following solutions
were added to 6 x 22mm glass coverslips: (a) control HBSS, or (b) A.
fumigatus diffusate, or (c) 1?. ochrochloron diffusate. To each of
these coverslips was added 50JJ.1 of 1x10^ (2. parvum stimulated mouse
PEC contained in RPMI-1640 with 20% fetal calf serum which had been
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heat inactivated at 56°C for 30 minutes. The coverslips were then
treated according to the method of Donaldson et al (8). This
involved incubating the treated coverslips for 1 hour at 37°C. The
cells in the coverslips were then washed in saline, fixed in methanol
and stained by Giemsa's stain. The coverslips were then mounted,
cell side down, onto glass microscope slides. Using a microscope
attached to a microcomputer-assisted digitising system, the greatest
diameters of 200 cells were measured. All tests were carried out in
triplicate.
Cell viability
Trypan blue exclusion was used to assess the viability of the cells
following incubation with the spore diffusates under the experimental
conditions.
Statistical analysis
The results were analysed using a two-way analysis of variance.
Student's 't'-tests were used to assess the statistical significanceof
differences in treatment means.
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RESULTS
Effect of spore diffusates on chemotaxis of PMN
Spore diffusates of A. fumigatus inhibited the number of cells
migrating towards the chemoattractant ZAS by approximately 46%
(p<0.001). Spore diffusates of _P. ochrochloron had no inhibitory
effect on the migration of the cells (Table 1). Further experiments
which involved measuring the random migration of the cells in HBSS
alone versus A. fumigatus diffusates in the lower compartment
(Table 2) confirmed that the spore diffusates of A. fumigatus were not
acting as a chemoattractant. A comparison of the effect of eight
different preparations of _A. fumigatus diffusate from isolates of the
same strain on the chemotaxis of human PMN towards the known
chemoattractant, ZAS, showed that this inhibitory activity was
reproducible (p<0.001) (Table 3).
Effect of spore diffusates on phagocytic cell spreading
Spore diffusates of _A. fumigatus were seen to inhibit the spreading of
C. parvum stimulated mouse PEC when compared with control HBSS and
with spore diffusates of _P. ochrochloron (see Figure). Measurement
of the mean diameters of the cells showed that those cells treated
with A. fumigatus diffusate were substantially smaller, by
approximately 54%, than those with control HBSS (Table 4). The
differences between cells treated with _A. fumigatus diffusate and the
controls were significant (both p<0.001).
Effect of spore diffusates on cell viability
The viability of the phagocytic cells incubated with the spore
diffusate was the same as that found after incubation in HBSS (>95%
viable) indicating that the spore diffusate was not cytotoxic. The
pH of the diffusate was 7.1 (the same as the HBSS).
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DISCUSSION
When phagocytic cells come into contact with microorganisms they
respond by undergoing a series of reactions which are collectively
referred to as activation (7). This process may include
phagocytosis (27), the release of reactive oxygen intermediates (3), and
secretion of other soluble mediators including substances which
attract other cells to the active site (10,31). Previous studies in
our laboratories have shown that spores of A. fumigatus are relatively
resistant to phagocytosis (22) and that they fail to trigger the
release, by phagocytic cells, of the potentially microbicidal reactive
oxygen intermediates (23). Moreover, spore diffusates of A.
fumigatus inhibit the phagocytosis of antibody-coated, radiolabe1led
sheep red blood cells and suppress the spontaneous release of reactive
oxygen intermediates by _C. parvum-stimulated mouse phagocytic
cells (23,24). Thus it appears that A. fumigatus spores release a
diffusable substance that has several effects of considerable
biological importance in ensuring their survival in the lung and
therefore enhancing their pathogenic potential. Preliminary
investigations have already shown that the spore diffusate is released
immediately spores are place in aqueous solution. This suggests that
it is a constituent present on or close to the surface of the spore
rather than a metabolite which is produced as a result of germination.
The inhibitory factor is dialysable and so has a molecular weight of
less than 14,000 daltons (23). It has a dose-dependent effect on the
inhibition of reactive oxygen intermediates by phagocytic cells (23).
The precise biochemical nature of this soluble diffusate is currently
under investigation. We have now attempted to pinpoint the effector
mechanism of the spore diffusate by examining its effect on cell
movement - a fundamental aspect of phagocytic cell activation. In
order for a phagocytic cell to become activated thereby enhancing its
phagocytic ability, a rearrangement of the cell membrane must occur
(12,32). This involves a complex process which requires a
coordinated interaction of the plasma membrane with contractile
elements in the cytoplasm (13,28). The changes are reflected in an
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enhanced ability of the cell to spread over a surface and to migrate
in response to chemical stimuli. Such functions are readily measured
in vitro, and we have been able to show that both are inhibited by the
diffusate of A. fumigatus spores. In contrast, spore diffusates of P_.
ochrochloron had no effect. Futher work confirmed that the spore
diffusate of A. fumigatus was not acting as a chemoattractant.
It therefore seems likely that spores of A. fumigatus are able to
resist attack by phagocytes by interfering with a fundamental aspect
of phagocytic cell activation thereby having both an inhibitory effect
on phagocytosis and by affecting the movement of other accessory cells
which may be recruited to the site as part of the host defence
antimicrobial network (4). Our previous work has shown, however,
that spores do become attached to the surface of phagocytes, both in
vivo and in vitro (22,23) and it is probable that the inhibitory
effects are only partially effective in preventing removal and killing
of the spores. Indeed it is clear from clinical experience that
phagocytes play an important part in preventing invasive aspergillosis
in that this disease occurs particularly in patients with acute
leukaemia and chronic granulomatous disease (2,6). The results of
other in vitro studies have shown that the supernatants of 3-day old
cultures of A^ fumigatus possess substances which interfere with the
functions of immunocompetent cells (5,19), whilst 7-day old cultures
interfere with the opsonic properties of complement (30). The
important difference between our results and those of other workers
(5,19,30) is that the inhibitory effect is produced by a substance
obtained from freshly released spores which are the elements that
first encounter the host defences.
Several questions remain to be answered with respect to the
pathogenicity of A. fumigatus. What is the precise nature of the
diffusate and how does it affect phagocytic cell membranes? As
A. fumigatus is so successful in resisting host defences, why is it
not more frequently a cause of lung disease since its spores are
inhaled by all individuals throughout the year? Why is it able to
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thrive in asthmatic, as opposed to bronchitic, airways? What are the
effects of corticosteroids in predisposing patients to develop
invasive disease? In view of the interactions between macrophages
and lymphocytes in normal host defence and the occasional occurrence
of invasive aspergillosis in patients after influenza (18), what role
do lymphocytes play in the elimination of the organism? The answers
to these questions may have implications for future management of
opportunistic infections and allergic bronchopulmonary aspergillosis.
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TABLE 1
The effect of spore diffusates on the migration
of human PMN towards zymosan activated serum
Experiment Treatment
HBSS " A. fumigatus P. ochrochloron
control diffusate diffusate
1 68.5 (4.8) 32.6 (3.4) 68.4 (6.0)
2 62.9 (1.2) 36.2 (4.8) 62.6 (0.0)
3 83.3 (7.6) 46.2 (0.0) ND
Results of three separate experiments expressed as the mean (SD) of
the number of cells migrated per 5 high power fields
Hanks' balanced salt solution
ND = not done
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TABLE 2
Effect of A. fumigatus diffusates on
random migration of human PMN cells
Treatment No. of cells migrated
Top compartment Lower compartment per 5 high power fields









Results expressed as the mean (SEM) of two experiments
Hanks' balanced salt solution
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TABLE 3
The effect of 8 different preparations of A., fumigatus diffusate















The effect of spore diffusates on the spreading of
C. parvum-stimulated mouse peritoneal exudate cells
Cell diameter Percentage
Treatment Mean (SD) inhibition of spreading
*HBSS control 20.2 (2.9) -
A. fumigatus 9.2 (0.5) 45. 5
diffusate
P. ochrochloron 19.3 (2.6) 4. 5
dif fusate
Results given are the mean (SD) of three separate experiments




The effect of spore diffusates on the spreading of
parvum-stimulated mouse peritoneal exudate cells.
(a) Hanks' balanced salt solution (control)
(b) A. fumigatus diffusate
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